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Abstract 
Phosphorylation and dephosphorylation of proteins and lipids are the major 
post-translational modifications involved in virtually all molecular signaling pathways 
in the cell and are catalyzed by kinases and phosphatases respectively. Abnormal 
variation in kinase and phosphatase activity leads to the development of several 
human diseases. Phosphatase of regenerating liver (PRL)-3 is a dual specificity 
phosphatase that has been related to cell proliferation, migration, invasion, and 
epithelial to mesenchymal transition. Interestingly, while PRL-3 is aberrantly 
overexpressed in primary and metastatic tumors, it is barely expressed at all in healthy 
human tissue. Therefore, PRL-3 represents a promising therapeutic target in cancer 
treatment and an emerging prognostic marker for tumor progression. However, 
finding robust PRL-3 substrate candidates remains a challenge in the field. The aim of 
the present work is to gain insight in both the cellular and molecular pathways where 
PRL-3 is involved.  
The first part of this project is focused on the characterization of the role of 
PRL-3 in epithelial cell polarity using organotypic 3D-culture systems. We show that 
overexpression of PRL-3 disrupts epithelial architecture by promoting the 
development of cysts with ectopic lumens that arise from mispositioned midbodies. 
Furthermore, we propose a novel cellular mechanism where midbodies are retained in 
the lateral membrane due to acceleration of cytokinesis driven by PRL-3 
overexpression. 
The second part of the work deals with investigating PRL-3 PI(4,5)P2 
phosphatase activity in cells, which was previously established in vitro. Here, we 
demonstrate this activity in vivo with a novel technique developed for this purpose. 
Moreover, we prove that the low phosphoinositide phosphatase activity of PRL-3 and 
its specific interaction with PI(4,5)P2 are essential for enhancing clathrin-mediated 
internalization. 
In conclusion, we show that PRL-3 overexpression disrupts epithelial cell 
polarization probably by accelerating cytokinesis, and we demonstrate that it is a 
phosphoinositide phosphatase, increasing clathrin-dependent endocytosis. 
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Zusammenfassung 
Phosphorylierung und Dephosphorylierung von Proteinen und Lipiden sind die 
häufigsten posttranslationalen Modifikationen, die in allen molekularen Signalwegen 
der Zelle involviert sind und durch Kinasen beziehungsweise Phosphatasen katalysiert 
werden. Eine Fehlfunktion der Kinase- oder Phosphataseaktivität kann zur 
Entwicklung verschiedenster Krankheiten führen. Die „Phosphatase of regenerating 
liver“ PRL-3 ist eine doppelspezifische Phosphatase, die mit Metastasierung sowie den 
zu Grunde liegenden Prozessen wie Zellvermehrung, Migration, Invasion und dem 
Übergang von Epithel- zu Mesenchymgewebe in Verbindung gebracht wird. 
Während PRL-3 in primären Tumoren und Metastasen überexprimiert wird, ist die 
Expression im gesunden menschlichen Gewebe kaum nachweisbar. Daher 
repräsentiert PRL-3 einen vielversprechenden therapeutischen Ansatzpunkt in der 
Krebstherapie und dient als Marker zur Erkennung von Tumorprogression. Die 
Erforschung von bisher weitestgehend unbekannten PRL-3 Substraten ist jedoch noch 
immer im Fokus der aktuellen Forschung in diesem Bereich. Das Ziel der 
vorliegenden Arbeit ist es daher, weitere Einblicke in die Funktion von PRL-3 
hinsichtlich zellbiologischer sowie molekularer Signalwege zu gewinnen. 
Im ersten Teil des Projekts wird die Rolle von PRL-3 in der Polarität von 
Epithelzellen mit der Verwendung von Organ-repräsentierenden 3D Kultursystemen 
charakterisiert. Wir zeigen, dass eine Überexpression von PRL-3 die 
Epithelarchitektur der Zelle zerstört: So weisen die sich im 3D System entwickelnden 
Zysten, ausgehend von falsch lokalisierten Midbodies, ekotopische Lumen auf. 
Desweiteren demonstrieren wir einen neuen zellulären Mechanismus, bei welchem es, 
ausgelöst durch PRL-3 Überexpression, zu einer Beschleunigung der Zytokinese und 
einer daraus resultierender Ansammlung von Midbodies in der lateralen 
Zellmembran kommt. 
Der zweite Teil der Arbeit befasst sich mit der Erforschung der PRL-3 PI(4,5)P2 
Phosphatase Aktivität innerhalb von Zellen, die zuvor bereits in vitro gezeigt werden 
konnte. Mit der Verwendung einer neuen, speziell für diesen Zweck entwickelten 
Technik ist es uns möglich die Dephosphorylierung auch in vivo zu demonstrieren. 
Außerdem können wir nachweisen, dass sowohl die niedrige Phosphoinositid 
Phosphatase Aktivität von PRL-3 als auch die spezifische Wechselwirkung von PRL-3 
mit PI(4,5)P2 essentiell für eine verbesserte Clathrin-vermittelte Endozytose sind. 
XVIII	  
Zusammenfassend zeigen wir, dass die Überexpression von PRL-3 zu einer 
Störung der Polarität von Epithelzellen führt, vermutlich durch eine Beschleunigung 
der Zytokinese. Desweiteren demonstrieren wir PRL-3 als eine Phosphoinositide 
Phosphatase, welche die Clathrin-vermittelte Endozytose erhöht. 
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1.1. Protein phosphatases 
In eukaryotic cells, rapid responses to external stimuli, besides internal 
homeostasis preservation, are achieved through an integrated network of fine-tuned 
intracellular signaling pathways based on post-translational modifications (PTMs) that 
increases the functional complexity and dynamism of the proteome (Snider, 2013; 
Knorre et al., 2009; Cohen, 2002). Among the different types of PTMs, 
phosphorylation plays a central role in all intracellular processes by activating or 
inhibiting protein enzymatic activity, modifying protein subcellular localization, and 
changing protein-protein interaction affinity. Protein phosphorylation mainly occurs 
on hydroxyl-containing residues: tyrosine, serine, and threonine (Cohen, 2002; 
Hendriks et al., 2013). Protein kinases are the enzymes that catalyze the covalent 
binding of a phosphoryl group to these residues, while protein phosphatases act as 
their counterpart by transferring the phosphate group from the phosphorylated amino 
acid to a water molecule (Cohen, 2002). Furthermore, phosphorylation is not an event 
restricted to proteins: kinases and phosphatases are also involved in the regulation of 
signal transduction affecting the phosphorylation of non-protein substrates, such as 
phosphatidylinositol phosphates (PIPs) (Majerus and York, 2009) or carbohydrates for 
proper starch and glycogen metabolism (Worby et al., 2006; Romá-Mateo et al., 2016). 
 
1.1.1. Protein phosphatase superfamilies 
While protein kinases have evolved from a common ancestor, protein 
phosphatases do not share any structural similarities and apparently, evolved 
independently (Tonks, 2006; Alonso et al., 2004). Historically, phosphatases can be 
classified into three superfamilies based on the enzymatic mechanism, although this is 
still currently being refined due to their complexity and new discoveries in the field 
(Fahs et al., 2016; Li et al., 2013; Duan et al., 2015; Liberti et al., 2013). 
1. Protein serine/threonine phosphatases (PSTPs): Catalysis strictly 
requires the presence of metal ions in the enzyme active site and proceeds with 
direct phosphate hydrolysis, without an intermediate. Within PSTPs families 
phosphoprotein phosphatases (PPPs) and protein phosphatase 2C (PP2C) the 
active site is highly conserved, so substrate specificity is achieved by regulatory 
subunit interaction with the catalytic subunit, rather than by specific amino acid 
sequence recognition (Shi, 2009; Brautigan, 2013). 
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2. Haloacid dehalogenase (HAD): Catalytic activity is driven by a nucleophile 
superfamily in which the nucleophilic aspartic acid in the active site is an absolute 
requirement for the activity (Seifried et al., 2013).  
 
3. Protein tyrosine phosphatase (PTP): This is the largest superfamily with 96 
members sharing the consensus catalytic signature motif His-Cys-X5-Arg (X= any 
amino acid). The active site contains a cysteine that forms a phosphoenzyme 
intermediate with the substrate (Tonks, 2006; Tonks, 2013; Li et al., 2013). The 
enzymatic mechanism is explained in more detail in the next section, as the 
subject of this thesis belongs to this family. 
 
1.1.2. Protein Tyrosine Phosphatases  
Protein dephosphorylation reactions driven by a PTP are a two-step 
mechanism. First, the thiol group of the catalytic cysteine acts as a nucleophile and 
attacks the phosphorus atom of the phosphate group. A conserved aspartic acid 
residue from a flanking loop facilitates this first step by acting as an acid while, in the 
second step, it acts as a general base, activating a water molecule that hydrolyses the 
phosphocysteine intermediate (Fig. 1) (Tremblay, 2009; Tonks, 2013). Within the PTP 
superfamily, two classes can be distinguished. 
 
Figure 1. Catalytic mechanism of protein tyrosine phosphatases. Relevant active site amino 
acids are drawn using the Lesk color scheme. R = substrate.   
 
•  Classical PTP family: These cytoplasmic, as well as transmembrane, enzymes 
are characterized by phosphotyrosine specificity (Tonks, 2006; Tonks, 2013). Most 
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of the function, structure, and regulation findings have been revealed through the 
study of PTP1B, which is considered the prototype for this family (Tonks, 2003). 
 
•  Dual Specificity Phosphatases (DSPs): These enzymes are a heterogeneous 
group of non-transmembrane proteins characterized by a shallow catalytic pocket 
able to accommodate phosphotyrosine residues but also phosphoserine, 
phosphothreonine, and non-protein substrates (Pulido et al., 2013; Patterson et al., 
2009; Tonks, 2013; Worby et al., 2006). Phosphatase and tensin homolog (PTEN) 
is one of the most remarkable example of DSPs with a broad range of substrate 
specificity due to a catalytic pocket that is large enough to accommodate 
phosphotyrosine, phosphoserine, phosphothreonine, and the head group of PIPs 
(Song et al., 2012; Maehama, 1998; Tamguney and Stokoe, 2007; Zhang et al., 
2012). 
 
 
1.2. Phosphatases of regenerating liver (PRLs)  
PRL phosphatases (PTP4A genes) belong to the DSP family. They comprise 
three small (20 kDa), single domain members (PRL-1, PRL-2, and PRL-3) that share 
high sequence identity. As a PTP, PRLs contain the conserved catalytic signature 
within a shallow active site that is unusually hydrophobic (Rios et al., 2013; Al-
Aidaroos and Zeng, 2010; Bessette et al., 2008). PRLs contain a CaaX prenylation 
motif at the C-terminus (a is an aliphatic amino acid and X is any amino acid). The 
prenyl modification is unique within PTPs and essential for their anchoring to the cell 
membrane (Q Zeng et al., 2000). Close to the lipidation motif, a basic amino acid-
containing section, known as the polybasic sequence, is required for their plasma 
membrane localization, and it could also serve as a Golgi apparatus export signal 
(Parmar et al., 2014), although this has not yet been proven. The catalytic activity of 
PRLs is redox-regulated by the formation of an intramolecular disulfide bond between 
the catalytic cysteine (Cys104) and the conserved Cys49, which is similar to other 
DSPs, such as PTEN (Boivin and Tonks, 2010; Skinner et al., 2009). PRLs are 
involved in molecular pathways related to cell proliferation, migration, invasion, 
tumor growth, and metastasis (Fig. 2) (Rios et al., 2013; Bessette et al., 2008; Stephens 
et al., 2005), which make them a unique class of oncogenic phosphatases that might 
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play a causative role in tumor development and metastasis (Guzińska-Ustymowicz 
and Pryczynicz, 2011).  
 
Figure 2. The signaling network of the PRL phosphatase family. Several signaling pathways 
involved in epithelial mesenchymal transition (EMT) (orange), cell migration/invasion (green), 
and proliferation (blue) are affected upon PRLs’ presence. Arrows and lines indicate indirect effects 
due to the absence of known substrates. Adapted by permission from John Wiley: The FEBS 
Journal (Rios et al.), copyright (2013). 
 
The main difference among PRLs is the distinct pattern of tissue distribution. 
Whereas PRL-1 and PRL-2 are ubiquitously expressed in adult human tissues 
(Dumaual et al., 2006), PRL-3 seems to be much more restricted. Although PRL-3 
mRNA is found in most tissues, with higher levels in heart and skeletal muscle (Mele et 
al., 2015, www.gtexprotal.org, www.proteinatlas.com), the actual protein has only 
been confirmed in rat fetal heart tissue and mouse fetal intestine, adult heart, skeletal 
muscle, brain, pancreas and lung (Matter et al., 2001; Guo et al., 2006; Zimmerman et 
al., 2014).  
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1.3. Phosphatases of regenerating liver -3 (PRL-3) 
1.3.1. Subcellular localization of PRL-3 
PRL-3 is mainly found in the plasma membrane, Golgi apparatus, endosomes, 
and to a lesser extent, in the endoplasmic reticulum (Rios et al., 2013; Qi Zeng et al., 
2000; Krndija et al., 2012). This particular subcellular localization is governed by its 
C-terminal lipidation and polybasic sequence. Unlike PRL-1 and PRL-2, the CaaX 
motif of PRL-3 contains two consecutives cysteines. The farnesylation of the first 
cysteine facilitates the palmitoylation on the second one leading to a unique double 
lipidation within the PRL family (Nishimura and Linder, 2013; Rubio and Köhn, 
2016). Protein palmitoylation was proven to be a plasma membrane traffic signal 
(Linder and Deschenes, 2007). Nevertheless, polybasic sequence deletion inhibits 
PRL-3 plasma membrane localization, while a non-palmitoylable PRL-3 mutant 
(PRL-3 C171S) does not show a different cellular distribution compared to WT (data 
unpublished), suggesting that plasma membrane localization might be exclusively 
driven by the polybasic sequence.  
 
1.3.2. Regulation of PRL-3 expression 
The aforementioned discrepancy between mRNA and protein expression in 
several human tissues can only be explained by the extremely restricted regulation of 
PRL-3 levels at the transcriptional, translational, and post-translational stages (Fig. 3). 
Several possible scenarios have been reported in the past providing data often difficult 
to integrate, considering the different experimental conditions used. Some examples 
are discussed here.  
1.3.2.1. Transcriptional regulation 
Vascular endothelial growth factor (VEGF) stimulation activates PRL-3 
transcription through the transcription factor myocyte enhancer factor 2C (MEF2C) 
(Fig. 3). However, this was only investigated in human umbilical vein endothelial cells 
(HUVEC) (Xu et al., 2011). On the other hand, PRL-3 is able to up-regulate VEGF 
expression in lung cancer cell lines, together suggesting the possibility of a positive 
feedback loop for PRL-3 transcriptional regulation (Ming et al., 2009). PRL-3 has also 
been postulated as a direct transcriptional target gene of tumor suppressor p53 (Fig. 
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3), although opposing results have been observed in different cell lines, suggesting that 
it is cell-type specific (Basak et al., 2008; Min et al., 2010). Moreover, PRL-3 may also 
be negatively regulated at the transcription level by transforming growth factor 
(TGFβ) (Fig. 3) through mothers against decapentaplegic homolog (Smad3) (Jiang et 
al., 2011). Since TGFβ is often found to be comprised in cancer, it could explain PRL-
3 aberrant expression in several kinds of tumors (see also section 1.3.4.).   
 
Figure 3. Regulation of PRL-3 expression in cells. Final PRL-3 protein content in cells is 
tightly regulated at the transcriptional (blue), translational (orange), and post-translational stages 
(green). Adapted by permission from Portland Press: Biochemical Society Transactions Journal 
(Rubio and Köhn), copyright (2016). 
 
1.3.2.2. Translational regulation 
PRL-3 mRNA contains triple GCCCAG motifs in the 5’ untranslated region 
(5’-UTR) that interacts with PolyC-RNA-binding protein (PCBP1) retarding PRL-3 
mRNA incorporation into the ribosome (Fig. 3). Therefore, PCBP1 overexpression 
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inhibits PRL-3 translation, and an inverse correlation between protein levels of PRL-3 
and PCBP1 has been observed in primary tumors (Wang et al., 2010).  
1.3.2.3. Post-translational regulation 
PRL-3 protein stability is also tightly regulated and repressed via proteasome 
degradation upon ubiquitination. FK506-binding protein (FKBP38) interaction with 
PRL-3 leads to the ubiquitination of the phosphatase (Myung-Suk Choi et al., 2011), 
while the ubiquitin-specific protease (USP4) is in charge of deubiquitination (Xing et 
al., 2016) (Fig. 3). The oncogenic abundance of the PRL-3 protein has been correlated 
with the presence or deletion of many ubiquitination-related proteins (Myung-Suk 
Choi et al., 2011; Xing et al., 2016). 
 
1.3.3. Physiological roles of PRL-3  
Unfortunately, physiological functions of PRL-3 remains unclear as its 
investigation faces technical challenge (Ríos et al., 2014; Fahs et al., 2016). PRL-3 
knockout mice have not provided clear conclusions since they do not present any clear 
phenotype during development or adult life, with the only exception being a small 
perturbation in the ratio of gender in offspring (Zimmerman et al., 2013). However, 
deletion of PRL-2 in mice leads to severe fetal growth retardation due to reduced 
placental development (Dong et al., 2012), suggesting that the functions of the two 
phosphatases do not overlap in vivo. 
 
1.3.4. Oncogenic roles of PRL-3 
Historically, PRL-3 was first found highly overexpressed in several kinds of 
metastatic lesions derived from colorectal cancer, whereas it was not detected in the 
primary tumor nor in the normal colorectal epithelium, establishing PRL-3 as a 
metastasis-associated phosphatase (Saha et al., 2001). However, numerous recent 
studies have correlated aberrant PRL-3 expression with both metastasis and also 
primary tumor formation with a poor prognosis outcome in multiple epithelial-related 
(breast, gastric, colon, ovarian, prostate, kidney, bladder, and lung) and non-
epithelial-related cancers like acute myeloid and lymphoblastic leukemia (Al-Aidaroos 
and Zeng, 2010; Bessette et al., 2008; Guzińska-Ustymowicz and Pryczynicz, 2011; 
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Stephens et al., 2005; Cheng et al., 2013; Ren et al., 2009; Sun et al., 2017; Chong et al., 
2014; Grönroos et al., 2017; Mariscal et al., 2016; Xiong et al., 2016; Lian et al., 2016; 
Wang et al., 2008; Maacha et al., 2016; Vandsemb et al., 2016; Hollander et al., 2016; 
Nakayama et al., 2016; Zhang et al., 2015; Yeh et al., 2016; Yeh et al., 2015; Zhou et al., 
2014). In fact, PRL-3 knockout mice exposed to procarcinogenic and inflammatory 
agents presented a reduction in colon tumor development (Zimmerman et al., 2013), 
which raises the question of whether PRL-3 is an actual oncogene. 
Epithelial to mesenchymal transition (EMT) is an extremely complex cell 
remodeling process critical during development and organogenesis where an epithelial 
cell loses its characteristic polarity and acquires migratory and invasive capabilities. In 
an adult organism, the cell plasticity conferred by EMT is the first step required for 
tumor metastasis (Diepenbruck and Christofori, 2016). PRL-3 may promote EMT as 
one of its oncogenic features in a phosphoinositide 3-kinase (PI3K)-dependent 
manner, as was shown in DLD-1 human colorectal cancer cells (Wang et al., 2007). 
PI3K is a classical oncogene involved in PIP phosphorylation, mainly converting 
phosphatidylinositol (4,5)–bisphosphate (PI(4,5)P2) to phosphatidylinositol (3,4,5)–
triphosphate (PI(3,4,5)P3) in the plasma membrane (see also section 1.3.5.). PI(3,4,5)P3 
acts as a key second messenger in a broad range of cellular programs like cell 
migration, survival, and growth. Due to this, sustained PI(3,4,5)P3 signaling is strictly 
associated with tumorigenesis (Yuan and Cantley, 2008), and a strong negative 
feedback loop driven by PTEN is required to ensure that this phospholipid is only 
transiently available at the cell surface (Carracedo and Pandolfi, 2008). Interestingly, 
elevated PRL-3 levels correlate with a reduction in PTEN (Wang et al., 2007). 
Additionally, through PI3K, PRL-3 downregulates epithelial markers like E-cadherin, 
β3 integrin, and γ-catenin (Wang et al., 2007; Liu et al., 2009; Zhao et al., 2008), and up-
regulates mesenchymal markers like fibronectin and Snail (Wang et al., 2007).  
PRL-3 overexpression also provokes the activation of another classical 
oncogene, the protein tyrosine kinase Src (Liang et al., 2007). Src is involved in several 
cellular processes such as differentiation, motility, and adhesion, and its aberrant 
activation has been related with many human cancer types (Roskoski, 2004). PRL-3 
mediates Src activation leading to constant phosphorylation of downstream targets of 
Src, such as ERK1/2. Moreover, PRL-3 itself is a Src substrate and a positive 
feedback loop may exist (Liang et al., 2007; Fiordalisi et al., 2013). Taking into 
consideration the drastic morphological and molecular changes that are needed for 
EMT and cell migration and invasion, PRL-3 might be affecting multiple signaling 
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pathways that have yet to be fully elucidated.  
 
1.3.5. PRL-3 substrate candidates 
Identification of PRL-3 substrates that correlate with the clinical and cellular 
phenotype observed upon PRL-3 overexpression remains the most challenging 
unsolved question in the field (Ríos et al., 2014; Fahs et al., 2016). During the last 
decade several substrates have been postulated for PRL-3, although the link between 
their dephosphorylation and cellular impact has not been strong enough to directly 
link them with the PRL-3 overexpression-caused cellular phenotypes. These potential 
substrates are PI(4,5)P2, β1 integrin, ezrin, keratin 8, nucleolin, stathmin, and 
elongation factor 2 (EF2), focal adhesion kinase (FAK) and sodium-hydrogen 
exchanger regulatory factor 1 (NHERF1)(McParland et al., 2011; Orsatti et al., 2009; 
Peng et al., 2006; Mizuuchi et al., 2009; Ping Zheng et al., 2010; Semba et al., 2010; 
Tian et al., 2012; Peng et al., 2009). However, of these only PI(4,5)P2, β1 integrin, and 
ezrin have been confirmed to be directly dephosphorylated by PRL-3, while a 
correlation between PRL-3 overexpression and reduced phosphorylation of the other 
proposed substrates has been shown and an indirect effect cannot be excluded. 
Moreover, recently PRL-3 was shown to also function as a pseudophosphatase given 
that the PRL-3 active site serves to interact with the magnesium transporters CNNM3 
and CNNM4 without dephosphorylating them (Zhang et al., 2017; Funato et al., 
2014). Substrates relevant to this study are discussed in the following: 
• PI(4,5)P2: PIPs are phosphorylated derivatives of the lipid phosphatidylinositol 
(PI). Reversible phosphorylation at positions 3, 4, and 5 position of the inositol 
ring generates seven interconvertible species (Fig. 4A) (Di-Paolo and De Camilli, 
2006; Le-Roy and Wrana, 2005; Saarikangas et al., 2010; Shewan et al., 2011). All 
seven PIPs are minor components of eukaryotic cell membranes but are critical 
for several fundamental biological processes (Balla, 2013; Di-Paolo and De 
Camilli, 2006; Saarikangas et al., 2010). Indeed, abnormal PI metabolism is 
related to many human diseases such as cancer, diabetes, and autoimmune 
disorders (Bunney and Katan, 2010; Balla, 2013; Majerus and York, 2009). Each 
PIP is spatially restricted in cellular membranous compartments (Fig. 4B). They 
can be rapidly interconverted from one species to another by lipid kinases and 
phosphatases, and the cleavage of the inositol head group by phosphoinositide-
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specific phospholipase C enzymes (PLCs) serve to propagate and amplify 
signaling. PI(4,5)P2 participates in virtually every event that occurs at the cell 
surface, including endo- and exocytosis, ion channel-mediated transport, 
cytokinesis, cell shape, motility, polarity, and adhesion, by modulation of its own 
levels and by its compartmentalization within the plasma membrane 
(McLaughlin et al., 2002). Recently, it was described that PRL-3 can 
dephosphorylate PI(4,5)P2 in vitro (McParland et al., 2011), but the biological 
consequences of this activity and in vivo confirmation remain unaddressed.  
 
Figure 4. Phosphatidylinositol phosphate structures and subcellular localization. A 
Phosphatidylinositol molecules are formed by a fatty acid backbone attached to an inositol ring 
thought a phosphate. Positions 3, 4 and 5 can be phosphorylated in any combination giving rise to 
7 species. R1 and R2 = aliphatic chains. B Each phosphoinositide localizes to specific 
membranous compartments also contributing to its identity. EE = early endosome. MVB = multi-
vesicle body. Adapted by permission from MacMillan Publishers LTD: Nature Chemical Biology 
(Kutateladze), copyright (2010). 
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• β1 integrin: Integrins are transmembrane proteins that mediate cell-cell and 
cell-extracellular matrix interactions. They are always found as heterodimers that 
contain an α and β subunit, but only the β subunits can be phosphorylated in the 
cytosolic region (Takada et al., 2007; Shattil et al., 2010). PRL-3 is an integrin-
associated protein with preference for α1 and β1 integrin (Peng et al., 2009; Peng 
et al., 2006; Tian et al., 2012). Furthermore, PRL-3 is able to dephosphorylate β1 
integrin at pTyr783 (Tian et al., 2012), but its biological significance remains 
unknown. 
• Ezrin: Belonging to the Ezrin/Radixin/Moesin (ERM) family, Ezrin works as 
molecular scaffold between actin filaments and the plasma membrane. Tyr 
and/or Thr residue phosphorylation and PI(4,5)P2 binding are both required for 
the exposure of the actin binding sites (Neisch and Fehon, 2011). Therefore, since 
PRL-3 can dephosphorylate Ezrin at pThr567 (Forte et al., 2008), it might 
counteract Ezrin opening and activation. However, this effect was not confirmed 
in other experimental conditions, suggesting that this finding could be cell-type 
specific (Mizuuchi et al., 2009). 
 
 
 
1.4. Cell polarity and epithelial architecture maintenance 
1.4.1. Structure of mammalian epithelia 
Epithelial tissues contain a single sheet of clasped epithelial cells providing an 
impermeable barrier between two interfaces and are prone to forming cysts or 
tubules. In cysts the single layer of epithelial cells surrounds a central hollow lumen 
leading to a spherical shape, whereas in tubules this shape is elongated and cylindrical. 
Normally, in epithelial organs such as lung, mammary glands, or kidney, a 
combination of both structures can be found, forming a network of branching tubules 
that terminate in cysts (Brien et al., 2002). Each cell taking part in an epithelial sheet is 
polarized, showing three types of plasma membrane domains that are 
morphologically and chemically different: a) an apical membrane that faces inward 
toward the lumen, b) a basal membrane that interacts with the extracellular matrix 
(ECM) through integrin and non-integrin receptors and, c) a lateral surface that 
establishes tight junctions, desmosomes, and adherens junctions with neighboring cells 
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to ensure tissue impermeability (St Johnston and Ahringer, 2010; Brien et al., 2002; 
Roignot et al., 2013; McCaffrey and Macara, 2009; Datta et al., 2011). The 
heterogeneous distribution of both proteins and lipids across the plasma membrane 
creates a clear apico-basal polarity. The epithelium also provides some consistency 
and continuity to the tissue through a thick cortical belt of actin linked to the apical 
surface through ERM proteins. In the lateral membrane, members of the cadherin 
family bridge the adjacent plasma membranes of neighboring cells, forming 
desmosomes and adherens junctions that carry out adhesive functions (Baum and 
Georgiou, 2011). Tight junctions are located in the interphase between apical and 
lateral membranes and prevent membrane component diffusion between both 
domains (Matter and Balda, 2003).  
 
1.4.2. Protein and lipid compartmentalization 
As previously mentioned, epithelial cell polarity is defined as a heterogeneous 
distribution of different proteins and lipids throughout the cell. This 
compartmentalization is achieved through the cooperative contribution of different 
cellular machineries that take charge of protein and lipid segregation: the partitioning 
defective and atypical protein kinase (Par3/Par6/aPKC) complex, PIP asymmetric 
distribution, and polarized membrane-trafficking pathways. 
• The Par3/Par6/aPKC polarity complex: This complex is a set of 
evolutionarily conserved proteins coupled to the junction structures (St Johnston 
and Ahringer, 2010). aPKC (isoforms ιPKC and ζPKC) is a serine/threonine 
protein kinase, and Par3 and Par6 are PDZ domain-containing scaffold proteins 
between the kinase and the tight junction. All three form a complex established 
by direct interactions subjected to different levels of regulation. Par6/aPKC 
recruitment is driven by cell division control protein 42 (Cdc42), which when 
activated binds to Par6 leading to aPKC activation. On the other hand, Par3 is 
recruited through the interaction of adhesion complex proteins and junctional 
adhesion proteins. Then, the active Par6-aPKC complex is recruited at the tight 
junction site through an association with Par3. The asymmetric localization of the 
complex promotes tight junction maturation and thereby contributes to protein 
and lipid segregation between apical and lateral membranes (Suzuki and Ohno, 
2006; Aranda et al., 2008). In addition, Par3 also recruits the Ras-related C3 
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botulinum toxin substrate (Rac) to the tight junction site and exchanges it with T-
cell lymphoma invasion and metastasis 1 (TIAM1), which is required for the 
apical recruitment of PTEN and is necessary to induce PI asymmetry at the cell 
surface (Feng et al., 2008; Chen and Macara, 2005).  
• Phosphatidylinositol phosphates: Asymmetric PIP distribution across the 
plasma membrane is fundamental for apical and basolateral membrane identity 
determination (Shewan et al., 2011). PI3K activation is a necessary part of the 
signaling pathways required for functional differentiation of epithelial cells 
(Laprise et al., 2002). As a consequence, PI(3,4,5)P3 levels in polarized epithelial 
cells are increased compared to non-polarized cells. However, its presence is 
restricted to the basolateral domain due the aforementioned apical recruitment of 
PTEN, which acts as a barrier by converting PI(3,4,5)P3 to PI(4,5)P2 and therefore 
prevents PI(3,4,5)P3 diffusion in the apical domain (Fig. 5) (Comer and Parent, 
2007; Datta et al., 2011; Martin-Belmonte et al., 2007). As a result, PI(4,5)P2 is 
enriched at the apical surface, even though it can appear throughout the plasma 
membrane (Martin-Belmonte et al., 2007; Gassama-Diagne et al., 2006). This 
characteristic PIP distribution along the cell surface is crucial for the 
establishment and maintenance of cell polarity, and is achieved by the 
asymmetric recruitment of PIP-specific lipid-binding proteins, although the 
identity of these targets is still unknown. 
• Polarized membrane traffic: In order to maintain each membrane domain 
protein and lipid identity, the uptake, transport, and cell surface delivery of a 
each kind must be vectorial and regulated (Apodaca et al., 2012). On one hand, 
sorting signals present in the cytoplasmic cargo, transmembrane domain, or 
extracellular domain decoded by the corresponding transport machinery are 
required to ensure proper delivery to the correct membrane (Mellman and 
Nelson, 2008). While basolateral membrane proteins contain cytoplasmic 
domains like YXXØ-like or dileucine (LL/IL) motifs (Gonzalez and Rodriguez-
Boulan, 2009), apical sorting determinants are more varied. Attachment to the 
membrane by a glycosylphosphatdylinositol anchor, extracellular glycosylation, 
Bin/ Amphiphysin/Rvs (BAR) domain-containing proteins, and belonging to 
lipid rafts are an example for apical sorting (Weisz and Rodriguez-Boulan, 2009; 
Mattila et al., 2012; Stechly et al., 2009; Mishra et al., 2010; Dudek et al., 2010). On 
the other hand, the membrane-trafficking network within the cell must also be 
polarized (Fig. 5). During protein biosynthesis, proteins are trafficked from the 
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endoplasmic reticulum to the Golgi apparatus, and distinct carriers for apical or 
basolateral membrane cargoes exist, although the specific carrier types are still 
unknown (Jacob and Naim, 2001; Farr et al., 2009). Moreover, cell surface 
delivery from the Golgi apparatus can be direct or indirect through Ras-related in 
brain (Rab)8a and Rab11a GTPase-positive recycling endosomes (Ang et al., 
2004; Cramm-Behrens et al., 2008), through Rab4 endosomes exclusively for 
apical transport (Cramm-Behrens et al., 2008), or through Rab10-positive 
common recycling endosomes (CRE). Within the CRE, endosomes coming from 
the Golgi apparatus are mixed with apical or basolateral early endosomes coming 
from the plasma membrane (Bucci et al., 1994). Again, cargoes need to be sorted 
from CRE according to their destination (Wang et al., 2000; Babbey et al., 2006; 
Henry and Sheff, 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Membrane-trafficking pathways in epithelial cells. Proteins, lipids, and fluids are 
internalized from the apical and basal membrane domain into apical (AEE) or basal (BEE) early 
endosomes, respectively. Then, they can either be recycled to the same membrane domain or 
transported to the common recycling endosome (CRE) where they mix with newly synthesized 
proteins coming from the Golgi apparatus. Consequently, they are trafficked to the recycling 
endosome (RE) or directly to the membrane. Newly synthesized proteins present in the Golgi 
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apparatus can be transported to the destination membrane domain directly, through RE or CRE. 
PI(4,5)P2 and PI(3,4,5)P3 lipids are compartmentalized in the apical and lateral-basal 
membrane, respectively. Adapted by permission from MacMillan Publishers LTD: Nature Cell 
Biology (Apodaca et al.), copyright (2012).  
The cytoskeleton also contributes in membrane transport directed by several 
proteins of the kinesin family. For example, Kifc3, Kif5B, and Kif17 are all 
involved in apical cargo transport (Noda et al., 2001; Jaulin and Kreitzer, 2010; 
Jaulin et al., 2007). Finally, vesicle fusion to the plasma membrane mediated by N-
ethylmaleimide-sensitive factor attachment receptors associated with target 
membranes (t-SNAREs) proteins are also different according to the destination 
domain. Whereas syntaxin-1,-2, and -3 are involved in apical membrane fusion, 
syntaxin-4 localizes exclusively to the basolateral surface (Sharma et al., 2006; 
Torkko et al., 2008). 
 
1.4.3. Three-dimensional epithelial cell model: a tool to study 
epithelial architecture in health and disease 
In order to study molecular, cellular, and morphological mechanisms related 
with epithelial cells, canonical two-dimensional (2D) cell culture is not the best model 
to use since it does not recapitulate the physiologically distinctive features of epithelial 
cells in vivo. Indeed, epithelial cells grown in 2D are not polarized, are flat, and do not 
establish strong cell-cell interactions. Epithelial cells require external stimulation in 
order to differentiate and organize into an epithelial monolayer fed from an ECM 
microenvironment. Due to these limitations in 2D culture, efforts in the last two 
decades have been focused on the development of an artificial environment that 
resembles in vivo conditions.  
Currently, Madin-Darby canine kidney (MDCK) epithelial cells and human 
Michigan Cancer Foundation 10A (MCF10A) breast cancer cells are extensively used 
to study epithelial cells in three dimensional (3D) culture (Apodaca, 2010; Debnath et 
al., 2003; Bryant et al., 2010; Bryant et al., 2014; Gálvez-Santisteban et al., 2012; Qu et 
al., 2015; Rodríguez-Fraticelli et al., 2015; Schlüter and Margolis, 2009; Jaffe et al., 
2008). In the presence of the 3D matrix, both cell lines are able to form spherical 
structures, named cysts or acini depending on the epithelial cell origin (Debnath and 
Brugge, 2005). MDCK cysts are described as a single layer of polarized epithelial cells 
surrounding a central hollow fluid-filled lumen. In these conditions, the apical domain 
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delineates the central lumen, while the basal membrane faces outside establishing 
protein interactions with the ECM, mimicking the epithelial architecture described in 
1.4.1. (Schlüter and Margolis, 2009). The plasticity of this 3D epithelial model also 
allows cellular and molecular biology tool applications such as protein knockdown, 
cDNA overexpression, and live-cell imaging, and being crowned as a powerful system 
to examine the molecular and cellular aspects of epithelial morphogenesis and related 
diseases (Debnath and Brugge, 2005; Brien et al., 2002).  
Notably, this 3D epithelial model has been extensively used since their 
development, not only to understand molecular mechanisms beyond lumen formation 
and maintenance but also in tumor promotion and development. Indeed, loss of 
polarity, luminal filling, epithelial architecture disruption, escape from apoptosis, and 
invasive behavior are considered key steps during epithelial organ tumorigenesis, all of 
which can be studied using these 3D models (Burstein et al., 2004; Jaffe et al., 2008; 
Debnath and Brugge, 2005; Leung and Brugge, 2012).    
 
1.4.4. De Novo lumen formation  
During development, tubular structures can develop either by a mechanical 
deformation by major morphogenetic movements of a pre-existing epithelial sheet, or 
by the programmed conversion of mesenchymal cells into epithelial cells and 
generation of a central lumen de novo through a complex molecular transformation 
known as mesenchymal-epithelial transition (MET), the opposite process to EMT (see 
also section 1.3.4.) (Lubarsky and Krasnow, 2003). Within this second alternative, two 
mechanisms for de novo lumen generation have been determined: cavitation and 
hollowing (Bryant and Mostov, 2008; Datta et al., 2011). For lumen generation by 
cavitation, a minimal critical cell mass is required. The inner cell population that is 
not in contact with the ECM suffers selective apoptosis, while the outer layer of cells 
progressively differentiates into polarized epithelial cells (Fig. 6). This process was 
observed in MCF10A 3D cysts mimicking mammary gland development, which have 
also been proven to be formed by the same mechanism (Debnath et al., 2002; Mailleux 
et al., 2007; Humphreys et al., 1996). 
For lumen generation through hollowing, which is of relevance to this study, 
polarization is generated from the very first epithelial cell division where the apical 
membrane domain separates and is coupled to polarized exocytosis, followed by fluid 
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and ion efflux in order to facilitate lumen growth and filling. As a result, a small lumen 
is initially formed in the center of the system that will grow as the cells continue to 
divide (Fig. 6). This mechanism has been proven in 3D MDCK cystogenesis, as well 
as during zebrafish gut development (Apodaca et al., 2012; Bagnat et al., 2007; Bryant 
and Mostov, 2008; Datta et al., 2011).  
 
Figure 6. Hollowing and cavitation mechanisms for de novo lumenogenesis. Polarization is 
generated from the very first epithelial cell division by hollowing. Then, the small lumen opened 
in the center of the system continually grows with ongoing cell divisions. However, lumenogenesis 
by cavitation requires a minimal critical cell mass before the inner cell population (not in 
contact with the ECM) suffers selective apoptosis, while the outer layer of cells differentiates into 
polarized epithelial cells. Adapted from Current Biology, 21, Datta, A., Bryant, DM. and 
Mostov KE, “Molecular regulation of lumen morphogenesis”, R127, Copyright (2011), with 
permission from Elsevier. 
 
In MDCK cysts, de novo lumen formation requires for the originally non-
polarized cells to receive initial external inputs to provide spatial coordinates in order 
to establish the direction of lumenogenesis and to induce apico-basal polarization 
(Schlu et al., 2009). The initial signal comes from laminins and collagen IV present at 
the ECM that set an axis to orient the lumen position upon physical interaction with 
cellular β1 integrin (Treyer and Müsch, 2013; Cohen et al., 2004; Datta et al., 2011). 
Thereafter, primordial intercellular junctions (not tight junctions) are formed via a 
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multitude of adhesion molecules, like cadherins, in the cell-cell contact region, which 
establishes the second spatial cue (Datta et al., 2011). After the polarity axis is set, the 
next step is the specification of the “apical membrane initiation site” (AMIS), a 
specialized membrane domain situated in the core region of the cell-cell contact zone 
and surrounded by the primordial junctions where apical determinants are transiently 
enriched by vectorial membrane-trafficking (Apodaca, 2010; Bryant et al., 2010). The 
establishment of this region by selective delivery of apical determinant-containing 
vesicles (named polarized exocytosis) is the determining step to specify the lumen 
position since the lumen will subsequently open in this precise place delineated by the 
newly formed tight junctions (Wang et al., 2014; D. Li et al., 2014; Apodaca et al., 
2012; Schlüter et al., 2009). The lumen will then start to form during the first 
cytokinesis around the midbody, the structure created within the intercellular bridge 
during cytokinesis (Fig. 7) (Steigemann and Gerlich, 2009; D’Avino and Capalbo, 
2016; Overeem et al., 2015; Schlüter and Margolis, 2009). 
During AMIS specification at the two-cell stage, several apical signaling 
molecules, like the podocalyxin precursor (Podxl)-NHERF-1-Ezrin complex that is 
essential for apico-basal polarization, are not properly compartmentalized yet and are 
found diffused throughout the plasma membrane or at the basal surface (Bryant et al., 
2014). After this point, transcytosis of these apical components from the basolateral 
membrane to the forming luminal domain rapidly occurs, relying on the Rab11a-
Rab8 guanine nucleotide exchange factor (Rabin8a)-Rab8a cascade. Apical cargo is 
taken up from the basolateral surface into FIP5/Rab11a positive vesicles. Then, 
Rab8a is recruited into those vesicles through Rabin8, which is able to control motor 
proteins, such as myosin-5B, for apical domain approach (Apodaca et al., 2012; Bryant 
et al., 2010; Dongying Li et al., 2014). Finally, the hetero-octameric exocyst complex 
mediates apical cargo release into the target membrane creating and enhancing the 
AMIS. Moreover, this exocyst complex also localizes the Par3-aPKC complex and the 
Cdc42 activator Cdc42-GEF Tuba to the AMIS, which both contribute to this initial 
stage of lumenogenesis (Zuo et al., 2009; Apodaca, 2010; Bryant et al., 2010).  
When AMIS is completely established, lumen maturation proceeds with Par3 
and exocyst subunits Sec8 and Sec10 relocalization to the tight junction regions 
before the lumen physically opens (Bryant et al., 2010). Par3 displacement drives the 
heterogeneous distribution of PTEN towards the tight junction border by physical 
interaction, leading to the exclusion of PI(3,4,5)P3 from the apical membrane (see also 
section 1.4.2.).  
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Finally, the last step of de novo lumen generation is the actual opening of the 
lumen. This stage is controlled by apical recruitment and activation of channels, 
pumps, and anti-adhesive proteins in charge of facilitating cell-cell membrane 
repulsion (Bryant and Mostov, 2008). These anti-adhesive proteins carry highly 
negatively charged groups, such as glycosyl and/or sialyl moieties, in their 
extracellular domains to accomplish their function by electrostatic repulsion (Meder et 
al., 2005). This feature may explain why glycosylation in the extracellular domain is a 
cargo signal for apical delivery as previously described. 
 
1.4.5. Lumen growth and maintenance in MDCK cysts 
Since the apico-basal polarity axis in epithelial cells surrounding a lumen 
formed by the hollowing mechanism is already established from the first cell division, 
lumen growth is driven by continual division of the integrant epithelial cells. 
Normally, when cells in culture undergo mitosis, they reduce their contact with the 
substratum and neighboring cells to a minimum, and start to form a round shape. 
However, this behavior in epithelial cell would lead to the loss of polarity during cell 
division and subsequent problems in the restoration of the polarity axis. For that 
reason, all lateral, but not basal, junctions are kept during this process to ensure the 
maintenance of the polarity throughout the whole epithelium (Jinguji and Ishikawa, 
1992; Baker and Garrod, 1993). Despite this, mitosis entails a big morphological 
change driven by the actomyosin contractile ring in charge of membrane fission at the 
end of the cell division, so partial rearrangement of these junctions is necessary for 
completion of the process (Morais-de-Sá and Sunkel, 2013; Ragkousi and Gibson, 
2014). Like in the first cell division prior to the lumen opening, the AMIS is always 
recruited at the midbody and surrounds it during cell cytokinesis. This structure is 
then accompanied by apical machinery components able to develop a new lumen by 
themselves, so it must be delivered directly into the apical membrane in order to keep 
a single lumen, as well as to provide more apical components to the apical domain 
(Jaffe et al., 2008; Dongying Li et al., 2014; Morais-de-Sá and Sunkel, 2013; Overeem 
et al., 2015; Schlüter et al., 2009; Apodaca et al., 2012). Then, cell-cell junction 
rearrangements required during cell division must be coordinated with the mitotic 
process to ensure the apical release of the midbody after abscission. While tight 
junctions are kept in the interphase between the apical and lateral membrane to avoid 
temporary loss of epithelium impermeability, E-cadherin that is normally distributed 
	  	   	   	  
	   1.	  Introduction	   	  	   	  
22	  
in desmosomes and adherens junctions all along the lateral membrane is enriched 
close to the tight junctions before the actomyosin contractile ring is formed (Gloerich 
et al., 2017; Ragkousi and Gibson, 2014).  
In this scenario, midbody remnants seem to play a role after abscission, even if it 
is just as a scaffold for the AMIS. Indeed, it has been suggested that these remnants 
could participate in non-cytokinetic functions, such as cell fate determination and cell 
polarity specification (Chun-Ting Chen et al., 2013; Kuo et al., 2011; Morais-de-Sá 
and Sunkel, 2013). In fly notum and chick spinal cord, post-mitotic midbodies of 
neurons were found at polarized/apical domains, giving rise to the idea that post-
mitotic midbodies might specify neuronal polarity (Pollarolo et al., 2011; Chun-Ting 
Chen et al., 2013). In Drosophila follicular epithelium, apical midbody localization 
provides a positional cue critical for the formation of the apico-basal axis of the tissue, 
as confirmed by disruption of the epithelial architecture in the case of the ectopic 
localization of the midbody (Morais-de-Sá and Sunkel, 2013). Finally, in transgenic 
mice expressing the GFP labeled midbody remnant marker mitotic kinesin-like 
protein (MKLP1), midbody remnants seem to mark the apical membrane of the 
embryonic neuroepithelium and adult intestinal crypts (Maliga et al., 2013). 
Altogether, these findings suggest that midbodies have a role after cytokinesis, 
overturning the idea that they are just mitotic leftover that must be degraded.  
The apical positioning of the midbody together with the AMIS is achieved by a 
two-step process (Jaffe et al., 2008). First, the mitotic spindle must be oriented parallel 
to the basal membrane and perpendicular to the apico-basal membrane during 
metaphase. This alignment is achieved by its anchoring to the lateral membrane 
through astral microtubules. The assembly is controlled by a protein complex formed 
by guanine nucleotide-binding protein α i (Gαi), leu-gly-asn repeat protein (LGN), and 
the nuclear mitotic apparatus protein (NuMA) in a Par3/aPKC and E-Cadherin-
dependent manner (Fig. 7) (Zhen Zheng et al., 2010; Hao et al., 2010; den Elzen et al., 
2009; Gloerich et al., 2017). Loss of spindle orientation in polarized epithelial cells 
leads to midbody mispositioning (Fig. 7) and therefore to epithelial architecture 
disruption (Jillian C Pease and Tirnauer, 2011; Noatynska et al., 2012; Fleming et al., 
2009; Jaffe et al., 2008; Overeem et al., 2015; Shahbazi and Perez-Moreno, 2015). 
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Figure 7. Mechanisms for ectopic lumen formation through post-mitotic midbody 
mispositioning. At the early cystogenesis stage, apical components containing vesicles are recruited 
around the midbody during the first cell division forming the AMIS, which will turn into a lumen 
after abscission. In subsequent cell divisions, to ensure the single lumen maintenance, the midbody 
is delivered to the apical membrane with a planar orientation of the mitotic spindle to the apical-
basal axis (1) followed by asymmetric furrow ingression (2). Loss of mitotic spindle orientation or 
loss of asymmetric furrow ingression may affect the apical positioning of the midbody leading to 
ectopic lumen development. Apical membrane = light red; basolateral membrane = brown; γ-
tubulin = dark red; nuclei and chromosomes = blue; midbody and midbody remnants = green; 
apical endosomal compartment = orange.  
 
 
The second step in apical midbody positioning occurs when chromosomes move 
to the distal spindle poles during anaphase, and a cleavage furrow starts to be formed. 
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The progression of this furrow is driven by the actomyosin contractile ring, a transient 
structure located inside the plasma membrane at the location of the cleavage furrow. 
The mechanical tension applied from the contractile ring would be, theoretically, the 
same throughout the cleavage furrow if membrane composition is homogeneous, 
ending in a symmetric abscission (Mendes Pinto et al., 2013). However, a differential 
junctional protein composition along the apico-basal axis in polarized cells leads to an 
asymmetric cell division that pushes the cytokinetic bridge to the apical membrane, 
facilitating delivery of the midbody to this membrane domain (Fig. 7) (Jaffe et al., 
2008). Unfortunately, the mechanism controlling this process is not well understood. 
Septins and anillin have been implicated in asymmetric cell division in C. elegans, but 
no further information has been added to this discovery (Maddox et al., 2007). Since 
loss of asymmetric abscission could inherently lead to an inappropriate midbody 
positioning (Fig. 7), epithelial architecture disruption is a plausible hypothetical 
scenario that would also potentially promote tumor formation (Jaffe et al., 2008; 
Overeem et al., 2015; Schlüter et al., 2009).   
  
 
1.5. Cellular cytokinesis  
Cytokinesis is the last step of mitosis where the cytosolic content of a single cell is 
divided into two. The cellular process begins with the assembly and narrowing of an 
equatorial contractile ring. Close to completion, the central region of the mitotic 
spindle is reorganized into a midbody that, from the center of the intracellular bridge, 
is in charge of direct abscission by action of the endosomal sorting complexes required 
for transport (ESCRT-III) proteins. The present section dissects the molecular 
mechanism of each cytokinetic step (Green et al., 2012).  
  
1.5.1. Establishing the place of cytokinesis 
During anaphase, homologous chromosomes are separated and the spindle 
midzone is assembled between them. This structure consists of parallel microtubules 
with minus ends pointing to the poles and plus ends aggregated with the plus ends of 
the oppositely oriented microtubules, forming a narrow overlapped region called the 
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central spindle (Euteneuer and McIntosh, 1980; Glotzer, 2009). The formation of this 
region requires microtubule cross-linker protein regulator of cytokinesis (PRC1), 
kinesin (KIF4), and MKLP1 (Glotzer, 2009). This process is regulated by polo-like 
kinase (Plk1), the chromosomal passenger complex (CPC) formed by the kinase 
AuroraB and three additional regulatory subunits, and the centralspindlin, a protein 
complex formed by MKLP1, kinesin-6, and two molecules of CYK-4, a GTPase 
activating protein (GAP) that also recruits epithelial cell transforming protein (Ect2) to 
the central spindle (Fig. 8A) (Carmena et al., 2009; Ruchaud et al., 2007; Glotzer, 
2009; Pavicic-Kaltenbrunner et al., 2007). Several of these complexes might play a key 
role in promotion of the contracting ring assembly, but how the signal reaches the 
cortex from the central spindle remains unknown (Carmena et al., 2009; Barr and 
Gruneberg, 2007). 
 
Figure 8. Animal cell cytokinetic stages. A Signaling from the anaphase spindle and cortex 
generate an equatorial zone of active RhoA. B,C Active RhoA induces actomyosin contractile ring 
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assembly, which changes cell shape by constriction. D The midbody is formed in the matured 
midzone upon ring constriction. It has 3 regions: core, ring, and flanks. E For the final membrane 
abscission, ESCRT-III complex is recruited at the midbody sides, generating two daughter cells. 
Adapted by permission from Annual Reviews: Annual Review od Cell and Developmental 
Biology(Green et al.), copyright (2012).  
 
 Meanwhile, active RhoA is accumulated in a narrow equatorial zone 
promoting the recruitment of contracting ring proteins and delineating the site of 
contractile ring assembly (Piekny et al., 2005; Bement et al., 2006). The particular 
distribution of active RhoA is not only driven by central spindle components, but also 
by the distal asters formed around the centrosomes that corral active RhoA, 
preventing it from spreading out from the cellular equator (Fig. 8A) (von Dassow, 
2009). 
 
1.5.2. Actomyosin contractile ring 
After equatorial cortex zone specification, the contractile ring is assembled. It is 
composed of a thin layer of filamentous proteins cross-linked around the cellular 
equator beneath the cell surface (Cao and Wang, 1990). The ring is composed by 
myosin II and actin filaments that are the mechanical components of the complex; 
septins that bind to the membrane; and anillin that serves as a scaffold of the other 
three (Fig. 8B,C) (Eggert et al., 2006; D’Avino, 2009; Piekny and Maddox, 2010). It 
also contains actin nucleation, polymerization, disassembly, capping, and cross-linking 
proteins that regulate ring formation and constriction by disassembly (Wu and 
Pollard, 2005; Eggert et al., 2006).   
 
1.5.3. Cell abscission 
As the ring closes, the midzone is remodeled, forming the midbody in the center 
of the intracellular bridge. The presence of the spindle microtubules trapped in this 
bridge by the midbody inhibits the final membrane pinch by the actomyosin 
contractile ring. Therefore, the ring must be replaced by a ESCRT-III protein 
network that, together with midbody microtubule disassembly, will bring about 
abscission that is driven by spansin (Guizetti and Gerlich, 2012; Caballe and Martin-
Serrano, 2011; Connell et al., 2009). During midbody packing, three distinctive 
regions can be observed (Fig. 8D): the midbody core containing the microtubule 
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overlap region, KIF4, and PRC1; the midbody ring formed together with the leftovers 
of the contractile ring including centralspindlin, Ect2, anillin (to anchor the midbody 
to the plasma membrane), RhoA, Arf6, and centrosomal protein (Cep55); and the 
midbody flank, which includes AuroraB and MKLP2 (Hu et al., 2012). 
At both sides of the formed midbody, the ESCRT-III protein complex, 
consisting of seven core proteins called charged multivesicular body proteins 
(CHMPs), five regulatory proteins, and 2 vacuolar protein sorting-associated (VSP4) 
in charge of polymer disassembly (Morita, 2012), drives the abscission of membrane 
necks by spiral polymerization upon Cep55-mediated recruitment (Fig. 8E) (Carlton et 
al., 2012). Before physical separation takes place, cells must pass through a cytokinetic 
checkpoint regulated by kinases Plk1, AuroraB, and Unc-51-like kinase 3 (ULK3) in 
order to control lagging chromosomes, tension forces at the midbody, or nuclear pore 
defects. Abscission timing is dictated by the efficiency of this checkup where all three 
kinases must be inactivated in order to proceed. Plk1 phosphorylates Cep55 
preventing its recruitment to the midbody, but when Plk1 is degraded during mitotic 
exit, Cep55 is then transported to the cytokinetic bridge scaffolding ESCRT-III 
complex (Bastos and Barr, 2010; Carlton and Martin-Serrano, 2007; Morita, 2012; 
Johnson et al., 2013). Aurora B, present in the midbody flank, prevents premature 
abscission by phosphorylation of ESCRT-III component CHMP4C, essential for 
ESCRT-III polymerization (Carlton et al., 2012), while ULK3 works downstream of 
AuroraB, phosphorylating IST1, a VSP4 ESCRT-III subunit, preventing complex 
disassembly (Caballe, Dawn M Wenzel, et al., 2015).  
Together with the midbody and the ESCRT-III complex, membrane trafficking 
of furrow assembly-promoting proteins and membrane remodeling in the intracellular 
bridge are essential for the successful abscission (Neto et al., 2011). Membrane 
remodeling is driven by selective endocytosis and exocytosis and the main endocytic 
pathway related with this process is clathrin-dependent endocytosis (Warner et al., 
2006). Membrane remodeling increases PI(4,5)P2 presence at the intercellular bridge 
where it organizes cytoskeletal elements necessary for the late steps of cytokinesis 
(Echard, 2008).  
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1.6. Clathrin-dependent endocytosis  
In eukaryotic cells, very few molecules can passively enter and exit the cell 
across the plasma membrane unaided by proteins. Adenosine triphosphate (ATP)-
powered pumps, channel proteins, and transporters are embedded in the 
phospholipidic bilayer to support ion flux and small molecule uptake. However, these 
cellular tools are not able to facilitate the transport of larger macromolecules and 
particles. In order to accomplish this, these materials are engulfed by an area of the 
plasma membrane, which then buds inside the cell and forms a vesicle containing the 
ingested components in a process called endocytosis. There are many different 
endocytic pathways already known, with more being discovered as research in the 
field continues. The most common and best described ones are reviewed by Doherty 
and McMahon (Doherty and McMahon, 2009). In the present section, I will focus on 
the molecular mechanisms behind clathrin-dependent endocytosis (CDE), the first 
endocytic pathway described in the literature and the one most commonly used by 
eukaryotic cells, where cargo is packaged into vesicles with the aid of a clathrin coat.  
 
1.6.1. CDE stages 
CDE is crucial for signal transduction, neurotransmission, regulation of many 
plasma membrane activities, cytokinesis, and nutrient uptake into the cell. These 
clathrin-coated vesicles can be found in several membranous cellular compartments. 
However, the term CDE is only applied to vesicles formed from the plasma 
membrane (McMahon and Boucrot, 2011). In this context, clathrin-coated vesicle 
formation proceeds through five morphologically different stages. 
 
Figure 9. Clathrin-dependent endocytosis stages. Nucleation CCP formation is initiated by 
AP2 recruitment to PI(4,5)P2-rich zones of the plasma membrane after recruitment of EPS15, 
intersectins, and FCHO proteins. Cargo selection μ-subunit and σ-subunit of AP2 interact 
with specific cargo directly or through cargo-specific adaptors. Coat assembly Clathrin is 
recruited to AP2-rich zones where it polymerizes into hexagons and pentagons forming a spherical 
  |
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coat. Scission Dynamin polymerizes at the neck of the forming vesicle, inducing membrane 
scission. Uncoating Auxilin recruits HSC70 for clathrin coat disassembly, which makes 
clathrin available for another round of CDE. Adapted by permission from MacMillan Publishers 
LTD: Nature Reviews Molecular Cell Biology (McMahon and Boucrot), copyright (2011). 
 
1.6.1.1. Nucleation 
Historically, the initiation of the clathrin-coated pit (CCP) was thought to be 
boosted by the recruitment of adaptor protein 2 (AP2) to the plasma membrane 
through its binding to PI(4,5)P2 and to endocytic motifs contained in the cytoplasmic 
tails of the cargo (McMahon and Boucrot, 2011; Höning et al., 2005; Collins et al., 
2002). Nevertheless, recent investigations have unveiled that a putative nucleation 
module is assembled prior to AP2 recruitment, marking the site of clathrin 
recruitment and vesicle budding. This module is formed by FCH domain only 
(FCHO) proteins, intersectins, and epithelial growth factor receptor (EGFR) pathway 
substrate (EPS15), and it is recruited to the plasma membrane through PI(4,5)P2 
interaction (Fig. 9). The F-BAR domain of FCHO proteins can only bind to 
membranes with very low curvature, but its membrane-bending activity starts to 
generate a slight curvature necessary for procedure progression (Stimpson et al., 2009; 
Henne et al., 2010). 
1.6.1.2. Cargo selection 
As previously mentioned, the proteins of the putative nucleation module are in 
charge of recruiting AP2 to the plasma membrane in order to mediate cargo selection 
in collaboration with other cargo-specific adaptors and clathrin polymerization (Fig. 
9). Due to its specific interaction with PI(4,5)P2, AP2 is exclusively acting in the 
plasma membrane, while similar adaptor proteins work in CCP formation from other 
membranous compartments (Robinson, 2004). AP2 is the most abundant protein 
component in CDE after clathrin and acts as a major hub of interaction during CCP 
maturation, making it one of the key components of the endocytic pathway (Blondeau 
et al., 2004). Together with AP2, a broad range of accessory adaptor proteins are 
required for specific cargo selection. For example, Dishevelled interacts with Frizzled 
(Yu et al., 2007), stonin 2 binds to synaptojanin (Haucke and De Camilli, 1999), Numb 
recruits Notch (Giebel and Wodarz, 2012), and β-arrestin sequesters G protein-
coupled receptors (GPCR) (Shukla et al., 2014). Whichever is the case, the accessory 
adaptor always binds to the core AP2 (Edeling et al., 2006). Also, FCHO proteins 
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contain a ligand-binding domain, meaning cargo selection might start as early as CCP 
nucleation (Henne et al., 2010). Moreover, the AP180 amino-terminal (ANTH) and 
epsin N-terminal homology (ENTH) domains, which are membrane-binding and 
membrane-bending proteins, respectively, are also able to address cargo selection 
(Ford et al., 2001; Ford et al., 2002). It has been recently postulated that all of the 
proteins listed here and others involved in cargo selection are also curvature effectors 
in order to ensure that curvature is generated independently of the nature of the cargo 
(McMahon and Boucrot, 2011). 
1.6.1.3. Clathrin coat assembly 
After cargo has been selected and bound to AP2, around 100 soluble clathrin 
triskelia per vesicle are recruited from the cytosol to aid in coat formation in a 
combination of hexagonal and pentagonal arrays (Fig. 9) (McMahon and Boucrot, 
2011). As a consequence of clathrin polymerization, the pit curvature is stabilized and 
some adaptor proteins, like epsin and EPS15, are displaced to the edge of the pit 
where they function more effectively (Hinrichsen et al., 2006). Traditionally, it has 
been assumed that vesicle curvature is given by clathrin polymerization. However, 
clathrin binds to the flexible domains of AP2, AP180, and epsin, suggesting that the 
bending strength that clathrin imparts is not enough and that other curvature effectors 
are necessary to force vesicle bending (McMahon and Boucrot, 2011).  
1.6.1.4. Vesicle scission 
Prior to the complete scission of the clathrin-coated vesicle, a high negative 
curvature neck must be formed to close the gap left by the internalized section of 
membrane. This mechanochemical process is driven by dynamin (Kosaka and Ikeda, 
1983), which is recruited to this particular region by BAR domain-containing 
proteins, such as endophilin, amphiphysin, and sorting nexin (SNX9), that bind to 
high curvature membranes, like in the neck of budding vesicles, through a Pro-rich 
domain that interacts directly with the SRC homology (SH3) domains of these 
proteins (Ferguson et al., 2009). Dynamin polymerizes around the neck and undergoes 
a conformational change upon guanosine triphosphate (GTP) hydrolysis, leading to 
membrane fission (Fig. 9) (Sweitzer and Hinshaw, 1998). 
 
   
	  	   	   	  
	   1.	  Introduction	   	  	   	  
31	  
1.6.1.5. Vesicle uncoating 
Once the vesicle is detached from the plasma membrane, the clathrin 
machinery must be disassembled and returned back into the cytosol to be reused for 
another round of CCP formation and to allow endosome fusion with other vesicles 
(McMahon and Boucrot, 2011). Clathrin-coat disassembly is driven by the ATPase 
heat shock cognate (HSC70) and its cofactor, auxilin (Fig. 9). After the clathrin-coated 
vesicle buds, auxilin is recruited to the ankles and terminal domains of clathrin 
triskelia. Subsequently, HSC70 is recruited by auxilin towards the foot of the tripod 
formed by clathrin where the uncoating reaction starts (Schlossman et al., 1984; 
Ungewickell et al., 1995). According to in vitro studies, one auxilin and three or less 
HSC70 proteins per triskelia are required to achieve the maximum disassembly rate 
(Böcking et al., 2011). It has been predicted that this uncoating process can only occur 
due to the fact that the clathrin-coated sphere is not complete. Indeed, when vesicle 
scission takes place, the clathrin-coating does not proceed over the zone where the 
neck was present, leaving a gap where disassembly can easily be initiated (McMahon 
and Boucrot, 2011). Together with HSC70 and auxilin, changes in the PI 
composition of the clathrin-coated vesicle are necessary for clathrin disassembly. 
PI(4,5)P2 phosphatase synaptojanin mediates this process, but whether PI(4,5)P2 
dephosphorylation facilitates auxilin recruitment or activates any other mechanisms 
remains unknown (Cremona et al., 1999).   
  
1.6.2. PI conversion during CDE  
Together with clathrin and AP2, PI(4,5)P2 is a key hub in CDE. Its initial 
presence is as essential as the subsequently regulated dephosphorylation to other PIP 
species across the clathrin-coated vesicle. CCP nucleation is highly dependent on the 
general abundance of PI(4,5)P2 in the plasma membrane since numerous endocytic 
adaptor proteins required for CCP initiation, like AP2, recognize this phospholipid 
(Fig. 10). PI(4,5)P2 is synthesized in the plasma membrane from PI4P by type I 
phosphatidylinositol phosphate 5’-kinases (PIP5K) α, β, and γ, and CCP nucleation 
depends on their activity since enhanced PI(4,5)P2 synthesis leads to an increase of 
CCP events (Balla, 2013; Antonescu et al., 2011).  
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Figure 10. PI conversion along clathrin-coated vesicle formation. PI(4,5)P2 enrichment (red) is 
required for FCHO and AP2 recruitment to the plasma membrane during CDE nucleation, and it 
is generated by PIP5K. CCP maturation is driven by progressive lipid conversion from PI(4,5)P2 
to PI(3,4)P2 (green). First, synaptojanin and SHIP2 dephosphorylate PI(4,5)P2 to form PI4P 
(yellow) and then, PI3K C2α phosphorylates it, forming PI(3,4)P2 in order to facilitate 
recruitment of SNX9. After vesicle scission, PI(3,4)P2 (green) might be dephosphorylated to form 
PI3P (blue) by INPP4A/B. Adapted from BBA-Molecular and Cell Biology of Lipids, 
1851(6), Posor, Y., Eichhorn-Grünig, M. and Haucke, V., “Phosphoinositides in endocytosis”, 
p 799, Copyright (2015), with permission from Elsevier. 
 
During CCP maturation, 5-phosphatase synaptojanin-p170 (Snj1) and SH2 
domain containing inositol 5-phosphatase (SHIP2) are recruited to the core of the 
CCP (Antonescu et al., 2011; Nakatsu et al., 2010). At this stage of the procedure, the 
dependence of clathrin coat stability on PI(4,5)P2 associated adaptor proteins may be 
reduced, meaning that PI(4,5)P2 presence in this plasma membrane region is not 
essential and can be readily converted to PI4P by the 5-phosphatases (Fig. 10) (Posor et 
al., 2015; Antonescu et al., 2011). Then, PI3K C2α is recruited to the CCP in a 
clathrin-dependent manner to enable PI4P conversion to PI(3,4)P2 (Fig. 10) 
(Hammond et al., 2012; Nakatsu et al., 2010) . PI(3,4)P2 production allows SNX9 
recruitment and facilitates the transition of an open shallow CCP to an Ω–shaped 
structure, both needed for vesicle scission (Posor et al., 2013). Moreover, as was 
previously mentioned, this postulated switch from PI(4,5)P2 to PI(3,4)P2 might also 
facilitate clathrin-coated vesicle uncoating by recruitment of HSC70 and auxilin 
(Cremona et al., 1999).  
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1.6.3. Clathrin-coated pits and plaques  
Although CDE has been explained in the CCP formation context, in eukaryotic cells 
two different ways of clathrin-mediated uptake exist. The aforementioned “canonical” 
pathway is where the coated pit leads to a curved clathrin lattice that deforms the 
underlying membrane, giving rise to the coated vesicles. However, clathrin-coated 
plaques are formed by a large extended clathrin lattice formed almost exclusively by 
hexagonal arrays, leading to low curvature budding endocytosis. Therefore, while pits 
are small and rapidly internalized (less than 2-3 min), plaques are much larger and the 
internalization slows down (several minutes). Presence of pits, plaques, or both 
together on the cell surface depends on the role of the membrane domain. For 
example, in Henrietta Lacks (HeLa) or Swiss albino mouse embryo tissue (Swiss 3T3) 
cells, the long-lived coated plaques are at the adherent surface in contact with the 
culture dish, whereas most, if not all, the clathrin-coated vesicles formed at the free 
surface are pits (Saffarian et al., 2009). 
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Aberrant protein expression of the dual specificity phosphatase PRL-3 is 
involved in the development of cancer progression and metastasis. Interestingly, while 
its expression has been observed in a variety of cancer cells and tissues, it is barely 
found in healthy human adult tissue. Clinical and cell culture studies have revealed 
that PRL-3 overexpression leads to the activation of several oncogenic signaling 
pathways involved in cell proliferation, migration, invasion, and EMT. While 
enhanced cell growth can be explained by PRL-3’s interaction with CNNMs, the 
exact molecular mechanisms behind the other phenotypes remain obscure due to the 
lack of PRL-3 substrates.  
Since PRL-3 has been predominantly linked to cancers of epithelial origin, the 
group of Dr. Köhn has focused their studies on the dissection of the role of PRL-3 in 
epithelial cells leading to a cancer-related phenotype in 3D MDCK cyst model. 
Therefore, the challenging main goal of my thesis was to discover putative PRL-3 
substrates in an organotypic 3D cell culture model in order to shed light into the 
mechanisms by which PRL-3 promotes epithelium-derived cancer. In chapter 3, 
entitled “The role of PRL-3 in epithelial architecture”, a phosphoproteomics 
approach was envisioned in an epithelial 3D cell culture model to elucidate PRL-3 
substrates, followed by restricting the substrate searching window to the cellular 
context of PRL-3 action, defined through a fluorescent microscopy study of MDCK 
cystogenesis that was started previously by Dr. Giulia Varsano in the Köhn group.  
The pursuit of PRL-3 substrates was followed in a non-protein context in 
chapter 4, entitled “The role of PRL-3 in clathrin-dependent endocytosis”. 
Previously, our lab has published that PRL-3 has PI(4,5)P2 phosphatase activity in 
vitro. My goal was to further corroborate this finding in vivo and to search for a cellular 
function for this novel PRL-3 activity. Since PI(4,5)P2 homeostasis is necessary for 
CDE and PRL-3 is internalized through this specific endocytic pathway, I focused my 
research on this context. 
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PRL-3 accelerates cytokinesis timing, altering the post-mitotic 
midbody position during epithelial development and 
maintenance 
 
3.1. Results 
Aberrant pathological PRL-3 mRNA and protein expression has been found 
throughout several cancer types, but according to the cell type origin, most are 
epithelial cancer (Rios et al., 2013; Al-Aidaroos and Zeng, 2010; Guzińska-
Ustymowicz and Pryczynicz, 2011; Bessette et al., 2008; Rouleau et al., 2006). 
However, the effect of high PRL-3 expression on epithelia development and 
maintenance has never been studied, neither at the cellular nor tissue level. In order 
to examine these effects, the stable overexpression of PRL-3 in MDCK cell cysts, an 
extensively used epithelial cell model (Debnath and Brugge, 2005; Schlüter and 
Margolis, 2009; Bryant et al., 2010; Apodaca, 2010; Bryant et al., 2014; Gálvez-
Santisteban et al., 2012; Rodríguez-Fraticelli et al., 2015), was previously established in 
the Köhn laboratory. Embedded in a gelatinous extracellular protein mixture, single 
MDCK cells are able to develop spherical cysts containing a single hollow lumen in 
the center surrounded by a monolayer of polarized cells facing the apical membrane 
to the lumen and the basal membrane to the extracellular matrix (Schlüter and 
Margolis, 2009). Since actin is enriched below the apical membrane, it is used as an 
apical marker as well as to delineate the lumen of the cyst (Fig. 11A). In this model, 
the Köhn group demonstrated that the overexpression of the wild type (WT) version 
of PRL-3 fused to GFP frequently led to the abnormal formation of multiple lumens 
within a cyst (Fig. 11B,D), a phenotype related with cancer progression through 
epithelia architecture disruption (Debnath and Brugge, 2005; Hao et al., 2010; Jaffe et 
al., 2008; Schlüter et al., 2009). This defect depends on PRL-3 phosphatase activity 
because the stable overexpression of the catalytically inactive GFP-fused mutant of 
PRL-3 (GFP-PRL-3 C104S) in MDCK cysts did not show a different phenotype 
compared to the parental phenotype (Fig. 11C,D).  
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Figure 11. PRL-3 WT overexpression in MDCK 3D-cysts led to ectopic lumen formation. 
A-C 3D reconstruction of 72 hr parental (A), GFP-PRL-3 WT (B), or GFP-PRL-3 C104S 
(C) overexpressing MDCK cysts. Representative 2D plane from the selected cysts is shown in the 
bottom left corner. Scale bars, 5 μm. D Amount of MDCK cysts with a single lumen at 72 hr. 
Mean ± SEM of three independent experiments. n=300. Adapted by permission from Company 
of Biologists LTD: JCS (Lujan et al.), copyright (2016). 
 
3.1.1. PRL-3 down-regulation is needed in healthy epithelial cells 
For a deeper phenotypic characterization, the levels of GFP-PRL-3 (WT and 
C014S) in MDCK stable cell lines, which are a pool of GFP positive clones, were first 
analyzed to ensure that the findings were due to a difference in protein expression. 
The PRL-3 protein is tightly regulated in cells (Myung Suk Choi et al., 2011; Xing et 
al., 2016) leading to heterogeneous cell-to-cell PRL-3 expression levels, in which 
sometimes expression is even completely lost. Therefore, repetitive FACS selection of 
GFP positive cells was carried out to maintain a population that was as homogeneous 
as possible. Due to their innate heterogeneity, PRL-3 protein levels were analyzed by 
flow cytometry, a single cell analysis method. Figure 12 illustrates this heterogeneity 
and shows that GFP-PRL-3 C104S expression was higher overall than the WT 
version, suggesting that the phenotype described in MDCK cysts was due in fact to 
the phosphatase activity of PRL-3. 
 
Figure 12. Population distribution of GFP-
fused PRL-3 WT or C104S content in MDCK 
cells measured by flow cytometry. Black: MDCK; 
green: MDCK GFP-PRL-3 WT; red: MDCK 
GFP-PRL-3 C104S. The experiment was done 
in triplicate. n=2x105 cells/replicate. Adapted 
by permission from Company of Biologists LTD: 
JCS (Lujan et al.), copyright (2016). 
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In order to discard the notion that this phenotype is cell type specific, PRL-3 
overexpression was also carried out in Caco-2 cells, another widely used epithelial cell 
model (Jaffe et al., 2008; Ivanov et al., 2008; Townley et al., 2012). In contact with 
extracellular matrix, Caco-2 cells also develop into spherical single-centered lumen-
containing cysts like MDCK (Fig. 13A). As expected, the stable overexpression of 
GFP-PRL-3 WT in Caco-2 cysts also disrupted the parental phenotype by multiple 
lumen formation (Fig. 13B,D) and the catalytically inactive mutant (PRL-3 C104S) 
showed a phenotype comparable to the control (Fig. 13C,D), supporting the idea that 
the effect of PRL-3 on epithelia architecture is not cell type specific. 
 
Figure 13. PRL-3 WT overexpression in Caco-2 cysts also led to ectopic lumen formation. A-
C Confocal images of 72 hr parental (A), GFP-PRL-3 WT (B) or GFP-PRL-3 C104S (C) 
overexpressing Caco-2 cysts. Scale bars, 10 μm. D Amount of Caco-2 cysts with a single lumen 
at 72 hr. n=300. Mean ± SEM of three independent experiments. Adapted by permission from 
Company of Biologists LTD: JCS (Lujan et al.), copyright (2016). 
 
To further study the effect of the phosphatase activity of PRL-3 in MDCK cysts, 
PRL-3 activity was modulated by mutation. In the Köhn group, it has been recently 
found that mutation of the glutamic acid of the PRL-3 catalytic site (PRL-3 E50R) 
increases its phosphatase activity against un-natural substrates (DiFMUP) and in vitro 
characterized substrates like PI(4,5)P2 (B. Hoeger, M. Köhn, unpublished data). The 
stable overexpression of GFP-PRL-3 E50R in MDCK cysts did not show any 
difference compared to PRL-3 WT (Fig. 14A,B), suggesting that the aggressiveness of 
the phenotype does not depend on PRL-3 activity. Moreover, in order to ascertain if 
the phenotype was specific for PRL-3 or common for all PRLs since they are all 
related to cancer but have different outcomes and prognoses (Rios et al., 2013), GFP-
PRL-1 WT was transiently electroporated into MDCK cysts. Figure 14C,D shows 
that transfection with PRL-1 also leads to the multiple lumen phenotype of MDCK 
cysts but to a lesser extent compared to the PRL-3 WT, demonstrating that although 
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both of them show a similar phenotype, the degree of architectural disruption may be 
due to difference in substrate specificity (Rios et al., 2013; McParland et al., 2011). 
 
Figure 14. PRL-3 E50R and PRL-1 WT overexpression in MDCK cysts also led to ectopic 
lumen formation. A,C Confocal images of 72 hr GFP-PRL-3 E50R (A) or GFP-PRL-1 WT 
(C) overexpressing MDCK cysts. Scale bars, 10 μm. B,D Amount of MDCK cysts with a 
single lumen at 72 hr. n=300. Mean ± SEM of three independent experiments. C and D are 
adapted by permission from Company of Biologists LTD: JCS (Lujan et al.), copyright (2016). 
 
Consistent with the normal phenotype shown upon PRL-3 C104S 
overexpression in both MDCK and Caco-2 cysts, the multiple lumen phenotype 
observed for PRL-3 WT overexpressing cysts can be rescued in a concentration-
dependent manner when treated with a cell-permeable selective PRL inhibitor, 
Analog 3 (Hoeger et al., 2014) (Fig. 15A,B). Consequently, parental and GFP-PRL-3 
C104S overexpressing Caco-2 cysts do not show any change in the number of single 
lumen-containing cysts upon Analog 3 treatment (Fig. 15B). Nevertheless, MDCK 
cysts and cysts overexpressing GFP-PRL-3 C104S treated with Analog 3 slightly 
increased the proportion of normal cysts (Fig. 15A). This behavior could be due to the 
presence of endogenous PRL-3 in MDCK cells, but also to endogenous PRL-1 or 
PRL-2 since I have previously demonstrated that PRL-1 overexpression also gives rise 
to a similar phenotype, and Analog 3 inhibits all PRLs (Hoeger et al., 2014).  
 
Figure 15. Multiple-lumen phenotype of MDCK cysts upon PRL-3 WT overexpression in 
MDCK cysts can be reverted with PRL inhibitor Analog 3. Graphs represent the amount of cysts 
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with a single lumen in 72 hr MDCK (A) or Caco-2 (B) cysts or cysts stably expressing GFP-
PRL-3 WT or GFP-PRL-3 C104S. Cells were treated with Analog 3 or DMSO as a control. 
n = 300. Mean ± SEM of three independent experiments. Adapted by permission from Company 
of Biologists LTD: JCS (Lujan et al.), copyright (2016).  
 
In order to clarify this finding, a considerable number of unsuccessful attempts 
were conducted to detect endogenous PRL-3 WT in MDCK and Caco-2 cells by 
Western blot (WB), using the Michigan Cancer Foundation breast cancer (MCF-7) 
and the Homo sapiens colon colorectal carcinoma (HCT116) cell lines as positive 
controls (data not shown) (Geiger et al., 2012; Wang et al., 2010; Xing et al., 2016). 
Additionally, several specific PRL-3 antibodies from different sources were used, but 
all failed. To increase the sensitivity of the assay, different approaches were taken 
including loading up to 400 μg of total cell protein per sample; pre-treating cells with 
MG-132, a proteasome inhibitor, to avoid protein degradation; or 
immunoprecipitating PRL-3 from whole cell lysates. Unfortunately, it was not possible 
to detect endogenous PRL-3 using any of these methods. Moreover, most of the 
antibodies applied were not selective enough and membrane blots showed extra bands 
in the region where PRL-3 was expected to be found. Since PRL-3 lipidation can 
affect its migration in sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE), the expected molecular weight in the blotted membrane might not 
correspond to the real one. Therefore, since the band detected in the region near the 
molecular weight of PRL-3 cannot be directly discarded as unspecific binding of the 
antibody, PRL-3 knockdown was done in MCF-7 and HCT116 cells to study the 
origin of those bands. Silencing efficiency was confirmed by reverse transcription 
polymerase chain reaction (RT-PCR), but the same band appeared in both control 
and PRL-3 knockdown cells, showing that the resulting bands were, indeed, due to 
antibody unspecificity. Sections 5.3.7. and 5.3.8. contain a deeper explanation of the 
different approaches to detect endogenous PRL-3 by WB. 
Since endogenous PRL-3 detection was not possible by WB, a deep mass-
spectrometric (MS) analysis, used to detect proteins with low expression levels, was 
carried out in MDCK cells overexpressing human GFP-PRL-3 WT and GFP-PRL-3 
C104S as internal human PRL-3 controls in collaboration with Marco Hennrich from 
the group of Dr. Anne-Claude Gavin (Structural and Computational Biology Unit, 
EMBL Heidelberg). The overexpressed human version of PRL-3 was detected, 
confirming that the analysis worked properly, but endogenous dog PRL-3 was not 
detected. Interestingly, peptides corresponding to dog PRL-1 and PRL-2 were also 
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detected, though no distinction could be made between them due to a high sequence 
consensus for both proteins. These results suggest that the slight increase in single 
lumen-containing cyst percentage of parental and GFP-PRL-3 C104S overexpressing 
MDCK cysts under Analog 3 treatment might be due to endogenous PRL-1 and/or 
PRL-2, confirming that other PRLs are able to exert the observed phenotype on 
MDCK cystogenesis. 
Although deep MS did not detect endogenous PRL-3, undetectable levels of the 
phosphatase may still be present, which could affect lumen formation. Therefore, 
PRL-3 was knocked down by small interfering RNA (siRNA) in MDCK and Caco-2 
cysts and knockdown efficiency was confirmed by RT-PCR (Fig. 16). No difference in 
the proportion of single lumen-containing cysts was observed after PRL-3 knockdown 
compared to control, indicating the absence of PRL-3 in both epithelial cell systems 
and suggesting that PRL-3 might not be needed for cell polarity.   
 
Figure 16. MDCK and Caco-2 cells do not contain endogenous PRL-3. A DNA 
multiple alignment of sense PRL-3 siRNA sequence with human PRL-1, -2 and -3. 
Several mismatches with PRL-1 and -2 make unspecific knockdown unlikely. B 
Proportion of single lumen MDCK cysts electroporated with control or PRL-3 siRNA 
after 48 hr. PRL-3 mRNA content was measured by one-step RT-PCR using ACTB 
mRNA as loading control. C Proportion of single lumen Caco-2 cysts transfected with 
control or PRL-3 siRNA after 48 hr. PRL-3 mRNA content was measured by one-step 
RT-PCR using RNA pol II mRNA as control. B,C n=300. Mean ± SEM of three 
independent experiments. Adapted by permission from Company of Biologists LTD: JCS 
(Lujan et al.), copyright (2016). 
 
It is remarkable that, during the development of the previous experiments, 
PRL-3 mRNA was always measurable by RT-PCR (Fig. 16A,B), but no protein level 
was detected. This observation was already made in several cell lines where PRL-3 
mRNA is widely expressed, but only a few of them contained detectable levels of the 
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translated protein (Rubio and Köhn, 2016; Wang et al., 2010). Since this particular 
phenotype can be achieved through either translation inhibition (Wang et al., 2010) or 
by oppressive protein degradation (Xing et al., 2016; Myung Suk Choi et al., 2011), 
PRL-3 mRNA translation was studied by polysome fractionation (Chassé et al., 2016; 
Spangenberg et al., 2013) in MDCK cells overexpressing human GFP-PRL-3 WT as 
an internal control. This approach allows the separation of untranslated free mRNA 
from translated mRNA, which is bound to several ribosomes (polysome), by sucrose 
gradient centrifugation (Fig. 17A). After sample division and mRNA extraction, the 
levels of hPTP4A3 (human PRL-3), dPTP4A3 (dog PRL-3), and Renilla (loading 
control) mRNA in each fraction were measured by RT-PCR.  
 
Figure 17. Endogenous PRL-3 mRNA is translated in MDCK cells. A MDCK polysome 
fractionation: protein absorption detection from MDCK cell lysate solved by gradient 
centrifugation and collected in 1 mL fractions. B Extracted mRNA was assayed by one-step RT-
PCR using Renilla mRNA as an extraction and loading control. C mRNA intensity 
quantification from the bands plotted in B. Adapted by permission from Company of Biologists 
LTD: JCS (Lujan et al.), copyright (2016). 
 
As expected, hPTP4A3 was translated and the difference between translated and 
free mRNA was less than 25% (Fig. 17B,C). However, dPTP4A3 was also translated 
(Fig. 17B,C) and the amount of polysome bound mRNA was 6 times bigger than free 
mRNA, implying that dPRL-3 is constantly translated in MDCK cells. This result 
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suggests that PRL-3 protein down-regulation might be driven by protein degradation. 
In this scenario, the equilibrium between translation and degradation is shifted 
towards translation for hPRL-3 and degradation for dPRL-3. This dynamic 
equilibrium is highly regulated and even small differences between two cells from the 
same cell population can result in dramatic changes in protein expression level and 
may explain the heterogeneity in MDCK GFP-PRL-3 (WT or C104S) stable cell lines 
(Fig. 12). 
Since PRL-3 protein is undetectable in both MDCK and Caco-2 cells, it is not 
possible to study the endogenous effect of PRL-3 on cell polarity using these 
established epithelial cell models. Indeed, there is no epithelial cell line available at 
this time that develops into these hollow round-shaped cysts containing detectable 
levels of PRL-3 protein. Therefore, we used MCF-7 breast cancer cells, the only 
epithelial cell line that expresses the PRL-3 protein and is able to form 3D polarized 
structures (Geiger et al., 2012; Wang et al., 2010). Unlike MDCK cysts, MCF-7 cells 
develop into 3D tubular branched structures containing single or multiple actin 
positive lumens in the branch ends when in contact with the extracellular matrix (Fig. 
18A) (Lee et al., 2007; do Amaral et al., 2011). To study the effect of endogenous PRL-
3 in these MCF-7 structures, the phosphatase was first inhibited by treating the cells 
with Analog 3. Figure 18B shows that when cells were treated with the PRL inhibitor, 
the proportion of single lumen-containing branch ends increased in a concentration-
dependent manner.  
 
Figure 18. Endogenous PRL-3 is responsible for the multiple lumen-containing branch ends in 
MCF-7 3D structures. A 3D reconstruction of 15 days grown MCF-7 structure. The dashed 
square highlights a branch end that can present a single lumen (bottom left) or multiple lumens 
(bottom right). Scale bars; 100 μm (up), 50 μm (down). B Proportion of branch ends with 
single lumen in MFC-7 3D structures. Cells were treated with Analog 3 or DMSO (control) for 
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15 days. C DNA multiple alignment of the sense region of PRL-3 shRNA sequence with human 
PRL-1, -2 and -3. D Uninduced or induced PRL-3 knockdown with 1 mM IPTG in control 
cells or PRL-3 shRNA MCF-7 cells over 4 days. PRL-3 mRNA was assayed by one-step RT-
PCR using REEP as a control. E Proportion of branch ends with a single lumen in 3D 
structures of MCF-7 stably expressing IPTG inducible control or PRL-3 shRNA. Cells were 
untreated or treated with 1 mM IPTG for 15 days. B,E n=300. Mean ± SEM of three 
independent experiments. Adapted by permission from Company of Biologists LTD: JCS (Lujan 
et al.), copyright (2016).  
 
In order to corroborate this result, PRL-3 was also knocked down. However, 
since these structures need over 14 days for lumen opening, transient siRNA 
transfection was not viable. Therefore, a stable isopropyl β-D-1 thiogalacto-
pyranoside (IPTG) inducible PRL-3 short hairpin RNA (shRNA) (Fig. 18C) MCF-7 
cell line was made to maintain PRL-3 knockdown during structural development (Fig. 
18D). Upon PRL-3 silencing, the phenotype was comparable to the Analog 3 
treatment (Fig. 18B,E) supporting the previous findings, and together suggesting a 
pathophysiological role of PRL-3 in epithelia-containing organs. 
Besides disruptions in epithelial architecture, enhanced cell proliferation and 
invasion are other cancer hallmarks that can be studied in these epithelial cell models, 
in order to fully understand the effect of PRL-3 in this context. To examine 
invasiveness, parental, GFP-PRL-3 WT, and GFP-PRL-3 C104S overexpressing 
MDCK cysts were cultured in Matrigel-Collagen I (1:1) to allow cell invasion from the 
cyst towards the gelatinous matrix (Kwon et al., 2011). While parental and GFP-PRL-
3-C104S expressing MDCK cyst did not show invasive behavior, MDCK GFP-PRL-
3 WT cysts presented a tubular invasive phenotype (Fig. 19A-D). Regarding 
proliferation, the size of parental, GFP-PRL-3 WT, and GFP-PRL-3 C104S 
overexpressing MDCK cysts was measured at 72 hr, but no difference in cyst size was 
detected (Fig. 19E), showing that PRL-3 overexpression is not related with aberrant 
cell proliferation in this epithelial system. However, this experiment revealed that the 
length of the apical-basal axis in MDCK GFP-PRL-3-C104S cysts increased, which 
lead to smaller lumens (Fig. 19F). This intermediate phenotype in MDCK cysts might 
be due to a substrate-trapping effect, as GFP-PRL-3-C104S can still bind its substrates 
but not dephosphorylate them. 
Taken together, these results are a strong indication of an epithelial cancer-
related phenotype driven by PRL-3, whose overexpression disrupts epithelial 
architecture and enhances cell invasion as its pathophysiological role. Since high levels 
of PRL-3 induce multiple lumen branch ends in MCF-7 3D cell structures, and other 
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epithelial models, like MDCK or Caco-2 3D, do not need the presence of PRL-3 to 
ensure their correct development, a low level or absence of PRL-3 would be needed in 
healthy epithelial tissue to guarantee the correct architecture. 
 
Figure 19. PRL-3 overexpression induces invasiveness in MDCK cysts. A-C Invasion assay: 
Confocal images of 96 hr parental (A), GFP-PRL-3 WT (B), or GFP-PRL-3 C104S (C) 
overexpressing MDCK cysts seeded in Matrigel-Collagen I (1:1). Scale bars, 5 μm. D 
Proportion of invasive cysts 96 hr after seeding. n=60. E Diameter of parental, GFP-PRL-3 
WT, and GFP-PRL-3 C104S MDCK cysts measured 72 hr after seeding. n=90. F Lumen 
radius and distance between apical and basal membranes measured in parental and GFP-PRL-3 
C104S MDCK cysts measured 72 hr after seeding. n=90. D-F Mean ± SEM of three 
independent experiments. Adapted by permission from Company of Biologists LTD: JCS (Lujan 
et al.), copyright (2016). 
 
 
3.1.2. No substrate candidate was found by a phosphoproteomic 
approach in 3D MDCK cysts 
Phosphatase substrate identification can be a really challenging task (Fahs et al., 
2016). This can be even more difficult for PRL-3 as a DSP that can potentially 
dephosphorylate almost any phosphorylated protein and non-protein substrate that is 
also related with cancer promotion, a pathology where several molecular and cellular 
pathways are involved. The range of possibilities is virtually incalculable, so a 
screening process would be required to identify the best candidates for further 
individual study. In order to keep it simple, we reduced the search to polarized 
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epithelial cells using the system previously described in order to link substrate 
candidates to the presented phenotype.  
Hence, a phosphoproteomic approach was done in collaboration with Marco 
Hennrich, from the group of Dr. Anne-Claude Gavin (Structural and Computational 
Biology Unit, EMBL Heidelberg), by analyzing the phosphoproteome from 72 hr 
parental and GFP-PRL-3 C104S overexpressing MDCK cysts compared to MDCK 
GFP-PRL-3 WT MDCK cysts. Prior to MS phosphopeptide identification, the 
sample preparation protocol required some adjustment since the cysts are embedded 
in a matrix that contains high levels of extracellular proteins that must be discarded to 
avoid data masking by those proteins. Although dispase treatment is the most 
commonly used reagent for matrix dissociation (Chee and Pun, 2008), a gentle 
incubation with 0.25 % trypsin was enough to rid samples of the extracellular proteins 
(data not shown). After cellular protein extraction, a tryptic digestion of the protein 
content followed by phosphopeptide enrichment by TiO2 chromatography was 
performed (see Methods section 5.3.10).  
After computational analysis of the data obtained, we looked for 
phosphopeptides enriched more than 1.5 fold in parental and GFP-PRL-3 C104S 
overexpressing MDCK cells in at least 2 out of 3 replicates since we are investigating 
for direct substrates of the phosphatase. From the list obtained in the assay, only 4 hits 
were reliable according to the data filters used: 
• N’-ApSpSLNVLNVGGK-C’ from kinesin light chain-1 (KLC1). Single 
phosphorylation might be in either serine residue with a higher probability at 
S(3) and it is the most reliable hit obtained from the experiment. KLC1 
belongs to the kinesin holoenzyme, an ATP-dependent motor enzyme for 
cargo transport along microtubules in a plus-ended direction. KLC1 functions 
by binding directly to the cargo, while the heavy chains are the motor 
proteins bound to the microtubule (Fig. 20A) (Hirokawa et al., 2009). Kinesins 
are able to move vesicles, so they are involved in the dynamics of Golgi 
apparatus, endoplasmic reticulum, and secretory vesicles (Woźniak and Allan, 
2006; Hirokawa et al., 2009) where PRL-3 has been found (Qi Zeng et al., 
2000), so it is spatially likely that they can interact. Moreover, membrane-
trafficking pathways have been found critical for epithelial cell polarity 
(Apodaca et al., 2012), so perturbations in KLC1 might be involved in this 
process.  
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• N’-GIpSPIVFDR-C’ from YTH domain-containing protein 1 (YTHDC1). It 
is a nuclear alternative splicing regulator that binds specifically to RNAs that 
contain N6-methyladenosine (m6A), a modifier that plays a role in mRNA 
splicing efficiency (Xu et al., 2014). Moreover, YTHDC1 is also present in the 
cytoplasm promoting ribosome loading of its target mRNA (Wang et al., 
2015). Since YTHDC1 cell localization does not correlate with PRL-3 
membranous environment, it was discarded as a direct substrate candidate. 
 
• N’-ELpSNpSPPRENpSFGSPLEFR-C’ from serine/arginine repetitive 
matrix protein 2 (SRRM2). This peptide has up to 3 phosphorylation sites 
and several phosphorylation states have been detected, but drawing absolute 
conclusions with so many possible perturbations is difficult. SRRM2 is a 
spliceosome-associated factor involved in pre-mRNA splicing, sustaining 
precise genome stability and chromosome segregation (Zanini et al., 2017). Its 
exclusive presence in the nucleus suggests that the direct interaction with 
PRL-3 is unlikely. Therefore, SRRM2 was also discarded as a potential PRL-
3 substrate.  
 
• N’-LTFDSSFpSPNTGK-C’ from voltage-dependent anion channel 1 
(VDAC1). Although it contains 3 possible phosphorylation sites, the highest 
probability is at position S(8). VDAC1 is the most abundant VDAC protein 
located in the outer mitochondrial membrane for the exchange of metabolites 
between the cytosol and the mitochondria. Its interaction with B-cell 
lymphoma 2 (Bcl-2) proteins and other anti-apoptotic proteins also confers a 
function in mitochondrial-mediated apoptosis (Shoshan-Barmatz and Ben-
Hail, 2012). Besides its well-described role in mitochondria, it has been more 
recently found in the plasma membrane where, due to the characteristic 
voltage of that membrane, it remains in the closed state and only scaffold 
functions have been described for this localization so far (De Pinto et al., 
2010). Therefore, although it could interact with PRL-3 in the plasma 
membrane, it might not be the reason of the multiple lumen-containing cyst 
phenotype. 
Out of these 4 reliable hits, KLC1 was the only protein that, due to its functions, 
characteristics, and cell localization, would fit as a PRL-3 substrate candidate in the 
phenotype observed in an epithelial context. KLC1 consists of two domains: an α-
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helical coiled-coil heptad repeat domain in charge of interacting with the heavy chain 
and a C-terminal domain formed by six tetratricopeptide domains (TPR) thought to 
mediate cargo interactions followed by a variable sequence that leads to 19 different 
isoforms and infers cargo selectivity (Fig. 20A) (Woźniak and Allan, 2006; McCart et 
al., 2003). Furthermore, this selectivity is tightly regulated by protein phosphorylation 
in the cargo-binding domain and it has been an aim of study for the last several years 
(Vagnoni et al., 2011; Morfini et al., 2002). As expected, the KLC1 down-regulated 
phosphosite detected in 3D MDCK GFP-PRL-3 WT cysts compared to parental and 
GFP-PRL-3 C104S overexpressing MDCK cysts belongs to the cargo-binding 
domain, suggesting that PRL-3 might be regulating vesicle transport by KLC1 
dephosphorylation. Moreover, the intron that contains the phosphosite is only present 
in 4 isoforms named I, J, M, and N (Fig. 20B).  
 
Figure 20. PRL-3 overexpression induces KLC1 dephosphorylation in MDCK cysts. A 
Schematic representation of a kinesis heterotetramer. Kinesin heavy chain (KHC) contains the 
motor domain that binds to microtubule. KLC binds to KHC through the heptad repeat domain 
and to the cargo with the variable sequence. B Alignment of the variable sequence at the C-
terminus of the 4 isoforms that contain the candidate pSer (highlighted) to be dephosphorylated by 
PRL-3. C Western Blot of the λ-phosphatase assay in parental MDCK cells or MDCK stably 
overexpressing GFP-PRL-3 WT or GFP-PRL-3 C104S cells. Anti-KLC1 was used as 
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primary antibody. D Relative protein quantification from the bands plotted in C as a ratio 
between phosphorylated and non-phosphorylated KLC1.  
 
In order to assess KLC1 dephosphorylation by PRL-3, WB was carried out in 
2D parental, GFP-PRL-3 WT, and GFP-PRL-3 C104S overexpressing MDCK cysts 
using a KLC1 antibody to detect the phosphorylation status by run shift in SDS-
PAGE. In order to distinguish between different isoforms or phosphorylation status, 
MDCK cell lysates were treated with λ-phosphatase, a promiscuous phosphatase that 
removes all phosphates from the proteome (Vernia et al., 2009). Consequently, those 
bands that disappear upon λ-phosphatase incubation correspond to the 
phosphorylated version of the isoform that appears right below it, as observed in the 
two upper bands (Fig. 20C). Both band intensities were measured for every sample 
showing that PRL-3 WT was leading to a decrease of phosphorylation of that 
particular isoform as well as λ-phosphatase (Fig. 20C,D), confirming the results found 
by phosphoproteomics. This approach was also used in Caco-2 cells expressing GFP-
PRL-3 WT, but there was no dephosphorylation visible in this epithelial model (data 
not shown), suggesting that KLC1 might be a specific substrate in dog cells or that the 
intron that contains the target phosphoserine (pS) is more abundant in dog than in 
human cells. Indeed, the only dog isoform annotated in the Uniprot database contains 
the target phosphosite. 
Since the phosphoproteomic approach cannot distinguish between direct 
substrates and downstream effects (Fahs et al., 2016), additional biochemical assays are 
necessary. Therefore, to study if KLC1 is a direct substrate of PRL-3, an in vitro 
dephosphorylation assay of the peptide containing the KLC1 target pS was 
performed. The peptide was rationally designed placing the pS in the middle flanked 
by 5 and 6 amino acids on its N- and C-termini, respectively (N’-
MKRASpSLNVLNV-C’). In order to investigate if the peptide was dephosphorylated 
by PRL-3, an Enzcheck assay was carried out. Different concentrations of the peptide 
were incubated with 6 μM of E. Coli purified human PRL-3 and the free phosphate 
resulting from the dephosphorylation was measured by a coupled reaction driven by 
nucleoside phosphorylase (PNP) that incorporates the free phosphate to 2-amino-6-
mercapto-7-methylpurine riboside (MESG). The reaction is followed by absorption 
spectroscopy since the product obtained absorbs at 360nm (Webb, 1992). 
Unfortunately, PRL-3 did not dephosphorylate the KLC1 peptide suggesting that 
KLC1 dephosphorylation might actually be a downstream effect of PRL-3 
overexpression in MDCK 3D cysts (Fig. 21A). As a positive control, 100 μM of lipid 
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PI(4,5)P2 diC8 was used (McParland et al., 2011). Alternatively, both serines may have 
to be phosphorylated for the peptide to become a substrate, resembling the high 
density of negative charges found in PI(4,5)P2. 
In order to confirm this result, Biomol® Green, another free phosphate reporter, 
was used to overcome the incompatibilities with the Enzcheck approach. It is a 1-step 
end point phosphatase measurement method, which is a modification of the classic 
Malachite green reagent (Martin et al., 1985). In this case, slight dephosphorylation 
was detected (Fig. 21B) but was not significant.  
 
Figure 21. PRL-3 does not dephosphorylate KLC1 in vitro. A Enzcheck assay performed with 
6 μM purified human PRL-3 and different concentrations of pSer-containing KLC1 peptide. 
Mean ± SEM of three replicates. B Biomol® Green assayed at 3 different time points of 6 μM 
purified human PRL-3 incubation with different concentrations of pSer-containing KLC1 
peptide. Mean ± SEM of two replicates.  
 
The negative results obtained from the in vitro kinetic assay with the target pS-
containing peptide might be due to the requirement of the protein’s tertiary structure 
for efficient recognition and dephosphorylation by PRL-3. Therefore, the in vitro 
interaction between KLC-1 and PRL-3 was studied to distinguish both possible 
scenarios. With this purpose, parental, GFP-PRL-3 WT, and GFP-PRL-3 C104S 
overexpressing MDCK cells were lysed and a co-immunoprecipitation using anti-GFP 
nanobodies coupled to beads was conducted. In this experiment, the catalytically 
inactive mutant was used as a substrate-trapping control to enhance assay sensitivity, 
stabilizing the interaction between KLC1 and PRL-3 (Fahs et al., 2016). However, no 
interaction was detected by WB (Fig. 22A).  
Since there may be a weak interaction with the KLC1 and it might be limited to 
certain cellular stages, the method used to detect it may not be sensitive enough. 
Therefore, in order to increase the chance of detecting an interaction, co-localization 
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was promoted by lysing cells that were synchronized in cytokinesis since PRL-3 and 
KLC1 localization is enriched in the cytokinetic bridge (Fig. 34A,B) (Ai and Skop, 
2009). Unfortunately, no interaction was detected between KLC1 and PRL-3 WT 
nor KLC1 and PRL-3 C104S (Fig. 22B). Lastly, as an additional confirmation of the 
results, protein interactions and complexes were cross-linked with 1% of 
paraformaldehyde (PFA) in MDCK cell lysates overexpressing GFP-PRL-3 WT, or 
GFP-PRL-3 C104S, or with no overexpression (Kluger and Alagic, 2004; Fahs et al., 
2016). As expected, these results further confirmed that KLC1 is not interacting with 
PRL-3 (Fig. 22C), strongly suggesting that KLC1 dephosphorylation might be a 
downstream effect of PRL-3 overexpression in MDCK 3D cysts. 
 
Figure 22. PRL-3 does not physically interact with KLC1 in MDCK cells. Western Blot of 
GFP immunoprecipitation (IP) in untreated (A), synchronized in cytokinesis (B), or cross-linked 
with PFA (C) parental MDCK cells or MDCK cells stably overexpressing GFP-PRL-3 WT or 
GFP-PRL-3 C104S. Anti-KLC1 and anti-GFP were used as primary antibodies. GFP pull-
down efficiency analyzed by GFP presence in the raw cell lysate (input) and after IP (SN) is also 
shown.  
  
Although KLC1 does not seem to be a PRL-3 substrate, variation of its 
phosphorylation status as a result of upstream effects can originate from different 
localizations within the polarized MDCK cells. In parental MDCK 3D cysts, KLC1 
accumulated between the apical membrane and the nucleus (Fig. 23A) as expected 
since vesicle traffic toward the apical membrane is increased (Ai and Skop, 2009). 
Upon GFP-PRL-3 WT overexpression, KLC1 preserved its characteristic localization 
and, moreover, it did not seem to co-localize with PRL-3 (Fig. 23B,C).  
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Figure 23. PRL-3 WT does not co-localize with KLC1 in MDCK cysts. Confocal images of 
48 hr parental (A), GFP-PRL-3 WT (B), or GFP-PRL-3 C104S (C) overexpressing 
MDCK cysts stained with KLC1 antibody (magenta). Bottom: higher magnification images of the 
indicated regions showing KLC1 (left), PRL-3 (middle), and actin (right). Scale bars, 10 μm.  
 
Taken together, these results suggest that KLC1 dephosphorylation in PRL-3 
WT overexpressing MDCK cysts might be a downstream effect of aberrant 
phosphatase expression and might not be related with KLC1 cellular localization. 
However, the target phosphosite of KLC1 is only present in 4 out of 19 human 
isoforms. Therefore, a deeper study of each isolated tagged isoform could give a better 
picture of the effect of PRL-3 on the protein. Relative abundance of each isoform in 
cells is unknown, so the possibility that these 4 isoforms are not being abundant must 
be taken into consideration when an antibody that recognize all isoforms is used, as it 
is the case (Figs. 20C,D, 22A-C, 23A-C). Therefore, since the results obtained so far 
are not solid enough to rule out KLC1 as a direct substrate, further experiments 
should be performed in this direction.  
Besides the four hits from the phosphoproteomic assay previously mentioned, 
another 282 phosphopeptides (Appendix, Table1) were found to be up- or down-
regulated upon GFP-PRL-3 WT overexpression in MDCK cysts in 1 out of 3 
replicates. One of these hits was plakophilin-4 (PKP4) with 3 down-regulated pS-
containing phosphopeptides. PKP4 is an established binding partner in desmosomes 
and adherens junctions, both key for epithelia impermeability and epithelial cell 
polarity maintenance (Hofmann et al., 2009; Desai et al., 2009). Moreover, PKP4 
activity is related with Ras homolog family member A (RhoA), much like PRL-3 
(Ming et al., 2009). Therefore, PKP4 was assessed for its potential as a PRL-3 
substrate. 
PRL-3 C104S/KLC1/Actin/NucleiKLC1/Actin/Nuclei PRL-3 WT/KLC1/Actin/Nuclei
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First, to confirm the result obtained by phosphoproteomics, PKP4 
dephosphorylation by PRL-3 was analyzed on 2D MDCK cell lysate by adding 
different concentrations of E. Coli purified human PRL-3. Since there is no antibody 
available that selectively recognizes any of the PKP4 pS candidates, PKP4 was 
isolated by immunoprecipitation and incubated with PRL-3. Its phosphorylation 
status was measured by WB with a total anti-pS antibody. Surprisingly, in these 
conditions PKP4 was not phosphorylated (Fig. 24A) suggesting that it might only be 
phosphorylated in polarized cells. Repeating this experiment with polarized MDCK 
cell lysate requires a difficult technical set up. Due to this technical limitation, it was 
decided to assess whether PKP4 is a direct PRL-3 substrate beforehand by an in vitro 
dephosphorylation assay. 
Similar to the approach taken for KLC1, 3 peptides containing the pSer 
candidates in the middle of the sequence were purchased: PL1 à N’-
GQVGSSpSPKRSG-C’; PL2 à N’-GQDLRpSAVSPDL-C’; and PL3 à N’-
DLRSAVpSPDLHI-C’. The phosphatase activity of 6 μM of E. Coli purified human 
PRL-3 against each peptide was monitored by Enzcheck assay, and 100 μM of lipid 
PI(4,5)P2 diC8 was used as a positive control to test the intrinsic phosphatase activity of 
PRL-3. The results showed that PRL-3 was not able to dephosphorylate any of the 
proposed peptides (Fig. 24B), indicating that PKP4 is not a direct PRL-3 substrate. 
The absence of activity could be due to the lack of the tertiary protein structure of 
PKP4, and although it cannot be completely discarded as a potential substrate, no 
deeper investigations were pursued at this time. 
 
Figure 24. PRL-3 WT does not dephosphorylate PKP4 in vitro. A Western Blot from PKP4 
isolated from non MDCK cells and incubated with different concentrations of purified human 
PRL-3 (Ponceau staining). Dashed white lines mark the position of PKP4 that is not 
phosphorylated in non-polarized MDCK cells. B Enzcheck assay performed with 6 μM purified 
human PRL-3 and different concentrations of pSer-containing PKP4 peptides. Mean ± SEM of 
three replicates. 
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Another member of the plakophilin family, plakophilin-2 (PKP2), was also 
found as a protein-protein interaction candidate in a glutathione S-transferase 
(GST)-PRL-3 WT pull down in human embryonic kidney (Hek293) cells carried 
out previously by Dr. Giulia Varsano in the Köhn lab. Since PKP2 is also a 
component of the desmosome (Kirchner et al., 2012), it would be interesting to see if 
this interaction might explain the multiple lumen-containing MDCK cyst 
phenotype upon PRL-3 overexpression. As a first approach, the interaction 
detected in the large screening was assessed by PKP2 co-immunoprecipitation with 
GFP-PRL-3 in MDCK cells using GFP nanobodies coupled to beads. Besides GFP-
PRL-3 WT, GFP-PRL-3 C104S was used to stabilize the interaction due to its 
substrate-trapping effect. GFP-PRL-3 E50R was also utilized to determine if an 
increase of the phosphatase activity would lead to any change in PKP2. Based on 
the results seen in Figure 25A, PKP2 was discarded as an interaction partner with 
PRL-3.  
 
Figure 25. PRL-3 WT does not interact with PKP2. A Western Blot of GFP 
immunoprecipitation (IP) from parental MDCK cells or MDCK stably overexpressing GFP-
PRL-3 (WT, C104S, or E50R) cells. Anti-PKP2 and anti-GFP were used as primary 
antibodies. GFP pull-down efficiency is shown comparing GFP levels in IP and input. B-D 
Confocal images of 96 hr parental (A), GFP-PRL-3 WT (B), or GFP-PRL-3 C104S (C) 
overexpressing MDCK cysts stained with a PKP4 antibody (magenta). Bottom: higher 
magnification images of the indicated regions showing PKP2 (left), PRL-3 (middle), actin 
(right). Scale bars, 10 μm. 
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To remove any doubt, PKP2 localization was analyzed in 96 hr parental, GFP-
PRL-3 WT, and GFP-PRL-3 C104S overexpressing MDCK cysts fixed and stained 
with a PKP2 antibody. PKP2 is enriched in the lateral membrane in parental MDCK 
cysts (Fig. 25B) and this pattern does not change upon GFP-PRL-3 WT or GFP-PRL-
3 C104S overexpression (Fig. 25C,D). Additionally, PKP2 was not enriched where 
PRL-3 was concentrated (Fig. 25C,D). Altogether, these results suggest that PKP2 is 
not a PRL-3 interacting protein. 
In conclusion, the unsuccessful results obtained from the phosphoproteomic 
assay forced us to approach our PRL-3 substrate research in MDCK 3D cysts from 
another angle. Instead of looking for a substrate that could explain the phenotype first, 
we decided to undertake a deeper cellular study into the physical phenotype in order 
to decipher the original cellular process affected by PRL-3. The elucidation of this 
process would narrow our scope and simplify the search for PRL-3 substrates. 
 
3.1.3. PRL-3 induces fully polarized ectopic lumens from incorrectly 
localized AMIS 
The apical-basal cell polarity is established in MDCK cysts right after the first 
cell division, when the membranes that are in cell-cell contact acquire a clear apical 
identity in the center, and lateral identity between the apical and the basal membrane 
(Apodaca et al., 2012; Bryant et al., 2010; Apodaca, 2010). In order to find the cellular 
origin of the multiple lumen MDCK cyst phenotype, the cystogenesis process was 
studied in the reverse direction from how it naturally occurs. First, the resulting 
ectopic lumens that arose upon PRL-3 WT overexpression were analyzed to describe 
if they were still fully polarized. 
Well-defined tight junctions are formed during lumen opening, so we 
investigated the localization of these tight junctions in the ectopic lumens from PRL-3 
WT cysts. As a tight junction marker, the ZO-1 antibody, was used in 72 hr parental, 
GFP-PRL-3 WT, and GFP-PRL-3 C104S overexpressing MDCK cysts. Tight 
junctions were found localized to the boundary between the apical and lateral 
membrane flanking the central lumen in parental and GFP-PRL-3 C104S MDCK 
cysts (Fig. 26 A,C,D) as previously reported (Bryant et al., 2010; Martin-Belmonte et 
al., 2007). PRL-3-induced ectopic lumens were also surrounded by tight junctions 
(Fig. 26 B,D). Three dimensional reconstruction analysis of 660 cysts revealed that 
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these ectopic lumens seem to arise between lateral membranes and may be shared by 
two or more cells. Moreover, the architecture of these lumens can stay symmetric 
between cells like the central lumen in parental MDCK cysts, or show an invasive 
behavior towards one of the cells still flanked by tight junctions (Fig. 26 B,E).  
 
Figure 26. The appearance of ectopic lumens upon PRL-3 WT overexpression maintain intact 
tight junctions in MDCK cysts. A-C Confocal images of 72 hr parental (A), GFP-PRL-3 WT 
(B), or GFP-PRL-3 C104S (C) overexpressing MDCK cysts stained with a ZO-1 antibody 
(magenta). Right: higher magnification images of the indicated regions showing ZO-1 (up), actin 
(middle), PRL-3 (down). Scale bars, 10 μm. D The proportion of cysts with ZO-1 staining in 
the lumen. n=90. Mean ± SEM of three independent experiments. E Schematic representation of 
MDCK cells overexpressing PRL-3 WT presenting an asymmetric invasive ectopic lumen flanked 
with ZO-1 (magenta dots). Adapted by permission from Company of Biologists LTD: JCS 
(Lujan et al.), copyright (2016). 
 
Tight junction and actin staining together suggest that ectopic lumens are still 
fully polarized, but more apical membrane markers should be tested. Indeed, three 
PRL-3 substrate candidates, PI(4,5)P2 (McParland et al., 2011), Ezrin (Forte et al., 
2008), and Na+/H+ exchanger regulatory factor 1 (NHERF1) (Fang et al., 2015), are 
especially interesting since they are known to be decisive in cell polarity (Martin-
Belmonte et al., 2007; Fang et al., 2015) by delineating the apical membrane, 
suggesting a potential involvement in the mechanism by which PRL-3 causes the 
multiple lumen phenotype. 
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Heterogeneous distribution of PI(4,5)P2 and PI(3,4,5)P3 in the apical and 
lateral/basal membranes of polarized cells, respectively, is crucial for polarity 
maintenance that is achieved by the polarized distribution of PTEN (Martin-
Belmonte et al., 2007; Thapa and Anderson, 2012; Leslie et al., 2008). The presence of 
a PI(4,5)P2 phosphatase candidate like PRL-3 could potentially impair its 
characteristic membrane distribution. Therefore, PI(4,5)P2 presence in the apical 
membrane of 72 hr parental, pmKATE2-PRL-3 WT, and pmKATE2-PRL-3 C104S 
overexpressing MDCK cysts was analyzed by confocal microscopy. These cell lines 
also expressed the GFP tagged version of the Pleckstrin homology domain of 
phospholipase Cδ (GFP-PH-PLCδ), a cytosolic tagged domain that binds selectively to 
PI(4,5)P2. Consequently, PH-PLCδ translocates from the cytosol to PI(4,5)P2 
containing membranes, and therefore, can be used as a reporter of PI(4,5)P2 
concentration in the apical membrane. As expected, PI(4,5)P2 was qualitatively 
present at the apical membrane in all three parental, pmKATE2-PRL-3 WT, and 
pmKATE2-PRL-3 C104S overexpressing MDCK cysts (Fig. 27A-D). However, no 
decrease of PI(4,5)P2 levels, as measured by GFP-PH-PLCδ fluorescence intensity 
ratio between apical membrane and the rest of the cell, was detected (Fig. 27D).  
 
Figure 27. PRL-3 WT overexpression does not decrease PI(4,5)P2 levels in the apical domain 
of MDCK cysts. A-C Confocal images of 72 hr parental (A), pmKATE2-PRL-3 WT + 
GFP-PH-PLCδ (B), or pmKATE2-PRL-3 + C104S GFP-PH-PLCδ (C) overexpressing 
MDCK cysts. Right: separate channels showing actin or PRL-3 (WT or C104S) (up) and PH-
PLCδ (down). Scale bars, 10 μm. D PI(4,5)P2 dephosphorylation in the apical membrane 
measured as the fluorescence intensity ratio between apical and cytosolic membranes plus the basal 
GFP-PH-PLCδ in parental, pmKATE2-PRL-3 WT, and pmKATE2-PRL-3 C104S 
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overexpressing MDCK cysts. n=90. E,F Quantitative lipid MS in MDCK cysts or cysts stably 
expressing GFP-PRL-3 WT or GFP-PRL-3 C104S analyzed 5 days after seeding. The ratio 
between total phosphatidylinositol phosphates (PIP) and PIP2 is quantified (E) or given as an 
independent percentage compared to total phospholipids (F). D-F Mean ± SEM of three 
independent experiments. Adapted by permission from Company of Biologists LTD: JCS (Lujan 
et al.), copyright (2016). 
 
In order to corroborate this result, the overall phosphatidylinositol biphosphates 
(PIP2) content in MDCK cysts was measured by quantitative MS in collaboration with 
Dr. Britta Brügger (Heidelberg University Biochemistry Center–BZH, Heidelberg, 
Germany). Since all three PIP2 species have equal molecular weight, they are 
indistinguishable by MS and the result reflects the sum of all three. No difference was 
detected between GFP-PRL-3 WT overexpressing MDCK cysts compared to the 
controls (Fig. 27E,F). In light of these results, PRL-3 is apparently not 
dephosphorylating PI(4,5)P2 in the polarized cell context. However, PI(4,5)P2 
homeostasis is highly regulated at the cell surface (Czech, 2000) and a fast turnover 
cannot be detected by the current techniques used or any other approach developed 
so far. Therefore, we cannot fully discount our current hypothesis since, when PRL-1 
is overexpressed, which cannot dephosphorylate PI(4,5)P2 (Jin-Peng Sun et al., 2007; 
Rios et al., 2013), we observed a similar but weaker phenotype compared to PRL-3 
overexpression (Fig. 14D). Nevertheless, the specific localization of PI(4,5)P2 agrees 
with the conclusion that the overall cell polarity is not disturbed. 
In 2008, Forte et al. observed that PRL-3 overexpression leads to ezrin 
dephosphorylation on residue T(567), but no direct dephosphorylation has been 
described yet (Forte et al., 2008). Ezrin is a member of the Ezrin/Radixin/Moesin 
(ERM) family that functions as a linker between the plasma membrane and F-actin 
upon T(567) phosphorylation (Zhu et al., 2010). Since cytoskeleton assembly below the 
apical membrane on epithelial polarized cells is crucial for polarity establishment and 
maintenance, ezrin dephosphorylation in the apical membrane would disturb the cell 
polarity. Therefore, 72 hr parental, GFP-PRL-3 WT, and GFP-PRL-3 C104S 
overexpressing MDCK cysts were fixed and stained against both ezrin and pERM, 
which can detect phosphorylation of Ezrin T(567), Radixin T(564), and Moesin 
T(558) but was still used considering that MDCK cells express mainly ezrin 
(Wakayama et al., 2011). Ezrin was shown in the apical membrane partially co-
localizing with GFP-PRL-3 WT and GFP-PRL-3 C104S (Fig. 28A-D), confirming 
that cell polarity was undisturbed. However, compared to ezrin, pERM co-localized 
less with PRL-3 WT and PRL-3 C104S (Fig. 28D). A lesser co-localization of PRL-3 
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WT with the phosphorylated form of ezrin would suggest that some 
dephosphorylation might be occurring, but a similar tendency with PRL-3 C104S was 
also observed, discounting this hypothesis. In agreement with these results, the 
fluorescence intensity ratio measurement between pERM and ezrin showed no 
difference when GFP-PRL-3 WT was overexpressed compared to the parental and 
the GFP-PRL-3 C104S expressing MDCK cysts (Fig. 28E).  
 
Figure 28. PRL-3 WT does not dephosphorylate apical ezrin in MDCK cysts. A-C 
Confocal images of 72 hr parental (A), GFP-PRL-3 WT (B), or GFP-PRL-3 C104S (C) 
overexpressing MDCK cysts stained with ezrin and pERM antibodies. Right: separate channels 
showing PRL-3 (up), ezrin (middle), pERM (down). Scale bars, 10 μm. D Global Pearson 
correlation measured to study co-localization between PRL-3 WT or PRL-3 C104S, and ezrin 
or pERM. E Ezrin dephosphorylation measured by the fluorescence intensity ratio between 
pERM and ezrin in parental, GFP-PRL-3 WT, and GFP-PRL-3 C104S MDCK cysts. 
D,E n=90. Mean ± SEM of three independent experiments. Adapted by permission from 
Company of Biologists LTD: JCS (Lujan et al.), copyright (2016). 
 
The last apical marker examined was NHERF1, an adaptor protein that links 
several ion transporters with cellular receptors and other proteins. NHERF1 shifts 
from the apical membrane to the cytosol upon serine dephosphorylation, which has 
been related with cancer (Mangia et al., 2012), and it was recently proposed as a PRL-
3 substrate (Fang et al., 2015). Therefore, we tried to confirm NHERF1 
dephosphorylation upon PRL-3 overexpression in MDCK cells. With a specific 
NHERF1 antibody, the protein was immunoprecipitated from parental, GFP-PRL-3 
WT, and GFP-PRL-3 C104S 2D MDCK cell lysates. Its pSer status was analyzed by 
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WB with a total pSer antibody. However, the isolated NHERF1 were not 
phosphorylated, suggesting that it might already be dephosphorylated in 2D MDCK 
cells (Fig. 29A). Moreover, NHERF1 immunoprecipitation did not pull down 
overexpressed PRL-3 WT nor PRL-3 C104S implying that no interaction takes place 
between both proteins (Fig. 29A). These results suggest that NHERF1 might only be 
phosphorylated in 3D MDCK cysts. However, NHERF1 immunoprecipitation in 3D 
MDCK total cell lysates is not a feasible approach due to the amounts of cells 
required for the biochemical technique, which is very difficult to reach in 3D 
polarized cell culture. For that reason, and since NHERF1 plasma membrane or 
cytosol localization depends on its phosphorylation status, NHERF1 localization was 
checked in 72 hr fixed parental, GFP-PRL-3 WT, and GFP-PRL-3 C104S MDCK 
cysts. GFP-PRL-3 WT overexpressing MDCK cysts showed exclusive NHERF1 
plasma membrane localization as expected in parental and GFP-PRL-3 C104S 
MDCK cysts (Fig. 29B-D), postulating that NHERF1 might not be dephosphorylated 
by PRL-3 in this system, and corroborating once more that the polarity is not 
disturbed.  
 
Figure 29. PRL-3 WT co-localizes with NHERF1 in MDCK cysts but relocalization of 
NHERF1 through dephosphorylation was not detected, and neither was phosphorylation of 
NHERF1 in the WB from 2D MDCK cell culture. A Western Blot of NHERF1 
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immunoprecipitation (IP) from parental MDCK cells or MDCK stably overexpressing GFP-
PRL-3 WT or GFP-PRL-3 C104S cells. Anti-NHERF1, anti-pSer and anti-GFP were used 
as primary antibodies. NHERF1 pull-down efficiency analyzing NHERF1 presence in the raw 
cell lysate (input) and after IP (SN) is also shown. B-D Confocal images of 72 hr parental (B), 
GFP-PRL-3 WT (C), or GFP-PRL-3 C104S (D) overexpressing MDCK cysts stained with 
NHERF1 antibody. Bottom: separate channels of the highlighted regions showing PRL-3 (left), 
NHERF1 (middle), actin (right). Scale bars, 10 μm. 
 
So far, these results indicate that PRL-3 does not disturb the lumen identity and, 
consequently, the cell polarity per se. Therefore, we hypothesized that aberrant PRL-3 
expression might lead to lumen mispositioning instead. We then focused our studies in 
AMIS specification, an earlier step in lumenogenesis that precedes the lumen opening 
(Bryant et al., 2010; Apodaca, 2010). As was postulated, in 48 hr parental and PRL-3 
C104S MDCK cysts, that the AMIS, marked by the exocyst complex component 
Sec8, was recruited at both sides of cell-cell contacts in the center of the cysts marking 
the position of the future opened lumen (Fig. 30A,C,D) (citation). In PRL-3 WT 
overexpressing cysts, Sec8 stained AMIS is misplaced from the center of the cyst to 
the lateral membrane (Fig. 30B,D,E). In MDCK cysts, the delivery of apical 
determinants to the AMIS requires polarized vesicular trafficking (Bryant et al., 2010). 
In light of this, we tested the hypothesis that PRL-3 overexpression could redirect 
vesicle trafficking to PRL-3-induced ectopic lumens. Figure 30F-H shows that 
exocytic vesicles, labeled with BODIPY-Tr-Ceramide (Van der Sluijs et al., 1990), 
were indeed delivered to nascent PRL-3-induced lateral lumens. These results 
indicate that the AMIS is properly formed but mislocalized, what will give rise to an 
ectopic lumen opening. 
In conclusion, these results indicate that PRL-3 disrupts proper lumen 
positioning at the center of the cyst rather than completely abolishing cell polarity. 
Therefore, PRL-3 seems to intervene at an earlier step in lumenogenesis. 
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Figure 30. AMIS is correctly formed but mispositioned prior to formation of ectopic lumens in 
PRL-3 WT overexpressing MDCK cysts. A-C Confocal images of 48 hr parental (A), GFP-
PRL-3 WT (B), or GFP-PRL-3 C104S (C) overexpressing MDCK cysts stained with Sec8 
antibody. Bottom: separate channels of the highlighted regions showing PRL-3 (left), Sec8 
(middle), actin, or merge (right). Scale bars, 10 μm. D The proportion of cysts with central Sec8 
staining and E The proportion of cysts with Sec8 staining in the nascent lumen. Mean ± SEM 
of three independent experiments. n=90. F Selected pictures of time-lapse live-cell imaging of 48 
hr GFP-PRL-3 WT MDCK cysts showing vesicle trafficking (arrowheads) to ectopic AMIS. 
Scale bars, 10 µm. G,H Fluorescent BODIPY-TR ceramide stained vesicles tracked during 
time towards a nascent lumen when GFP-PRL-3 WT (G) or GFP-PRL-3 C104S (H) are 
overexpressed. The displacement of the vesicle is measured relative to the starting distance from the 
vesicle to the middle of the lumen. Negative values indicate vesicles approaching the lumen, while 
positive values indicate that vesicles move away from the lumen. n=15 of three independent 
experiments. A-E are adapted by permission from Company of Biologists LTD: JCS (Lujan et 
al.), copyright (2016). 
 
 
 
 
PRL-3 C104S/Sec8/Actin/Nuclei D
A CB
PRL-3 WT/Sec8/Actin/NucleiSec8/Actin/Nuclei
ActinSec8 Sec8Sec8
Pare
ntal
      
   GF
P-P
RL-3
 WT
      
   GF
P-P
RL-3
 C10
4S
0
25
50
75
100
%
 C
ys
ts
 w
ith
 c
en
tra
l S
ec
8
**** ****
ns
0
50
100
%
 lu
m
en
 w
ith
 S
ec
-8
Pare
ntal
      
   GF
P-P
RL-3
 WT
      
   GF
P-P
RL-3
 C10
4S
0 s 30 s 1 min 30 s 2 min 
GFP-PRL-3-WT BODIPY-Tr CeramideFE
H MDCK GFP-PRL-3 C104S
100 200
-6
-4
-2
0
2
t (s)
Di
st
an
ce
 to
 th
e 
lu
m
en
 
no
rm
al
ize
d 
to
 th
e 
or
ig
in
 (μ
m
)
aw
ay
 fr
om
 
lu
m
en
 
to
w
ar
ds
 th
e 
lu
m
en
 
100 200
-6
-4
-2
0
2
t (s)
Di
st
an
ce
 to
 th
e 
lu
m
en
 
no
rm
al
ize
d 
to
 th
e 
or
ig
in
 ( μ
m
)
aw
ay
 fr
om
 
lu
m
en
 
to
w
ar
ds
 th
e 
lu
m
en
 
G
MDCK GFP-PRL-3 WT
	  	   	   	  
	   3.	  The	  role	  of	  PRL-­‐3	  in	  epithelial	  architecture	  maintenance	   	  	   	  
68	  
3.1.4. PRL-3 alters the midbody apical localization affecting lumen 
positioning 
It has been recently reported that the AMIS is formed by the vesicular transport 
of apical components towards the midbody during and at the site of cytokinesis (D. Li 
et al., 2014; Jaffe et al., 2008). Consequently, the apical membrane is positioned by the 
midbody during and right after cytokinesis (Jaffe et al., 2008; Overeem et al., 2015; 
Schlüter et al., 2009).  
In order to determine the positions of midbodies in PRL-3 WT overexpressing 
MDCK cysts, different midbody markers were examined before the lumen was open 
(48 hr), including mitotic kinesin-like protein 1 (MKLP1), centrosomal protein 55 
(Cep55), AuroraB, and γ-tubulin. In parental and GFP-PRL-3 C104S MDCK cysts, 
all markers stained spotty structures attached to the apical membrane that will form 
the central lumen (Fig. 31A,C,D, E,F), confirming that the post-mitotical midbody 
remains right after cell division in the apical membrane, instead of being internalized 
and degraded. This staining was also found in the ectopic lumens formed when GFP-
PRL-3 WT is overexpressed in MDCK cysts (Fig. 31B,D,G,H). Cep55 is not 
exclusively found in the midbody, but rather can also be found in other subcellular 
structures like the centrosome (Martinez-Garay et al., 2006). Additionally, the MKLP1 
antibody showed high background fluorescence. Therefore, Cep55 and MKLP1 co-
localization was only quantified in apical spotty structures to guarantee that they were 
post-mitotical midbodies (Fig. 31A-C,I).  
Midbody remnant position was then distinguished between central (apical) or 
lateral retention in both MDCK and Caco-2 cysts overexpressing GFP-PRL-3 WT or 
GFP-PRL-3 C104S. The aberrant expression of PRL-3 WT led to the incorrect 
lateral localization of about 30-50% of post-mitotic midbody remnants compared to 
the central localization in parental and GFP-PRL-3 C104S MDCK cysts (Fig. 31J,K). 
To better understand the positioning of the midbody toward the apical membrane 
over time, we next carried out live cell-imaging experiments in PRL-3 C104S and 
PRL-3 WT overexpressing MDCK cysts using YFP-MKLP1 as a midbody reporter. 
At the two-cell stage, the post-mitotic midbody was maintained at the center in PRL-3 
C104S MDCK cysts (Fig. 31M), whereas PRL-3 WT altered its position from the 
central to the lateral membrane. Subsequently, the AMIS is formed around the 
midbody at that position (Fig. 31L). These results are in line with our observation that 
ectopic lumens arise from the AMIS positioned at the lateral membrane (Fig. 30D,E). 
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Figure 31. PRL-3 activity alters the position of the post-mitotic midbody. A-C Confocal 
images of 48 hr (nascent lumen) parental (A), GFP-PRL-3 WT (B), or GFP-PRL-3 C104S 
(C) overexpressing MDCK cysts stained with MKLP1 and Cep55 antibody. Bottom: separate 
channels of the highlighted regions showing actin (left), MKLP1 (middle left), Cep55 (middle 
right), actin, or merge (right). Scale bars, 10 μm. D The proportion of cysts with lumen 
containing midbodies. n=300. F-H Representative images of parental MDCK cysts (E,F) or 
MDCK cysts overexpressing GFP-PRL-3 WT (G,H) at 48 hr after plating stained with 
antibodies against midbody remnant proteins: AuroraB (E,G), γ-tubulin (F,H). Cysts in E and 
F were additionally stained with α-tubulin to visualize microtubules. Arrows indicate midbody 
remnants marking the lumen position. Scale bars, 10 μm. I The proportion of staining in the 
lumen that contains MKLP1 and Cep55 as a measure for co-localization. n=300. J,K 
Midbody remnants (MKLP1) in 48 hr cysts expressing GFP-PRL-3 WT. Arrows indicate 
midbody remnants with central (apical) (left) or lateral (right) localization. Proportion of 
midbody remnants presenting central (apical) or lateral localization in MDCK (J) or Caco-2 
(K) cysts and cysts stably expressing GFP-PRL-3 WT and GFP-PRL-3 C104S were 
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analyzed 48 hr after seeding. n=90. L,M Selected points of live-cell imaging of 45 hr cysts 
transiently co-expressing either pmKATE2-PRL-3 WT (L) or C104S (M), and YFP-
MKLP1. Arrow in L indicates a midbody remnant that gets retained at the lateral plasma 
membrane with subsequent ectopic lumen formation. Representative results of three biological 
replicates are shown. Arrow in I highlights the first midbody remnant; the arrowhead highlights 
the midbody remnant coming from the second cytokinesis. Scale bars, 10 µm. D,I,J,K Mean ± 
SEM of three independent experiments. Adapted by permission from Company of Biologists LTD: 
JCS (Lujan et al.), copyright (2016). 
 
It has been postulated that post-mitotic midbodies can participate in functions 
unrelated to cytokinesis, but the fate of the midbody after cytokinesis remains 
unknown in this MDCK cyst model (Chun-Ting Chen et al., 2013; Kuo et al., 2011; 
Pollarolo et al., 2011; Morais-de-Sá and Sunkel, 2013). Indeed, the first midbody 
(arrow) in Figure 31M stayed over time at the apical membrane after subsequent cell 
divisions. For that reason, we determined if the midbody remnants resulting from 
several cell divisions during cyst development were accumulated at the edge of the 
lumen or internalized and degraded. To accomplish this, parental, GFP-PRL-3 WT, 
and GFP-PRL-3 C104S MDCK 72 hr fixed cysts were stained with MKLP1 and 
Cep55 midbody markers. As previously described in proliferative epithelial surfaces in 
mice (Maliga et al., 2013), midbody remnants persisted through cell division, 
delineating the edge of the central and ectopic lumens when PRL-3 was overexpressed 
(Fig. 32A-E). This result suggests that midbodies could play a role in cell polarity and 
lumen maintenance since they persist long after cell division instead of being 
internalized or degraded.  
Figure 32. Post-mitotic midbodies remain during cell division delineating the edge of the open 
lumen. A-C Confocal images of 72 hr (open lumen) parental (A), GFP-PRL-3 WT (B), or 
GFP-PRL-3 C104S (C) overexpressing MDCK cysts stained with the MKLP1 and Cep55 
antibodies. Bottom: separate channels of the highlighted regions showing actin (left), MKLP1 
(middle left), Cep55 (middle right), actin, or merge (right). Scale bars, 10 μm. D The proportion 
of cysts with lumen containing midbodies and I the proportion of staining in the lumen that 
contains both MKLP1 and Cep55. Mean ± SEM of three independent experiments. n=300. 
Adapted by permission from Company of Biologists LTD: JCS (Lujan et al.), copyright (2016). 
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Taken together, these findings show that midbody remnants are positioned on 
the apical membrane after cytokinesis instead of being degraded, and suggest that the 
multiple lumen phenotype driven by PRL-3 is through midbody mislocalization 
during or after cell division. Moreover, it was demonstrated that these midbody 
remnants stay long after cell division, accumulating in the lumen, indicating a post-
mitotic role for this protein complex. 
 
3.1.5. PRL-3 alters the midbody remnant apical position by 
shortening cytokinesis timing 
Midbody apical positioning in MDCK cysts is achieved by the perpendicular 
orientation of the mitotic spindle during metaphase followed by an asymmetric 
abscission, which ensures the positioning of the midbody to the apical membrane. The 
disruption of any of those processes lead to lateral retention of the midbody and, 
consequently, the appearance of an ectopic lumen (Jaffe et al., 2008; Bryant et al., 
2010; D. Li et al., 2014; Schlüter et al., 2009; Overeem et al., 2015). Indeed, loss of a 
planar orientation of the mitotic spindle has been largely studied, due to its 
implication in carcinoma formation (J. C. Pease and Tirnauer, 2011; Noatynska et al., 
2012). Knockdown of tumor suppressors Par3 or Cdc42 disrupts spindle orientation in 
MDCK cysts, leading to the multiple lumen phenotype seen in PRL-3 overexpression 
(Hao et al., 2010; Jaffe et al., 2008). Therefore, we examined if aberrant GFP-PRL-3 
WT expression would affect mitotic spindle orientation. Mitotic spindles were stained 
with γ-tubulin and Hoechst, and measured at late metaphase as previously described 
in 48 hr parental, GFP-PRL-3 WT, and GFP-PRL-3 C104S overexpressing MDCK 
fixed cysts (Jaffe et al., 2008; Hao et al., 2010; Wei et al., 2012; Zhen Zheng et al., 2010; 
Rodriguez-Fraticelli et al., 2010). Upon GFP-PRL-3 WT overexpression, mitotic 
spindle orientation was undisturbed compared to parental and GFP-PRL-3 C104S 
MDCK cysts (Fig. 33A), signifying that PRL-3 might be altering the asymmetric 
abscission, which would also theoretically lead to failure of the apical delivery of the 
midbody. Unlike mitotic spindle misorientation, this explanation is currently only 
theoretical speculation (Jaffe et al., 2008; Overeem et al., 2015).  
In order to investigate this hypothesis, furrow ingression was stained with anillin, 
a actomyosin-based contractile ring scaffold protein (Piekny and Glotzer, 2008), in 
fixed 72 hr MDCK cysts, and measured as previously described (Liu et al., 2012). 
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GFP-PRL-3 WT overexpression in MDCK cysts did not disrupt asymmetric 
abscission when compared to parental and GFP-PRL-3-C104S overexpressing 
MDCK cysts (Fig. 33B). Consequently, PRL-3 must be affecting midbody positioning 
by a novel alternative mechanism. 
 
 
Figure 33. PRL-3 overexpression leads to midbody lateral retention in MDCK cysts in a 
mitotic spindle and asymmetric cleavage furrow ingression-independent manner. A Confocal 
images of 72 hr parental (left), GFP-PRL-3 WT (middle), or GFP-PRL-3 C104S (right) 
overexpressing MDCK cysts stained with a γ-tubulin antibody. Arrows indicate the orientation of 
the mitotic spindles. Spindle angle was analyzed and plotted (graph). Deg=degree. n=15 B 
Confocal images of 72 hr parental (left), GFP-PRL-3 WT (middle), or GFP-PRL-3 C104S 
(right) overexpressing MDCK cysts stained with an anillin (cleavage furrow) antibody. Bottom: 
separate channels of the highlighted cell in division showing nuclei or PRL-3 (left), actin (middle 
left), anillin (middle right), and merge (right). Asymmetry was measured as described in Methods 
section 5.3.5 and plotted (graph). Symmetric abscission=1. n=45. Scale bars, 10 µm. A,B 
Each result was plotted and the black lines represent the median (A) or mean (B) of three 
independent experiments. Adapted by permission from Company of Biologists LTD: JCS (Lujan 
et al.), copyright (2016). 
 
During cell division, PRL-3 WT and PRL-3 C104S were always (n=30) 
recruited to the cytokinetic bridge (Fig. 34A,B), suggesting that it might play a role 
during the last step of mitosis. Since an effect of PRL-3 in cytokinesis has never been 
addressed before, we decided to see if PRL-3 overexpression in MDCK cyst would 
affect it. Chromosome segregation prior to cell abscission is detected by AuroraB, 
which is then activated by phosphorylation. In turn, it phosphorylates MKLP1 
blocking cleavage furrow regression (Steigemann et al., 2009). The AuroraB inhibitor 
ZM447439 prevents MKLP1 phosphorylation leading to furrow regression and, 
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consequently, to cell tetraploidization (Ikezoe et al., 2007; Steigemann et al., 2009). 
Therefore, in order to study if PRL-3 might prevent MKLP1 phosphorylation 
abscission leading to tetraploid MDCK cells, ploidy was analyzed by flow cytometry 
quantification of incorporated Hoechst 33342 DNA staining. As anticipated, 
ZM447439-treated MDCK cells showed increased tetraploid cell population 
compared to the non-treated 2D MDCK cells (Fig. 34 C,D). However, 
tetraploidization when GFP-PRL-3 WT was overexpressed was comparable to non-
treated parental and GFP-PRL-3 C104S MDCK cells (Fig. 34C-F). These results 
confirm that PRL-3 does not prevent cell abscission. 
 
Figure 34. PRL-3 accelerates cytokinetic timing. A,B Confocal images of 48 hr GFP-
PRL-3 WT (left) or GFP-PRL-3 C104S (right) overexpressing MDCK cysts. Arrows indicate the 
position of the cytokinetic bridge. C-F Cell cycle analysis. MDCK cells (C), MDCK cells treated 
with 2 μM of ZM447439 (AuroraB inhibitor) over 48 hr (D), and MDCK cells stably expressing 
GFP-PRL-3 WT (E) or GFP-PRL-3 C104S (F) stained with Hoechst 3342 prior to analysis by 
flow cytometry. Blue: G0/G1; Ocher: S phase; Green: G2; White: tretraploid cell. G Abscission time 
is measured in parental, GFP-PRL-3 WT, or GFP-PRL-3 C104S overexpressing MDCK cells 
transfected with AuroraB to track cytokinesis over time. n=50. Each result was plotted and the black 
line represents the mean of three independent experiments. Adapted by permission from Company of 
Biologists LTD: JCS (Lujan et al.), copyright (2016). 
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After eliminating the possibility of cytokinetic failure, we then examined the 
abscission time in 2D parental, GFP-PRL-3 WT, and GFP-PRL-3 C104S 
overexpressing MDCK cells, using AuroraB as a reporter to stain the cytokinetic 
bridge. Upon aberrant PRL-3 WT expression, MDCK cells showed faster abscission 
(Fig. 34G). This novel discovered phenotype of PRL-3 might unveil a new scenario 
where cell abscission takes place earlier than the apical positioning of the midbody 
which, in turn, would lead to the described multiple lumen phenotype in this epithelial 
cell model. Moreover, this discovery also narrows our focus for future studies to find 
PRL-3 substrates that would explain the molecular mechanism behind the proposed 
phenotype. 
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3.2. Discussion  
Understanding how epithelial cells establish and maintain the axis of polarity is 
fundamental for our comprehension of how epithelial tissue organizes and how its 
deregulation may lead to tumor formation. During de novo lumenogenesis, apical 
lumen formation was proposed to be initiated by transport of apical components to 
the AMIS during cytokinesis, and that endosomes move along central spindle 
microtubules to fuse with the cleavage furrow plasma membrane around the 
midbody, which would finally generate an apical lumen (Dongying Li et al., 2014). In 
the present study, I confirm this hypothesis by showing the dependence of the 
establishment of the lumen on the correct position of the midbody remnants and 
through my finding that the midbody is an apical landmark. In addition, I oberserved 
that the midbody is maintained in the following division at the edge of the lumen, 
proposing that it could be needed to keep the apical specification. It was previously 
shown that the resolution of the membrane connection between two daughter cells, 
during abscission, requires targeting and fusion of exocyst vesicles with the 
intracellular-bridge plasma membrane. Several subunits of the exocyst complex, 
including Sec8 as seen in our data, localized to the midbody during abscission 
(Gromley et al., 2005) and were suggested to tether apical exocytic carriers to the 
AMIS (Bryant et al., 2010). This selective co-localization of key tethering factors of the 
exocyst complex at the midbody during abscission could be the link between midbody 
remnants and apical membrane as well as AMIS specification. 
PRL-3 does not appear to play a physiological role in lumen formation, but is 
found overexpressed in many epithelial cancers, and data points into the direction of 
PRL-3 being an oncogene (Rios et al., 2013; Zimmerman et al., 2013). Accordingly, we 
found that the overexpression of PRL-3 in a non-cancerous background (MDCK 
cysts) causes invasiveness and detrimental disorganization of epithelial structures, both 
fundamental events in tumor progression (McCaffrey and Macara, 2011). 
Unfortunately, the exact molecular mechanism could not be illuminated since PRL-3 
substrates where not found in this context due to the failure in the determination of a 
direct substrate through the phosphoproteomic approach in 3D MDCK cell culture. 
Thus far, protein and non-protein substrates have been suggested, but none is 
established (Rios et al., 2013). Indeed, the identification of PRL-3 substrates has 
remained extremely challenging since its discovery over a decade ago (Al-Aidaroos 
and Zeng, 2010; Rios et al., 2013). In the context of lumen formation, the suggested 
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PRL-3 substrates PI(4,5)P2 and Ezrin are interesting candidates as they are known 
determinants of cellular polarity (Martin-Belmonte et al., 2007). Nevertheless, we did 
not observe significant changes in the phosphorylation status of PI(4,5)P2 and Ezrin 
when overexpressing PRL-3. Rapid changes of tightly controlled phosphorylation 
levels like in the cleavage furrow during abscission, may however be difficult to detect 
in this 3D system also because synchronization is not possible, and it will take the 
development of elaborate, sensitive methods to make progress in this area. Moreover, 
protein-protein interaction between PRL-3 and its partners like ancient conserved 
domain protein/cyclin M (CNNM) proteins should be taken into consideration. 
Midbody positioning at the apical surface was postulated to be achieved through 
the combination of planar mitotic spindle orientation followed by asymmetric 
cleavage furrow ingression (Jaffe et al., 2008; Morais-de-Sá and Sunkel, 2013; Bryant et 
al., 2010) (Fig. 35). While mitotic spindle orientation has been extensively studied and 
polarity proteins like Par3 or Cdc42 have been described as key participants of the 
process (Fig. 35), loss of cytokinetic asymmetry in a spindle-independent manner still 
remains as a theoretical model (Fig. 35) (Jaffe et al., 2008; Hao et al., 2010; Dionne et 
al., 2015). However, I show that PRL-3 leads to midbody mispositioning 
independently of a mitotic spindle-misorientation or asymmetric abscission. Indeed, I 
found that PRL-3 accelerates cytokinesis timing. This result lead us to suggest that 
prevention of the apical positioning of the midbody, and subsequent abscission in the 
lateral membrane, could be also triggered by faster cytokinesis (Fig. 35), as midbody 
positioning happens exactly during cytokinesis. Therefore, in the present study, for the 
first time, I provide evidence for a third model where cytokinesis timing plays the 
pivotal role in apical midbody positioning. However, since following the apical or 
lateral positioning of the midbody by life-cell imaging in the 3D cysts is technically 
challenging and the technologies available does not allows that yet, it cannot be 
discarded an alternative mechanism where, upon PRL-3 overexpression, the midbody 
reaches the apical membrane after cytokinesis and then it is pushed back to the lateral 
membrane by the action of PRL-3 although this is an unlikely scenario. 
The molecular mechanisms underlying the abscission timing in epithelial cells, 
including a cytokinetic checkpoint, remains obscure due to its complexity (Green et al., 
2012; Carlton et al., 2012; Steigemann et al., 2009). One possible scenario relies on the 
regulation of the abscission checkpoint since cytokinesis timing seems to be dependent 
on checkpoint efficiency and it is a process governed by three kinases that must be 
counteracted in order to proceed. Therefore, PRL-3 could act downstream of 
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AuroraB causing a failure in abscission delay, like counteracting ULK3 or preventing 
Plk1 retention of Cep55 (Bastos and Barr, 2010; Carlton et al., 2012; Caballe, Dawn 
M. Wenzel, et al., 2015). However, although here I demonstrate that PRL-3 localizes 
to the site of cytokinesis, it is unclear if its involvement is direct or indirect. 
 
Figure 35. Reviewed mechanisms for ectopic lumen formation through post-mitotic midbody 
mispositioning. After lumen opening, to ensure the single lumen maintenance the midbody is 
delivered to the apical membrane by a planar orientation of the mitotic spindle to the apical-basal 
axis (1) followed by asymmetric furrow ingression (2). Loss of mitotic spindle orientation or loss 
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of asymmetric furrow ingression may affect the apical positioning of the midbody leading to ectopic 
lumen development. Furthermore, here we postulate a novel mechanism where faster abscission 
before the midbody reaches its luminal position (3) might also lead to lateral retention of the 
midbody, leading to the same multiple lumen phenotype. Apical membrane = light red; basolateral 
membrane = brown; γ-tubulin = dark red; nuclei and chromosomes = blue; midbody and 
midbody remnants = green; apical endosomal compartment = orange. 
In conclusion, I propose a novel mechanism for the loss of epithelial 
organization in cancer involving cytokinesis timing that could cause the misplacement 
of midbody remnants as an alternative model to the already postulated ones: loss of 
spindle orientation and disruption of asymmetric abscission. Moreover, I identify 
PRL-3 as an enzyme that triggers epithelial architecture disruption through this 
alternative process. 
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PRL-3 enhances clathrin-dependent endocytosis 
 by PI(4,5)P2 dephosphorylation 
 
4.1. Results 
Tumor metastasis is the second cause of death and responsible of nearly 90% of 
cancer-related deceases (Spano et al., 2012) but is still poorly understood. Metastasis is 
a multi-step process where the migration and plasticity of the cancer cell is required. 
Cell migration is a complex cellular process where several molecular pathways are 
involved and interconnected (Polacheck et al., 2013). Due to the complexity of this 
process and because of the absence of reliable substrate candidates (Rios et al., 2013), 
deciphering how the cancer-promoting PRL-3 may affect tumor cell migration 
remains challenging. However, two recent theories that can be interconnected have 
gained attention in the field. One postulates that PRL-3-induced migration involves 
direct interaction with β1 integrin (Foy et al., 2017; Krndija et al., 2012; Peng et al., 
2006; Peng et al., 2009), while Krndija et al. revealed that PRL-3 alters cell migration 
through enhanced recycling of matrix receptors. In the second scenario, Krndija and 
co-workers showed that PRL-3 enhances α5 integrins (heterodimer partner of β1 
integrin) recycling from the Golgi apparatus to the plasma membrane activating the 
class I ADP-rybosylation factor (Arf1), a small GTPase associated with the Golgi 
apparatus that regulates vesicle trafficking (Krndija et al., 2012; D’Souza-Schorey and 
Chavrier, 2006). Indeed, PRL-3 contains a MXXE Golgi-targeting motif (Honda et 
al., 2005) required for its interaction with Arf-1, and its deletion is sufficient to disrupt 
the PRL-3 migration phenotype (Krndija et al., 2012). Also, PRL-3 is mainly found in 
the plasma membrane as well as in the Golgi apparatus and in early and recycling 
endosomes (Qi Zeng et al., 2000; Krndija et al., 2012). Despite recycling rate 
increment, the overall surface α5 integrin concentration was unaffected upon PRL-3 
overexpression (Krndija et al., 2012), suggesting that α5 integrin uptake compensation 
might occur. Membrane trafficking pathways that take up or recycle integrins are 
essential for cell migration and any disturbance in integrin signaling or trafficking 
might contribute to cell invasion and migration during cancer metastasis (Paul et al., 
2015; Caswell et al., 2008). In addition, turnover of PI(4,5)P2 is required for clathrin-
mediated endocytosis, and PRL-3 was previously reported to have phosphatase 
activity against PI(4,5)P2 (McParland et al., 2011). For that reason, the aim of the 
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second part of the present project was to focus on the study of PRL-3 internalization 
and if PRL-3 actively participates in the endocytosis route where it is involved.  
 
4.1.1. PRL-3 is taken up from the plasma membrane by clathrin-
dependent endocytosis 
PRL-3’s presence in early endosomes (EE) suggests that it must be internalized 
through a membrane-bound endocytic pathway (Jovic et al., 2010) making the 
involvement of other membrane free routes unlikely, like through guanosine 
nucleotide dissociation factor (GDI)-like solubilizing factors (Chandra et al., 2012; 
DerMardirossian and Bokoch, 2005) or by lipid hydrolysis (Martin et al., 2011; Lin 
and Conibear, 2015). Before being trafficked to the EE, a portion of the plasma 
membrane is pinched off as an endosome (Mayor and Pagano, 2007). In the last 
years, several mechanisms to form those mentioned endosomes have been described 
(Mayor and Pagano, 2007; McMahon and Boucrot, 2011) and each cargo is 
exclusively selected by one or few of those pathways to be internalized (Traub, 2009). 
For example, the transferrin receptor is an archetypical cargo for CDE (Le Roy and 
Wrana, 2005), whereas the uptake of α5 integrin from focal adhesions (FAs), while 
canonically associated with CDE (Chao and Kunz, 2009), has been recently linked 
also to macropinocytosis and syndecan-4 mediated caveolar endocytosis (Paul et al., 
2015). Both examples were used as reporters in the study of Krndija et al. on recycling 
enhancement by PRL-3. The experiments were realized on Henrietta Lacks (HeLa) 
cells, where levels of caveolin (cav-1) are very low (Skretting et al., 1999). Therefore, 
proteins that can choose between clathrin and calveolar endocytosis prefer CDE if 
there is low expression of cav-1 (Singh et al., 2003). That limits α5 integrin to CDE or 
macropinocytosis but, since this second route is dependent on platelet-derived growth 
factor (PDGF) activation (Paul et al., 2015), it might rather be exclusively endocytosed 
by CDE in untreated HeLa cells. Then, it is likely that, if PRL-3 participates in both 
transferrin and α5 integrin recycling routes, the phosphatase might be internalized 
through the same common endocytic pathway, CDE. Therefore, confirming this 
hypothesis became the first step in our approach. 
In order to determine how PRL-3 is taken up from the plasma membrane, its 
internalization in HeLa cells transiently overexpressing GFP-PRL-3 WT was followed 
by confocal microscopy upon treatment with different endocytosis pathway selective 
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inhibitors. Unfortunately, there is no CDE inhibitor that could guarantee the 
exclusive inhibition of this pathway without altering others (Dutta and Donaldson, 
2012; Harper et al., 2013). For that reason, inhibitors of other pathways were used to 
discard alternative candidate routes. In order to discern if PRL-3 internalization was 
sensitive to the applied inhibitors, PRL-3 translocation to the cytosol was forced since, 
in normal conditions, PRL-3 is predominantly in the plasma membrane and an 
increment of the phosphatase in this region would be hard to measure. For this 
purpose, GFP-PRL-3 WT overexpressing HeLa cells were also treated with brefeldin 
A (BFA), an Arf protein inhibitor (Helms and Rothman, 1992) that leads to reversible 
disassembly of the Golgi apparatus preventing protein export from the Golgi to the 
cell surface (Krndija et al., 2012; Helms and Rothman, 1992; SG et al., 1992). 
Therefore, if the PRL-3 endocytosis pathway is not sensitive to the inhibitor used, it 
will accumulate in the cytosol upon BFA treatment since it can still get internalized 
but not recycled back to the plasma membrane. However, if the inhibitor is affecting 
PRL-3 uptake, the phosphatase will be retained in the cell surface since it cannot be 
endocytosed.  
Initially, HeLa GFP-PRL-3 WT cells were treated with 100 μM dynasore, a 
selective dynamin1, dynamin2 and mitochondrial dynamin-1-like protein (Dnp1) 
GTPase activity inhibitor (Macia et al., 2006). Among endocytic pathways, only CDE 
and caveolar internalization require dynamin for the endosome fission step, so these 
are the only ones sensitive to dynasore treatment. Confocal pictures every 30 min 
were acquired during 90 min of dynasore pre-treated HeLa GFP-PRL-3 WT cells 
after being treated with 20 μM BFA. PRL-3 internalization was measured by 
quantifying the GFP fluorescent intensity ratio between the plasma membrane and 
the cytosol (Fig. 36A-E). As expected, PRL-3 was accumulated in the cytosol when 
cells were treated only with BFA, while in DMSO or dynasore treated cells, the 
phosphatase remained in the cell surface (Fig. 36A-C,E). However, when HeLa GFP-
PRL-3WT cells were treated with both BFA and dynasore, PRL-3 still remained in 
the plasma membrane (Fig. 36D,E), demonstrating that PRL-3 internalization is 
sensitive to dynamin inhibition and suggesting that it may be internalized either by 
CDE or caveolar endocytosis.  
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Figure 36. PRL-3 is internalized in a dynamin-dependent manner in HeLa cells. A-D 
Confocal images of life HeLa cells transiently expressing GFP-PRL-3 WT after 90 min 
treatment with DMSO (A), 100 μM dynasore (B), 20 μM BFA (C) or 100 μM dynasore + 
20 μM BFA (D). Scale bar = 10 μm. E Fluorescence intensity ratio of GFP signal between 
plasma membrane (PM) and cytosol in GFP-PRL-3 WT HeLa cells treated as in A-D 
measured by confocal microscopy every 30 min during 90 min after treatment. n = 90 cells. 
Mean ± SEM of three independent experiments. F Alexa Fluor® 633 transferrin incorporation 
by HeLa cells treated with dimethyl sulfoxide (DMSO) or 100 μM dynasore measured by flow 
cytometry at different time points. n = 60.000 cells. Median ± SEM of three independent 
experiments.     
 
When cells were treated with both inhibitors, there was a mild internalization 
after 60 min suggesting that either PRL-3 can be internalized through another 
dynamin-independent pathway in a lesser extend or that the dynasore inhibition was 
not 100% efficient. In order to elucidate which scenario was taking place and also to 
confirm that dynasore was inhibiting dynamin at that dose and treatment time frame, 
CDE inhibition was measured performing a transferrin uptake assay by flow 
cytometry. HeLa cells were treated for 1 hour with DMSO or 100 μM dynasore and 
then incubated at 37 °C with Alexa Fluor® 633 nm tagged transferrin to let it get 
endocytosed through CDE. Internalization was stopped by cooling the cells, and the 
remaining tagged transferrin associated with the plasma membrane was removed 
with an acidic buffer. Endocytosed transferrin was measured by flow cytometry and 
the median fluorescent intensity was represented in Fig. 36F. The result shows that 1 
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hour treatment with 100 μM dynasore led to approximately 60% inhibition of CDE 
in HeLa cells suggesting that the mild internalization observed when HeLa GFP-
PRL-3WT cells were treated with both, BFA and dynasore, was due to residual 
dynamin activity. 
To discern if PRL-3 was internalized by CDE or by caveolar endocytosis, HeLa 
cells transiently overexpressing GFP-PRL-3 WT were treated with 25 μg/mL 
nystatin, an antifungal antibiotic that sequesters cholesterol, which is a lipid required 
in the plasma membrane for caveolae clustering. Thus, nystatin treatment inhibits 
caveolar endocytosis (Singh et al., 2003; Rothberg et al., 1990; Rothberg et al., 1992; 
Bolard, 1986). Before testing its effect on PRL-3 internalization, caveolar endocytosis 
inhibition efficiency was tested measuring the lactosylceramide (LacCer), a 
sphingolipid exclusively internalized by caveolar endocytosis (Singh et al., 2003), 
uptake rate by flow cytometry. Similar to the transferrin uptake assay, BODIPY® FL 
C5 tagged LacCer was incubated at 37 °C with HeLa cells pre-treated for 1 hour with 
DMSO or 25 μg/mL nystatin. Internalization was also stopped by cooling down the 
sample, and the remaining LacCer bound to the cell surface was cleared out with 5% 
defatted bovine serum albumin (DF-BSA) containing media. Internalized tagged 
LacCer was quantified by flow cytometry, showing that 1 hour treatment with 25 
μg/mL nystatin inhibited more than 60% of calveolar endocytosis in HeLa cells (Fig. 
37A). Although the inhibitory efficiency does not reach 100%, it should be sufficient 
to detect an effect in PRL-3 internalization, as was estimated when treated with 
dynasore (Fig. 36F). A higher concentration of nystatin might be toxic for HeLa cells 
and unpredictable side effects could interfere in the experimental read out. 
Then, as done upon dynasore treatment (Fig. 36A-E), HeLa GFP-PRL-3 WT 
cells were pre-treated for 1 hour with 25 μg/mL nystatin and PRL-3 internalization 
was followed by confocal microscopy during 90 min after BFA treatment. As 
expected, PRL-3 remained in the plasma membrane in HeLa cells treated with 
DMSO or only nystatin (Fig. 37B,C,F), while recycling inhibition by BFA forced 
PRL-3 translocation to the cytosol (Fig. 37D,F). When cells were treated with both, 
BFA and nystatin, PRL-3 was then internalized like with BFA only treatment (Fig. 
37E,F) demonstrating that PRL-3 endocytosis is not sensitive to cholesterol arresting 
by nystatin. 
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Figure 37. PRL-3 is internalized through clathrin-dependent endocytosis in HeLa cells. A 
BODIPY® FL C5 LacCer incorporation by HeLa cells treated with DMSO or 25 μg/mL 
nystatin measured by flow cytometry at different time points. n = 60.000 cells. Median ± SEM 
of three independent experiments. B-E Confocal images of life HeLa cells transiently expressing 
GFP-PRL-3 WT after 90 min treatment with DMSO (B), 25 μg/mL nystatin (C), 20 μM 
BFA (D) or 25 μg/mL nystatin + 20 μM BFA (E). Scale bar = 10 μm. F Fluorescence 
intensity ratio of GFP signal between plasma membrane (PM) and cytosol in GFP-PRL-3 WT 
HeLa cells treated as in B-E measured by confocal microscopy every 30 min during 90 min after 
treatment. n = 90 cells. Mean ± SEM of three independent experiments. G Confocal image of a 
pmKATE2-PRL-3 WT HeLa cell with BODIPY® FL C5 LacCer incorporated for 15 min. 
Right: higher magnification of selected region showing separated channels: LacCer (up), PRL-3 
WT (middle) and merge (down). Scale bar = 10 μm.    
 
This result implies that PRL-3 must be internalized by CDE, but to further 
corroborate the obtained result I performed a co-localization assay between 
pmKATE2-PRL-3 WT and BODIPY® FL C5-LacCer in fixed HeLa cells. From 64 
cells analyzed, 32±10% of LacCer-containing endosomes were positive for PRL-3 
while 44±8% of PRL-3-containing endosomes were positive for LacCer (Fig. 37G). 
This low percentage agrees with the conclusion that PRL-3 might not be internalized 
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through calveolar endocytosis. Regardless the mode of entry, internalized cargoes are 
usually delivered to the early endosome where different routes of internalization 
converge (Grant and Donaldson, 2009). This fact can explain that, even if PRL-3 and 
LacCer are not internalized through the same pathway, they still co-localize in one 
third of the analyzed endosomes, which might correspond to endosomes formed 
downstream. The settings of this assay do not distinguish between different kinds of 
endosomes within the cell. 
Finally, to further confirm that PRL-3 is internalized through CDE, a similar 
co-localization assay was realized with Alexa Fluor® 633 nm transferrin, a canonical 
CDE cargo (Le Roy and Wrana, 2005). From 67 cells quantified, 86±6% of 
transferrin-containing endosomes were positive for PRL-3 while 74±7% of PRL-3-
containing endosomes were positive for transferrin (Fig. 38). The lower co-localization 
percentage of transferrin positive PRL-3-containing endosomes may be due to that, at 
the moment of transferrin incorporation, some PRL-3 was already taken up or being 
recycled and those endosomes remained unstained with transferrin. 
 
 
Figure 38. PRL-3 is internalized through CDE 
in HeLa cells. Confocal image of a GFP-PRL-3 
WT HeLa cell with Alexa Fluor® 633 transferrin 
incorporated for 15 min. Right: higher magnification 
of selected region showing separated channels: 
Transferrin (up), PRL-3 WT (middle) and merge 
(down). Scale bar = 10 μm. 
 
The use of selective endocytosis inhibitors together with co-localization assays in 
HeLa cells demonstrate that PRL-3 gets internalized through CDE in this cell system, 
a cellular process where regulated dephosphorylation of proteins and lipids is required 
for the proper endosome formation. 
 
4.1.2. PRL-3 enhances CDE by the stabilization of productive 
clathrin coated pits (CCPs) 
Cell migration speed is dictated by the flux of integrins through the endocytic 
pathway rather than by their levels on the cell surface. Therefore, CDE of integrins in 
PRL-3 WT/Tranferrin
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FAs (mainly α5β1 integrin) regulates the ability of cancer cells to migrate and invade 
(Paul et al., 2015; Polo et al., 2004). Indeed, several modulators of CDE have been 
related with integrin internalization and adhesion disassembly, and therefore, with 
cell migration (Paul et al., 2015). For example, clathrin adaptor disabled homolog 
(Dab2) deletion inhibits cell migration (Paul et al., 2015; Teckchandani et al., 2009), 
Arf6 GTPase activating protein (GAP) and ankyrin repeat and PH domain (ARAP2) 
are required for α5β1 integrin internalization (Paul et al., 2015; Pei Wen Chen et al., 
2013; Campa and Randazzo, 2008), and the Arf5/Arf6 guanine nucleotide exchange 
factor (GEF) brefeldin A-resistant Arf (BRAG2) binds to clathrin and adaptor protein 
(AP2) and activates Arf5 to promote internalization of integrins in cancer cells (Paul et 
al., 2015; Sakurai et al., 2011; Moravec et al., 2012). Therefore, since PRL-3 is 
internalized through CDE and its overexpression is related with oncogenically 
enhanced cell migration and invasion, we analyzed the effect of PRL-3 on CDE.  
As a first approach, CDE rate variation in HeLa cells upon PRL-3 
overexpression was investigated measuring the transferrin internalization rate since it 
is incorporated exclusively by CDE (Le Roy and Wrana, 2005). As displayed before, 
in order to study the dynasore inhibitory effect, the CDE rate was measured at 
different incubation times of HeLa cells with Alexa Fluor® 633 transferrin at 37 °C. 
Transferrin incorporation was stopped at 4°C and the remaining transferrin bound to 
the cell surface was removed by acidic rinsing. Then, internalized transferrin was 
quantified by flow cytometry. In order to include an internal parental control, HeLa 
cells were transiently transfected with GFP-PRL-3 WT to obtain a mixed population 
of parental (GFP negative) and GFP-PRL-3 WT overexpressing (GFP positive) HeLa 
cells easy to sort and analyze independently by flow cytometry.  
As hypothesized, PRL-3 WT overexpression enhanced transferrin uptake, 
which corresponds to an increment of the CDE rate (Fig. 39). To elucidate if this 
observed phenotype depends on the phosphatase activity of PRL-3, the catalytic 
inactive mutant of the phosphatase (GFP-PRL-3 C104S) was transiently 
overexpressed in HeLa cells. PRL-3 C104S did not affect the CDE rate (Fig. 39) 
suggesting that CDE enhancement was due to the phosphatase activity of PRL-3. 
This result was confirmed in HeLa cells transiently transfected with GFP-PRL-3 WT 
pre-treated during 1 hour with the PRL inhibitor analog 3 (Hoeger et al., 2014), 
which rescued the phenotype. On the other hand, an increase of the intrinsic 
phosphatase activity of PRL-3 by a mutation close to the active site (GFP-PRL-3 
E50R) led to a decrease of the CDE rate (Fig. 39), suggesting that the observed 
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phenotype depends on the particular low activity of PRL-3. 
 
 
Figure 39. PRL-3 enhances CDE in HeLa cells. Alexa Fluor® 633 transferrin incorporation 
by HeLa cells (Ctrl) (black) and HeLa cells transiently overexpressing GFP-PRL-3 WT 
untreated (green) or treated with 50 μM analog 3 (blue), GFP-PRL-3 C104S (red) or GFP-
PRL-3 E50R (ocher) measured by flow cytometry at different time points. n = 30.000 cells. 
Median ± SEM of three independent experiments. 
 
To further corroborate that the increment of the CDE rate observed upon 
PRL-3 WT overexpression is not due to a side effect of protein aberrant 
overexpression, these results were confirmed by knocking down PRL-3. However, as 
in many other cell lines, endogenous PRL-3 protein level in HeLa cells is 
undetectable (Nagaraj et al., 2011). Therefore, the experiment was performed in cells 
where PRL-3 endogenous expression was already reported: the colorectal carcinoma 
HCT116 (Xing et al., 2016) and the breast cancer MCF-7 (Geiger et al., 2012; Wang et 
al., 2010) cell lines. PRL-3 was knocked down in HCT116 by siRNA transient 
transfection (Fig. 16A) 48 hours prior to the transferrin uptake assay. After the 
experiment was performed, remaining cell sample was used to confirm by RT-PCR 
that PRL-3 was efficiently silenced (Fig. 40A). Fig. 40B confirms that PRL-3 
enhanced CDE since its deletion led to a decrease of transferrin uptake as a reporter 
of CDE rate decay. These results were also corroborated in MCF-7 cells. However, 
transient PRL-3 knockdown efficiency was too low (data not shown) to perform a 
transferrin uptake assay since it cannot discriminate between transfected and 
untransfected cells. Therefore, an IPTG inducible PRL-3 shRNA MCF-7 cell line 
was used (Figs 18C, 40C) for homogeneous PRL-3 silencing. Moreover, an IPTG 
inducible Ctrl shRNA MCF-7 was used to discard off-target or IPTG disturbance in 
the assay. shRNA expression was induced during 4 days before carrying out the 
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transferrin uptake assay to ensure PRL-3 protein deletion. As expected, PRL-3 
silencing led also to decreased CDE rate in MCF-7 cells (Fig. 40D,E). These results 
not only confirm that PRL-3 phosphatase activity intervenes in CDE, but also shows 
that the phenotype described in HeLa cells is not cell type specific.  
 
 
Figure 40. Endogenous PRL-3 enhances CDE in HCT116 and MCF-7 cells. A PRL-3 
mRNA content in HCT116 cells transiently transfected with Ctrl or PRL-3 siRNA was 
measured by one-step RT-PCR using REEP mRNA as loading control. B Alexa Fluor® 633 
transferrin incorporation in HCT116 cells transiently transfected with Ctrl or PRL-3 siRNA 
measured by flow cytometry at different time points. C Uninduced or induced PRL-3 knockdown 
with 1 mM IPTG in control or PRL-3 shRNA MCF-7 cells during 4 days. PRL-3 mRNA 
was assayed by one-step RT-PCR using REEP as a control. D,E Alexa Fluor® 633 
transferrin incorporation in IPTG uninduced or induced control (D) or PRL-3 (E) shRNA 
MCF-7 measured by flow cytometry at different time points. B,D,E n = 60.000 cells. Median 
± SEM of three independent experiments. 
 
After describing that PRL-3 alters CDE, we investigated the origin of this 
phenotype. In order to form a clathrin-coated vesicle, the fist step is the recruitment 
of clathrin and adaptor proteins to the plasma membrane in a process named 
nucleation. This clathrin-coated pit (CCP) formed in the inner leaflet of the plasma 
membrane goes through a process of maturation where different proteins and lipids 
play a role in a hierarchical and tightly regulated manner. Finally, the vesicle is 
cleaved from the cell surface through dynamin-dependent fission (explained in detail 
in the Introduction) (Loerke et al., 2009; Doherty and McMahon, 2009; Loerke et al., 
2011; Kirchhausen et al., 2014). However, CCP maturation is gated by an endocytic 
checkpoint and the progression through this point is dependent on the CCP stability 
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given by concentration of cargo receptors, dynamin, AP2 adaptors, and probably also 
by other still unknown factors that CCPs must sequentially recruit along maturation 
to prevent coat disassembly. This quality control leads to the abortion of half of the 
nascent CCPs (Loerke et al., 2009; Antonescu et al., 2011).  
Therefore, an increment of CCP density on the plasma membrane, a faster 
maturation of the pit or a higher percentage of productive CCPs would lead to a 
faster CDE. All these parameters can be quantified by total internal reflection 
fluorescence (TIRF) microscopy of fluorescently tagged clathrin overexpressing cells. 
Using this technique, we can visualize only the cell plasma membrane in contact with 
the glass surface where they are cultured on (Fish, 2009; Mattheyses et al., 2010). 
Then, clathrin nucleation and disassembly or vesicle fission can be monitored 
(Antonescu et al., 2011) in presence or absence of PRL-3 WT in order to understand 
the effect of PRL-3 overexpression on CCP dynamics. With that purpose, I 
transiently transfected mEmerald-clathrin light chain B (CLTB) together with 
pmKATE2-CaaX or pmKATE2-PRL-3 (WT, C104S or E50R) in HeLa cells. The 
first striking fact shown by TIRF is that PRL-3 is not enriched in the CCP (Fig. 41A), 
which is a more characteristic feature known for CCP related kinases than from 
phosphatases.  
Regarding CCPs analysis, overexpression of pmKATE2-PRL-3 WT, but not 
PRL-3 C104S or PRL-3 E50R, resulted in an increase of the proportion of 
productive CCPs compared to the pmKATE2-CaaX control cell line (Fig. 41B), 
consistent with the phenotype observed in the CDE rate. This effect was also 
attenuated when cells were treated with PRL inhibitor, analog 3 (Fig. 41B). These 
results suggest that PRL-3 might contribute to achieving CCP stability, increasing the 
chances of passing through the endocytic checkpoint. Upon PRL-3 WT 
overexpression, lifetime of both, abortive and progressive CCPs, are slightly increased 
(Fig. 41C,D) indicating that the phosphatase might also be interfering with the 
assembly and maturation of the CCP. Inhibition of PRL-3 WT with analog 3 
abolishes its effect on the abortive CCP lifetime but not on the productive, while the 
catalytically inactive mutant shows a phenotype that is similar to the one of the 
pmKATE2-CaaX control cell line (Fig. 41C,D), confirming that the effect depends 
on PRL-3 activity. Here, PRL-3 E50R also increased the productive CCPs lifetime 
(Fig. 41D) while it did not affect the number of CPPs (Fig. 41B), suggesting that PRL-
3’s effect on CCP maturation does not dependent on its phosphatase strength, and 
that the small increase in lifetime does not have an impact on the increase in the 
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number of productive CCPs. Finally, CCP initiation density was also analyzed. 
Overexpression of PRL-3 WT did not modify CCP initiation density, indicating that 
the phosphatase is not affecting CCP nucleation (Fig. 41E). However, when its 
phosphatase activity was increased (PRL-3 E50R), the amount of nucleated CCPs 
dramatically decreased (Fig. 41E). This is consistent with the effect exhibited on CDE 
rate and suggests a link to its increased phosphatase activity, which decreases the 
amount of PI(4,5)P2 to a level that is below the one required for efficient nucleation.  
 
 
Figure 41. PRL-3 stabilizes CCP in HeLa cells. A TIRF microscopy picture showing the 
plasma membrane of a HeLa cell overexpressing pmKATE2-PRL-3 WT (red) and mEmerald-
CLTB (green). Right: separated channels of PRL-3 WT (up) and CLTB (down). Scale bar = 
10 μm. B-E Graph representation of percentage of CCPs with a lifetime of less (abortive) or 
more (productive) than 30s (B), average lifetime of abortive (C) or productive (D) CCPs; and 
CCP events initiation density (E) in HeLa cells transiently overexpressing pmKATE2-CaaX (69 
cells, 75017 endosomes) (black), pmKATE2-PRL-3 WT untreated (70 cells, 37827 
endosomes) (green) or treated with 50 μM analog 3 (61 cells, 51282 endosomes) (blue), 
pmKATE2-PRL-3 C104S (96 cells, 82399 endosomes) (red) or pmKATE2-PRL-3 E50R 
(86 cells, 42968 endosomes) (ocher). Dashed line in B represent 50%. Mean ± SEM (B,E) 
or standard deviation (C,D) of three independent experiments. 
 
These results were corroborated by PRL-3 knockdown in HCT116 and in 
inducible PRL-3 shRNA MCF-7 cells by siRNA transient transfection or IPTG 
induction, respectively (FIG. 42A,B) to confirm that the effect observed was not due 
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to an overexpression artifact. As expected, knockdown of PRL-3 in both, HCT116 
and MCF-7 cells, resulted in the decrease in the proportion of the productive CCPs 
(Fig. 42C,D) and also the decreased lifetime of abortive and productive CCPs (Fig. 
42E-H), confirming its positive effect in CCP stabilization and its slightly negative 
influence in CCP assembly and maturation. In MCF-7 cells, IPTG treatment to 
induce control shRNA expression also slightly affected abortive CCP lifetime (Fig. 
42G) probably as a side effect of the compound treatment. Also uninduced PRL-3 
shRNA MCF-7 presented increased productive lifetime compared to uninduced 
PRL-3 shRNA MCF-7 (Fig. 42H) probably also as a side effect of the different 
shRNA genome integration that led to two different cell lines with different 
characteristics. Knockdown of PRL-3 did not alter CCP initiation density in HCT116 
(Fig. 42I) but it did in MCF-7 (Fig. 42J), where a decrease of the density of events was 
observed upon PRL-3 knockdown. This diverting result suggests that PRL-3 might 
affect CCP nucleation in some cell lines, possibly depending on the present amount of 
PI(4,5)P2 in the cells.  
 
Figure 42. PRL-3 stabilizes CCP in HCT116 and MCF-7 cells. A PRL-3 mRNA content 
in HCT116 cells transiently transfected with Ctrl or PRL-3 siRNA was measured by one-step 
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RT-PCR using REEP mRNA as loading control. B Uninduced or induced PRL-3 knockdown 
with 1 mM IPTG in control or PRL-3 shRNA MCF-7 cells during 4 days. PRL-3 mRNA 
was assayed by one-step RT-PCR using REEP as a control. C-J Graph representation of 
percentage of CCPs with a lifetime of less (abortive) or more (productive) than 30s (C,D), 
average lifetime of abortive (E,G) or productive (F,H) CCPs and CCP events initiation density 
(I,J) in HCT116 cells (C,E,F,I) transiently transfected with ctrl siRNA (73 cells, 19396 
endosomes) (black) or PRL-3 siRNA (80 cells, 28823 endosomes) (green) or in IPTG 
uninduced or induced control shRNA (uninduced: 49 cells, 49244 endosomes; induced: 45 cells, 
47876 endosomes) or PRL-3 shRNA (uninduced: 45 cells, 56786 endosomes; induced: 47 
cells, 33249 endosomes) MCF-7 cells (D,G,H,J). Dashed line in C,D represent 50%. Mean 
± SEM (C,D,I,J) or standard deviation (E-H) of three independent experiments. 
 
Taken together, CCP dynamics analysis upon presence or absence of PRL-3 
confirms that the phosphatase actively participates in this process, stabilizing the CCP 
formation and slightly extending pit assembly and maturation. However, its action to 
increase the formation of productive CCPs seems to override its negative effect on pit 
assembly and maturation, since the overall outcome is an increase in the CDE rate. 
 
4.1.3. PRL-3 dephosphorylates PI(4,5)P2 in vivo 
From the stages of clathrin nucleation until vesicle scission and uncoating, CDE 
is tightly regulated by protein and lipid kinases and phosphatases (McPherson et al., 
2013). For example, presence of lipid PI(4,5)P2 in the bulk plasma membrane is 
essential for CCP initiation to recruit several PI(4,5)P2-binding domain-containing 
adaptor proteins, like AP2 (Höning et al., 2005), which are required for clathrin 
nucleation in the cell surface. Then, its turnover by 5’-dephosphorylation occurs 
within the CCP for its maturation and vesicle formation (detailed explained in the 
Introduction) (Antonescu et al., 2011). Indeed, knockout of PI(4,5)P2 kinases and 
phosphatases like phosphatidylinositol phosphate 5’-kinase (PIP5Kγ), the major 
PIP5K isoform in neurons, or synaptojanin (Snj1) in neuronal cells inhibit clathrin-
mediated recycling of synaptic vesicles (Wenk et al., 2001; Cremona et al., 1999; 
Harris et al., 2000). Recently, it has been demonstrated that PRL-3 is able to 
dephosphorylate PI(4,5)P2 (McParland et al., 2011) in vitro. This finding suggests that 
the phosphatase might be altering CDE through PI(4,5)P2 level modulation within the 
CCP. 
In order to address this hypothesis, I set out to corroborate the in vitro PI(4,5)P2 
phosphatase activity of PRL-3. However, the techniques available to determine lipid 
	  	   	   	  
	   4.	  The	  role	  of	  PRL-­‐3	  in	  clathrin-­‐dependent	  endocytosis	   	  	   	  
95	  
dephosphorylation in cells are not as selective and sensitive than for protein 
phosphorylation detection (Fahs et al., 2016). Moreover, PI(4,5)P2 homeostasis in the 
cell surface is tightly regulated by several kinases and phosphatase and it is subject to 
a rapid continuous turnover (Czech, 2000). For that reason, detection of in vivo 
PI(4,5)P2 dephosphorylation by a weak phosphatase like PRL-3 is a challenging task. 
In fact, several unsuccessful attempts have been carried out before setting up a 
reliable technique sensitive enough to detect it. Previously in Dr. Köhn’s laboratory, 
thin layer chromatography (TLC) was realized extracting phosphatidylinositol 
phosphates (PIPs) 32P labeled from parental and PRL-3 (WT and C104S) stably 
overexpressing Hek293 cells but no difference in PI(4,5)P2 level was detected (data not 
shown).  
Then, total PIP2 level from cell extract was measured by quantitative MS 
lipidomics, which is more sensitive and quantitative than TLC. The experiment was 
performed in collaboration with Dr. Britta Brügger’s laboratory (Heidelberg 
University Biochemistry Center – BZH, Heidelberg, Germany). In previous 
collaborations between the laboratories of Dr. Köhn and Dr. Brügger they tried to 
corroborate the in vitro PI(4,5)P2 dephosphorylation in PRL-3 stably overexpressing 
Hek293 cells. However, the PIP2 level was not significantly different between Flag-
PRL-3 WT Hek293 and parental or Flag-PRL-3 C104S overexpressing Hek293 cells 
(data not shown). Therefore, I tried to repeat the set experiment in HeLa cells, where 
the CDE-related phenotype was observed. Acidic/neutral lipid extraction was 
realized in parental HeLa cells and HeLa cells transiently transfected with GFP-PRL-
3 WT, GFP-PRL-3 C104S (catalytic inactive mutant), GFP-PRL-3 E50R 
(hyperactive mutant), GFP-PRL-1 WT (no PIP phosphatase activity) or type IV 5’-
phosphatase (5-ptase) (positive control (Varnai et al., 2006)) prior to MS measurement. 
Unfortunately, the results of this experiment were not analyzable since the controls 
used did not show the predicted PIP2 level (Fig. 43). Overexpression of the known 
PI(4,5)P2 phosphatase 5-ptase did not decrease the PIP2 levels while the 
overexpression of the negative control GFP-PRL-3 C104S showed a dramatic 
increase in PIP2 levels, although the high variability led to no statistically relevant 
differences among the samples (Fig. 43).  
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Figure 43. No PI(4,5)P2 dephosphorylation by 
PRL-3 was detected in HeLa cells by quantitative 
MS lipidomics. Acidic and neutral lipids were 
purified from HeLa cells (Ctrl) (black) and HeLa 
cells transiently overexpressing GFP-PRL-3 WT 
(green), GFP-PRL-3 C104S (red), GFP-PRL-3 
E50R (ocher), GFP-PRL-1 WT (purple) and 
GFP-5-ptase (dark aquamarine) and total PIP and 
PIP2 were measured by quantitative MS lipidomics 
and the ratio was plotted. Median ± SEM of three 
technical replicates. 
 
 
 
This unpredictable result can be due to technical problems or masked by the 
PI(4,5)P2 present in the nucleus (Mellman et al., 2008; Bunce et al., 2006). 
Theoretically, none of the proteins are able to dephosphorylate nuclear lipids since 
they exclusively localize in the cytosol and cell surface. However, downstream effects 
due to the overexpression of these particular proteins in HeLa cells may occur and 
the variation of total PI(4,5)P2 level in the cell becomes uncertain. For that reason, the 
experiment was repeated after nuclear extraction from HeLa cells. To set it up, I 
removed the nuclei from the HeLa cell sample. However, although the nuclei were 
successfully cleared out, PIP2 was undetectable (data not shown), probably due to the 
removal of PI(4,5)P2 nuclear fraction leaving only the cell surface-bound PIP2, which 
might be not enough material to be detected by MS lipidomics.  
The common factor of the previous techniques is that the lipid quantification 
was done mixing together a pool of cells and measuring the total PI(4,5)P2 present in 
the sample. However, small variations from cell to cell cannot be detected, which 
decreases the sensitivity of the methods. Therefore, single cell measurement 
techniques would theoretically increase the changes to detect a PI(4,5)P2 level 
decrease upon PRL-3 WT overexpression.  
To this end, initially immunofluorescence was tested with a specific PI(4,5)P2 
antibody in HeLa cells. Several fixation and permeabilization methods were tried out 
since the integrity of the plasma membrane is crucial for fluorescence measurement 
reliability. Nevertheless, none of the combinations tested led to plasma membrane 
staining in HeLa cells as previously shown in human osteosarcoma SaOS-2 cells 
(Ozkucur et al., 2011). Instead, the PI(4,5)P2 antibody was detecting only the nuclear 
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fraction of the lipid or, depending on the applied treatment, also a portion of a 
cytosolic PI(4,5)P2 fraction (Fig. 44). This behavior suggests that either the PI(4,5)P2 
nuclear fraction is much higher than the cell surface one, so that the fluorescence 
intensity in the nucleus is masking the signal from the plasma membrane, or the cell 
surface was compromised during the immunofluorescence procedure. Therefore, in 
our hands PI(4,5)P2 staining with antibodies is not a plausible technique in HeLa cells 
to determine a decrease of the given lipid in the plasma membrane.  
 
 
 
 
 
 
 
 
 
 
 
Figure 44. PI(4,5)P2 antibodies does not stain plasma membrane PI(4,5)P2 in HeLa cells. 
Confocal microscopy picture of HeLa cells fixed and permeabilized with different treatments for 
PI(4,5)P2 immunofluorescence. Scale bar = 25 μm. 
 
Keeping the idea of single cell PI(4,5)P2 measurement, the GFP-tagged PH 
domain of PLCδ (GFP-PH PLCδ), that selectively binds to PI(4,5)P2 (Balla et al., 2009) 
used in the previous chapter as a reporter of this lipid in the apical membrane of 
MDCK cysts, was transiently overexpressed in HeLa cells together with the 
pmKATE2 tagged CaaX motif (negative control), 5-ptase (positive control), PRL-3 
WT, PRL-3 C104S (catalyticaly inactive mutant) and PRL-3 E50R (hyperactive 
mutant used to increase PI(4,5)P2 dephosphorylation activity to increase the chances 
of detection) to determine PI(4,5)P2 levels in the cell surface. A similar technique 
based on the same principle has been recently used to determine phosphatidylinositol 
3-phosphate (PI3P) levels (Ketel et al., 2016). The PH domain PLCδ is a cytosolic 
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domain that only binds to the plasma membrane in presence of PI(4,5)P2. Since this 
lipid is frequently found in the cell surface in normal conditions, PH-PLCδ will be 
recruited to the plasma membrane (Fig. 45A). However, if 5-ptase is overexpressed 
and PI(4,5)P2 is dephosphorylated, the PH domain cannot be retained in the cell 
surface and is released to the cytosol (Fig. 45E). Another advantage of this method is 
that the PH domain cannot cross the nuclear pore, avoiding nuclear PI(4,5)P2 
detection that could mask the result (Fig. 45A-E). Then, quantifying the GFP 
fluorescence intensity ratio between the plasma membrane and the cytosol is a direct 
indicator of PI(4,5)P2 presence in the cell membrane: the lower the ratio is, the less 
PI(4,5)P2 remains in the plasma membrane.  
  
Figure 45. PRL-3 dephosphorylates PI(4,5)P2 in HeLa cells. A-E Confocal microscopy 
picture of life HeLa cells transiently overexpressing GFP-PH-PLCδ and pmKATE2-CaaX (A), 
pmKATE2-PRL-3 WT (B), pmKATE2-PRL-3 E50R (C), pmKATE2-PRL-3 C104S 
(D) or pmKATE2-5-ptase (E). Scale bar = 5 μm. F Box and whisker chart representing GFP-
PH-PLCδ fluorescence intensity ratio between plasma membrane (PM) and cytosol in A-E 
samples. Thick dashed line at ratio 1 represent total PI(4,5)P2 dephosphorylation at the plasma 
membrane. Thin dotted line at ratio 3.9 represents PI(4,5)P2 level in HeLa cells in normal 
conditions. n = 105 cells. Three independent experiments. 
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Despite being statistically significant, PI(4,5)P2 decrease upon PRL-3 WT 
overexpression was quite low and visually not obvious, so further methodology 
modifications were carried out. First, human bone osteosarcoma epithelial (U2OS) 
and Hek293 cell lines were used to test if the plasma membrane/cytosol ratio was 
higher in normal conditions in order to have a bigger working frame. Hek293 are 
rather small cells and the cytosol area pictured by confocal microscopy was not big 
enough to rely on the result. Moreover, the plasma membrane/cytosol ratio was 
lower than in HeLa cells (data not shown). On the other hand, U2OS cells are bigger 
than HeLa cells but they are very flat, so there is no clear plane where the plasma 
membrane is perpendicular to the confocal plane, and drawing a sharp picture of the 
cell surface is not possible. Instead, the U2OS plasma membrane is almost parallel to 
the pictured plane and it is seen as a fuzzy area that cannot be used for this kind of 
quantifications.  
As it was aforementioned, one of the handicaps for PI(4,5)P2 dephosphorylation 
detection inside the cell is that its homeostasis is highly regulated by several distinct 
kinases and phosphatases (Czech, 2000). Therefore, as soon as the lipid is 
dephosphorylated by PRL-3, it may be easily phosphorylated again by a neighbor 
kinase avoiding its detection by any technique. This might be the reason why, upon 
PRL-3 overexpression in HeLa cells, the decrease of PI(4,5)P2 levels is rather small. In 
order to corroborate our hypothesis, phosphatidylinositol (PI) kinases were inhibited 
to avoid new PI(4,5)P2 formation with wortmannin, a potent, covalent and irreversible 
phosphatidylinositol 3-kinase (PI3K) inhibitor that can also inhibit several PI4K and 
PI5K in the μM range (Standaert et al., 1995; McNamara and Degterev, 2011; Xie et 
al., 1999; Liu et al., 2001). pmKATE2-PRL-3 WT and GFP-PH PLCδ transiently co-
transfected in HeLa cells were treated with 50 μM wortmannin 1 hour before 
confocal microscopy pictures were taken. Compared to wortmannin treated parental 
HeLa cells, PRL-3 WT overexpression led to 35% decrease of PI(4,5)P2 level 
compared to the 7% difference when untreated (Fig. 46). As expected, pmKATE2-
PRL-3 E50R dephosphorylates even more PI(4,5)P2 than PRL-3 WT, and the 
catalytic inactive mutant overexpression (pmKATE2-PRL-3 C104S) did not modify 
the level of the lipid, whereas overexpression of pmKATE2-5-ptase abolished all 
PI(4,5)P2 from the cell surface when treated with wortmannin (Fig. 46). Moreover, 
also pmKATE2-PRL-1 WT, which does not show in vitro PI(4,5)P2 phosphatase 
activity (Rios et al., 2013), was co-transfected with GFP-PH PLCδ in HeLa cells and 
treated with 50 μM wortmannin during 60 min. Here, the PI(4,5)P2 levels were 
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comparable to parental and pmKATE2-PRL-3 C104S overexpressing HeLa cells 
(Fig. 46), confirming that PRL-1 cannot dephosphorylate this phospholipid. 
 
Figure 46. PRL-3 dephosphorylates 
PI(4,5)P2 in HeLa cells. Box and 
whisker chart representing GFP-PH-
PLCδ fluorescence intensity ratio between 
plasma membrane (PM) and cytosol in 
HeLa cells transiently overexpressing 
GFP-PH-PLCδ and pmKATE2-CaaX, 
pmKATE2-PRL-3 WT, pmKATE2-
PRL-3 E50R, pmKATE2-PRL-3 
C104S or pmKATE2-5-ptase and 
treated with 50 μM wortmannin during 1 
hour prior to image acquisition. Thick 
dashed line at ratio 1 represents total 
PI(4,5)P2 dephosphorylation at the 
plasma membrane. Thin dotted line at 
ratio 4.5 represents PI(4,5)P2 level in 
HeLa cells in normal conditions. n = 105 
cells. Three independent experiments. 
 
After setting up a suitable methodology to determine small variations of 
PI(4,5)P2 in the cellular plasma membrane, I use it to corroborate that not only 
aberrant PRL-3 expression but also endogenous levels of the protein are able to 
dephosphorylate PI(4,5)P2. Therefore, variation of the phospholipid was measured 
upon PRL-3 knockdown in MCF-7 and HCT116, which contain endogenous PRL-3 
protein levels (Fig. 47A,B). As predicted, PRL-3 knockdown in HCT116 cells 
transiently expressing GFP-PH PLCδ treated with 50 μM wortmannin during 60 min 
showed an increase of PI(4,5)P2 in the plasma membrane compared to control (Fig. 
47C). The same result was observed when PRL-3 silencing was induced in the IPTG 
inducible PRL-3 shRNA MCF-7 cell line compared to non induced and to IPTG 
induced and uninduced Ctrl shRNA MCF-7 (Fig. 47D).  
The extensive use of different cell lines with overexpression and knockdown of a 
PI(4,5)P2 phosphatase, together with the use of several positive and negative controls, 
demonstrate that the new microscopy method to determine PI(4,5)P2 content in live 
cells is robust and trustable, and it has been imperative to corroborate that PRL-3 
dephosphorylates PI(4,5)P2 also in vivo. Moreover, the new quantitative use of PIPs 
binding domain enrich their already high applicability (Balla et al., 2009).  
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Figure 47. PRL-3 dephosphorylates PI(4,5)P2 in HCT116 and MCF-7 cells. A PRL-3 
mRNA content in HCT116 cells transiently transfected with Ctrl or PRL-3 siRNA was 
measured by one-step RT-PCR using REEP mRNA as loading control. B Uninduced or 
induced PRL-3 knockdown with 1 mM IPTG in control or PRL-3 shRNA MCF-7 cells 
during 4 days. PRL-3 mRNA was assayed by one-step RT-PCR using REEP as a control. 
C,D Box and whisker chart representing GFP-PH-PLCδ fluorescence intensity ratio between 
plasma membrane (PM) and cytosol in HCT116 cells transiently transfected with ctrl siRNA or 
PRL-3 siRNA (C) or in IPTG uninduced or induced control or PRL-3 shRNA MCF-7 cells 
(D). Cells were treated with 50 μM wortmannin during 1 hour prior to image acquisition. Thick 
dashed line at ratio 1 represent total PI(4,5)P2 dephosphorylation at the plasma membrane. Thin 
dotted line at ratio 4.3 (C) or 4.2 (D) represents PI(4,5)P2 level in HCT116 or MCF-7 cells 
respectively in normal conditions. n = 105 cells. Three independent experiments. 
 
4.1.4. PRL-3’s effect on CDE depends on PI(4,5)P2 
dephosphorylation. 
GFP-PH PLCδ is a powerful quantitative tool that could be theoretically used 
to determine PI(4,5)P2 dynamics during CCP initiation and maturation and to 
determine if PRL-3 modifies it, what would link the confirmed substrate with the 
given phenotype. Indeed, this approach has been applied to investigate PI(4,5)P2 
enrichment in larger structures than CCPs such as the cleavage furrow of Drosophila 
spermatocytes (Wong et al., 2005) and the site of phagocytosis (Botelho et al., 2000). 
However, either a single or even tandem PH domains to increase PI(4,5)P2 affinity are 
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not able to detect the phospholipid within CCPs. PI(4,5)P2 in CCPs is probably 
sequestered by its numerous binding proteins recruited during its formation and 
hence unavailable for its detection (Antonescu et al., 2011). A similar PI(4,5)P2-binding 
domain that is also involved in CDE, the AP180 N-terminal homology (ANTH) 
domain from Src-like adapter (Sla2), has been successfully used in yeast (Yidi Sun et 
al., 2007), but not in mammalian cells (Antonescu et al., 2011).  
 Therefore, since direct visualization of PI(4,5)P2 in CCP context remains 
inaccessible, I indirectly investigated if PRL-3 was affecting CDE through PI(4,5)P2 
dephosphorylation by counteracting the action of the phosphatase with the 
overexpression of the corresponding kinase. Only if the substrate of a kinase is the 
product of a phosphatase the phenotype given by its partner can be rescued. 
Therefore, the rescue of the PRL-3 phenotype by a PIP kinase would strongly suggest 
that the hypothesis is correct. Although PI(4,5)P2 has been postulated as a PRL-3 
substrate, the position that is hydrolyzed remains unknown (McParland et al., 2011). 
However, since phosphatidylinositol 4-phosphate (PI4P) functions as a precursor pool 
of PI(4,5)P2 in the plasma membrane and it is also formed and required during CCP 
maturation (Schmid and Mettlen, 2013; Dickson et al., 2014; Antonescu et al., 2011), it 
is likely that PRL-3 might be dephosphorylating the 5’ position. Therefore, 
phosphatidylinositol 4-phosphate 5-kinase type I (PIP5K) was used to rescue PRL-3 
phenotype on CDE. Among the 3 existing isoforms of PIP5K (α, β and γ), the β 
isoform is located in endomembranes and γ is more predominantly present in 
neurons, while α is present in the cell surface and it has been already related to CDE 
(Schramp et al., 2015; Anderson et al., 1999; Brown and Auger, 2011). Therefore, 
PIP5Kα is the isoform that was used for the assays.  
First, PI(4,5)P2 content in untreated HeLa cells overexpressing blue fluorescent 
protein (BFP)-tagged PIP5Kα was measured with PI(4,5)P2 reporter GFP-PH PLCδ. 
As predicted, the PIP kinase overexpression increased the amount of PI(4,5)P2 in the 
cell surface (Fig. 48). BFP-PIP5Kα was also co-transfected with pmKATE2 PRL-3 
WT what partially counteracted the PI(4,5)P2 production given by the kinase (Fig. 48) 
corroborating that PRL-3 is a PI(4,5)P2 phosphatase. As a positive control of this 
PI(4,5)P2 production rescue, the PIP kinase was co-transfected with pmKATE2-5-
ptase, a proven PI(4,5)P2 phosphatase, also decreasing the phospholipid content in the 
plasma membrane (Fig. 48). However, PRL-3 was unable to completely rescue a 
PI(4,5)P2 content comparable to parental HeLa while 5-ptase was even stronger than 
the kinase leading to a slight drop of PI(4,5)P2 levels in comparison with the parental 
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control. This difference confirms that PRL-3 is not a strong phosphatase (Rios et al., 
2013; McParland et al., 2011) since cannot completely counteract the kinase effect, a 
fact that must be taken into consideration in future experiments. 
 
Figure 48. PIP5Kα overexpression  
increases PI(4,5)P2 levels in HeLa cells. 
Box and whisker chart representing GFP-
PH-PLCδ fluorescence intensity ratio 
between plasma membrane (PM) and 
cytosol in HeLa cells transiently 
overexpressing GFP-PH-PLCδ and 
pmKATE2-CaaX, pmKATE2-PRL-3 
WT, pmKATE2-5-ptase, BFP-PIP5Kα, 
BFP-PIP5Kα + pmKATE2-PRL-3 WT 
and BFP-PIP5Kα + pmKATE2-5-ptase. 
Thick dashed line at ratio 1 represent total 
PI(4,5)P2 dephosphorylation at the plasma 
membrane. Thin dotted line at ratio 3.9 
represents PI(4,5)P2 level in HeLa cells in 
normal conditions. n = 105 cells. Three 
independent experiments. 
 
After confirming that PIP5Kα is able to counteract PI(4,5)P2 depletion upon 
PRL-3 overexpression, I used the kinase as a tool to examine if it would also rescue 
the PRL-3 phenotype on CDE. Moreover, PRL-1 WT, which does not show 
PI(4,5)P2 phosphatase activity (Rios et al., 2013), was used as a negative control and 
the known PI(4,5)P2 phosphatase, 5-ptase, as a positive control. Hence CCP dynamics 
were again measured in mEmerald-CLTB transiently overexpressing HeLa cells by 
TIRF microscopy. The results are shown in Fig. 49. 
PRL-1 WT transient overexpression in mEmerald-CLTB HeLa cells showed a 
productive CCPs proportion, abortive CCPs lifetime and CCPs initiation density 
comparable to parental HeLa cells (Fig. 49A,C,E), supporting that PRL-3 might be 
affecting CDE by PI(4,5)P2 dephosphorylation. However, the lifetime of productive 
CCPs increased (Fig. 49D) suggesting that PRL-1 overexpression might slightly affect 
CCP maturation through another pathway. Since this action of PRL-3 seemed to 
counteract the increase in the formation of productive CCPs (chapter 4.1.2.), it is 
possible that this effect is caused by a common mechanism of PRL-1 and PRL-3, and 
not by PRL-3 dephosphorylating PI(4,5)P2. 
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Figure 49. PRL-3 stabilizes CCP through PI(4,5)P2 dephosphorylation in HeLa cells. Graph 
representation of percentage of CCPs with a lifetime of less (abortive) or more (productive) than 30s 
(A), percentage of CCPs with a lifetime of less than 30s (abortive), between 30s and 180s (pits) 
and more than 180s (plaques) (B), average lifetime of abortive (C) or productive (D) CCPs and 
CCP events initiation density (E) in HeLa cells transiently overexpressing pmKATE2-CaaX (69 
cells, 75017 endosomes) (black), pmKATE2-PRL-3 WT (70 cells, 37827 endosomes) (green), 
pmKATE2-PRL-1 WT (72 cells, 56204 endosomes) (purple), pmKATE2-5-ptase (68 cells, 
25075 endosomes) (aquamarine), BFP-PIP5Kα (34 cells, 18326 endosomes) (orange), BFP-
PIP5Kα + pmKATE2-PRL-3 WT (32 cells, 12210 endosomes) (pink) or BFP-PIP5Kα + 
pmKATE2-5-ptase (29 cells, 9475 endosomes) (brown). Dashed line in A represent 50%. Mean 
± SEM (A,B,E) or standard deviation (C,D) of three independent experiments. 
On the other hand, despite both being PI(4,5)P2 phosphatases, 5-ptase and 
PRL-3 showed a different effect on CCP dynamics. While PRL-3 was stabilizing the 
pit increasing the amount of productive CCPs, although its assembly and maturation 
was slowed down, PI(4,5)P2 ablation by 5-ptase overexpression dramatically reduced 
the proportion of productive CCPs, the lifetime of abortive and productive CCPs, 
and also resulted in less initial CCP events (Fig. 49A,C-E). Overexpression of a strong 
phosphatase like the 5-ptase is an extreme scenario were PI(4,5)P2 is almost not 
present anymore. Since its presence in the bulk plasma membrane is required for 
CCP nucleation, results observed in CCP density upon 5-ptase overexpression are 
consistent with this idea whereas PRL-3 overexpression, a weaker PI(4,5)P2 
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phosphatase, does not exert the same phenotype. This is also the case when 
comparing the PRL-3 phenotype with other proven PI(4,5)P2 phosphatases like Sjn1 
(Antonescu et al., 2011; Nakatsu et al., 2010). Since PI(4,5)P2 dephosphorylation in the 
core of the pit is necessary for CCP maturation, shorter lifetimes upon 5-ptase 
overexpression is also expected. However, PI(4,5)P2 dephosphorylation also leads to 
coating destabilization, so if the dephosphorylation is too fast, the CCP may not be 
stable enough to go through the endocytic checkpoint. This is in agreement with my 
finding that the abortive CCP proportion is increasing when 5-ptase is present. These 
findings are also in agreement with the intermediate phenotype observed upon PRL-3 
E50R overexpression in HeLa cells (Fig. 41B-E). The higher phosphatase activity of 
the mutant compared to WT is able to dephosphorylate enough PI(4,5)P2 from the 
bulk plasma membrane to decrease the CCP event density but it is not as potent as 5-
ptase to destabilize the clathrin coat affecting the abortive/productive relative 
contribution or lifetimes. Therefore, differences to the PRL-3 WT phenotype may be 
caused by the WT’s weaker phosphatase activity and possibly also by a different 
phosphatase distribution within the CCP.  
Consistently, an increase of PI(4,5)P2 in the bulk plasma membrane reached 
upon PIP5Kα overexpression in HeLa cells facilitates clathrin nucleation as observed 
in the increase of the density of events (Fig. 49E), which was previously proven 
(Antonescu et al., 2011). This PI(4,5)P2 production increase also stabilizes the CCP 
during maturation reflected in a higher productive population, but also in a longer 
productive CCP lifetime (Fig. 49A,D) since CCP maturation, driven by PI(4,5)P2 
dephosphorylation, will require more time to clear out the lipid from the pit. To gain 
a deeper understanding of both phenotypes, the productive population was divided in 
pit and plaque subpopulations (see Introduction) (Saffarian et al., 2009). Fig. 49B shows 
that PRL-3 overexpression increases both the pits and plaques proportion compared 
to parental HeLa cells, while PIP5Kα only modifies the plaques population. This 
result confirms that the increase of available PI(4,5)P2 in the plasma membrane by 
PIP5Kα enables clathrin polymerization in larger areas in the cell surface (Antonescu 
et al., 2011), what could potentially transform pits into plaques. On the other hand, as 
explained above PRL-3 dephosphorylation of PI(4,5)P2 leads to an increase in the 
proportion of productives, both pits and plaques, and it likely acts through another 
mechanism to increase the lifetime of the productives.  
When PRL-3 and PIP5Kα are both overexpressed in mEmerald-CLTB HeLa 
cells, then the observed phenotype is comparable to the one obtained through only 
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PIP5Kα overexpression (Fig. 49B-E), except for a reduction of CCP initiation which 
is comparable to that of parental HeLa cells. This difference in event initiation density 
can be explained by the fact that the presence of both together leads to lower 
PI(4,5)P2 levels than only with the kinase (Fig. 48). These results demonstrate that the 
kinase can counteract the PRL-3 phenotype confirming that PRL-3 affects CDE 
through PI(4,5)P2 dephosphorylation. Moreover, together with the phenotype exerted 
by PRL-3 E50R (Fig. 41B-E) where only the CCP density was affected, these finding 
suggests that the initial CCP nucleation is the most sensitive endocytosis stage to 
PI(4,5)P2 levels. 
When not considering the strength of the enzymatic activity, one could have 
expected that PRL-3 and PIP5Kα co-transfection would have led to a phenotype 
comparable to parental HeLa cells. As a proof of principle of the rescue experiment, 
the kinase was therefore also overexpressed with a known PI(4,5)P2 phosphatase, 5-
ptase. In this scenario, the CCP dynamics were comparable to the parental HeLa 
cells (Fig. 49B-E) except for the lifetime of productive CCPs, which was increased. 
These results suggest that the difference between this result and the one shown when 
PRL-3 and PIP5Kα were co-overexpressed was due to the catalytic potency of PRL-3 
and 5-ptase. While the strong phosphatase activity of 5-ptase could be counteracted 
by PIP5Kα, the kinase was stronger than PRL-3, exceeding the rescue towards the 
PIP5Kα overexpression phenotype. 
In order to determine if the observed CCP dynamics phenotype rescue driven 
by the PI5P kinase over PRL-3 and 5-ptase overexpression had an impact on the 
CDE rate, a transferrin uptake assay was performed with the same conditions used in 
the previous experiments. GFP-PRL-1 WT overexpression in HeLa cells did not alter 
the transferrin uptake rate (Fig. 50A) suggesting that the slight effect observed in 
productive CPP lifetime is not strong enough to alter CDE rate, reinforcing the 
hypothesis that PRL-3 affects CDE by PI(4,5)P2 dephosphorylation. When BFP-
PIP5Kα was overexpressed, then the CDE rate was slowed down (Fig. 50B) as 
previously demonstrated by Antonescu et al., since an increase in PI(4,5)P2 levels may 
uncouple CCP nucleation and maturation (Antonescu et al., 2011). Moreover, the 
increase of the plaques proportion might also affect CDE rate since they require 
longer time to get internalized (Saffarian et al., 2009). On the other hand, strong 
reduction of PI(4,5)P2 through GFP-5-ptase overexpression also led to a decrease in 
CDE rate (Fig. 50C), which is in agreement with the increase of abortive CCPs and 
the drop of CCP initiation. Finally, when BFP-PIP5Kα was co-transfected with GFP-
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PRL-3 WT or GFP-5-ptase, the given phenotype was rescued in both cases (Fig. 
50B,C), confirming that PRL-3 WT alters CDE through PI(4,5)P2 dephosphorylation.   
Taken together, after confirming that PRL-3 WT is a PI(4,5)P2 phosphatase, 
here we show that the phenotype observed in CCP stabilization and CDE 
enhancement upon PRL-3 overexpression is due to this phosphoinositide activity. We 
prove it by counteracting the decrease of PI(4,5)P2 within the CCP driven by PRL-3 
with the overexpression of the appropriate kinase, PIP5Kα. The lack of effect of PRL-
1 overexpression on CDE, which does not have PI(4,5)P2 phosphatase activity, 
supports this finding. Interestingly, the overexpression of 5-ptase resulted in the 
opposite phenotype compared to PRL-3 WT. This dramatic difference can be 
explained by the different strengths in phosphatase activity, since the overexpression 
of the PRL-3 hyperactive mutant (PRL-3 E50R) led to an intermediate phenotype 
between PRL-3 WT and 5-ptase in agreement with the aforementioned results. 
 
 
Figure 50. PRL-3 enhances CDE through PI(4,5)P2 dephosphorylation in HeLa cells. Alexa 
Fluor® 633 transferrin incorporation in HeLa cells (Ctrl) (black) and HeLa cells transiently 
overexpressing GFP-PRL-1 WT (purple) (A); GFP-PRL-3 WT (green), BFP-PIP5Kα 
(orange) or BFP-PIP5Kα + GFP-PRL-3 WT (pink) (B); or GFP-5-ptase (aquamarine), 
BFP-PIP5Kα (orange) or BFP-PIP5Kα + GFP-5-ptase (brown) (C) measured by flow 
cytometry at different time points. n = >2.000 cells/replicate. Mean ± SEM of ten (Ctrl), six 
(GFP-PRL-3 WT, BFP-PIP5Kα, GFP-5-ptase) and three (BFP-PIP5Kα + GFP-PRL-3 
WT, BFP-PIP5Kα + GFP-5-ptase) independent experiments. 
A B
C
0 5 10
0
25
50
75
100
t (min)
%
 In
te
ns
ity
 b
as
ed
 o
n 
10
 m
in
 C
trl
 
Ctrl
GFP-PRL-1 WT
0 5 10
0
25
50
75
100
125
150
t (min)
%
 In
te
ns
ity
 b
as
ed
 o
n 
10
 m
in
 C
trl
 
Ctrl
GFP-PRL-3 WT
BFP-PIP5K
BFP-PIP5K /GFP-PRL-3 WT
*
****
****
ns
***
ns
***
****
***
*
0 5 10
0
25
50
75
100
t (min)
Ctrl
BFP-PIP5K  
GFP-5-ptase
BFP-PIP5K /GFP-5-ptase
***
****
****
****
**
***
****
****
**
****
****
****
***
****
%
 In
te
ns
ity
 b
as
ed
 o
n 
10
 m
in
 C
trl
 
	  	   	   	  
	   4.	  The	  role	  of	  PRL-­‐3	  in	  clathrin-­‐dependent	  endocytosis	   	  	   	  
108	  
4.1.5. PRL-3 spatial localization within the CCP region is crucial for 
pit stabilization. 
The participation of PI(4,5)P2 in the formation of a vesicle through CDE is 
spatially and temporally regulated (Antonescu et al., 2011; Nakatsu et al., 2010; Yidi 
Sun et al., 2007; Posor et al., 2015). For that reason, the activity of PI(4,5)P2 kinases 
and phosphatases is also regulated in time and space. For example, while PIP5Kα is 
homogenously present in the plasma membrane to synthetize PI(4,5)P2 in the bulk cell 
surface to enable CCP initiation, Snj1 is only recruited within the initiated pit to 
proceed along the maturation phase (Antonescu et al., 2011). Therefore, a detailed 
investigation of PRL-3 localization during vesicle formation is required to understand 
its function in this process.  
Unlike Sjn1 (Antonescu et al., 2011), pmKATE2-PRL-3 WT overexpressed in 
HeLa cells is constantly present in the bulk plasma membrane, like PIP5Kα (Fig. 
41A). However, when closely examining its distribution within the CCP, PRL-3 
seems to redistribute to the periphery of the pit from the CCP nucleation until the 
vesicle is cleaved (Fig. 51A,B). Since PI(4,5)P2 is only dephosphorylated inside the pit 
during CCP maturation, the theoretical distribution of the lipid within the pit must be 
similar to the one observed for PRL-3 (Fig. 10). In order to quantify this particular 
distribution for PRL-3, the Pearson correlation between pmKATE2-PRL-3 and 
mEmerald-CLTB was measured, showing that PRL-3 levels are reduced in the center 
of the CCP compared to prenylated pmKATE2 (pmKATE2-CaaX) (Fig. 51B,C). 
PRL-3 distribution within the CCP also depends on its PI(4,5)P2 phosphatase activity 
because its inhibition with analog 3 (Hoeger et al., 2014) in HeLa cells modified its 
distribution within the CCP. Also pmKATE2-PRL-3 C104S and pmKATE2 PRL-1 
WT distribution was homogeneous compared to CLTB (Fig. 51B,C) confirming the 
hypothesis.  
During CCP nucleation and maturation, several proteins that take part of this 
machinery are recruited by interaction with PI(4,5)P2. Moreover, this phospholipid 
gets dephosphorylated during maturation. Combination of both features leaves the 
area with few available PI(4,5)P2 molecules, and this is the reason why it is not 
possible to detect it with fluorescently tagged PLCδ (Antonescu et al., 2011). 
Therefore, and based on its specific distribution around the CPPs, I hypothesized that 
PRL-3 might not only dephosphorylate PI(4,5)P2, but also interact with the lipid 
probably through the C-terminal polybasic sequence that the phosphatase contains 
	  	   	   	  
	   4.	  The	  role	  of	  PRL-­‐3	  in	  clathrin-­‐dependent	  endocytosis	   	  	   	  
109	  
adjacent to the lipidated cysteine. This sequence could potentially establish an 
electrostatic interaction with the negatively charged lipid.  
 
 
Figure 51. PRL-3 WT is relocated to the periphery of the CCP during vesicle formation. A 
TIRF microscopy time-lapse taking pictures every 5 s following a single vesicle formation 
(CLTB) showing PRL-3 localization (PRL-3 WT) within the CCP area in HeLa cells 
A
C
CLTB
PRL-3 WT
t (s) 0      5    10    15    20    25   30    35    40   45    50    55    60 
320 nm
pmKA
TE2-C
aaX 
pmKA
TE2-P
RL-3 W
T
pmKA
TE2-P
RL-3 W
T+An3
pmKA
TE2-P
RL-3 C
104S
pmKA
TE2-P
RL-3 E
50R
pmKA
TE2-P
RL-1 W
T
pmKA
TE2-5
-ptase
0.0
0.5
1.0
Pe
ar
so
n 
co
rre
la
tio
n 
fa
ct
or
***
CLTBPhosphatase CLTBPhosphatase
C
aa
X
PR
L-
3 
W
T
PR
L-
3 
W
T 
+ 
An
3
PR
L-
3 
C
10
4S
PR
L-
3 
E5
0R
PR
L-
1 
W
T
5-
pt
as
e
B
	  	   	   	  
	   4.	  The	  role	  of	  PRL-­‐3	  in	  clathrin-­‐dependent	  endocytosis	   	  	   	  
110	  
transiently overexpressing mEmerald-CLTB and pmKATE2-PRL-3 WT. B 3D representation 
of fluorescence intensity (z) of CLTB and pmKATE2-CaaX, pmKATE2-PRL-3 WT 
untreated or treated with 50 μM analog 3, pmKATE2-PRL-3 C104S, pmKATE2-PRL-3 
E50R, pmKATE2-PRL-1 WT or pmKATE2-5-ptase where a clathrin-coated vesicle is being 
formed (xy). C Pearson correlation between the CCP (CLTB) and the given phosphatase. The 
closer the value is to 1, the more phosphatase is found within the CCP. n = 30 cells. Mean ± 
standard deviation of three independent experiments.  
 
Indeed, it was previously mentioned that PRL-3 could bind to 
phosphoinositides similarly to PRL-1, through the polybasic sequence, but data was 
not shown (Sun et al., 2007). Then, the lack of available PI(4,5)P2 in the core of the pit 
would expel PRL-3 to a PI(4,5)P2-richer region surrounding the pit, where it can 
freely dephosphorylate more PI(4,5)P2. Theoretically, this process would form a ring 
around the pit where less PI(4,5)P2 would be available, which could delimitate 
nucleation expansion and ensure pit maturation. 
In order to prove this hypothesis, Dr. Pablo Rios, a colleague from Dr. Köhn’s 
laboratory, realized an in vitro interaction assay between purified non-lipidated human 
PRL-3 and PI(4,5)P2-containing liposomes to determine if they interact, using flow 
cytometry as readout. Indeed, PRL-3 WT interacts with PI(4,5)P2-containing 
liposomes in a lipid-concentration dependent manner (Fig. 52A). This interaction was 
specific for PI(4,5)P2 since it was stronger than with the other PIP species (Fig. 52B), 
where a residual interaction is observed, perhaps due to electrostatic unspecific 
interactions between the lipid phosphates and the polybasic sequence of PRL-3. As 
expected, this interaction depended on the polybasic sequence of PRL-3, since 
mutations of the positively charged amino acids to alanine (GFP-PRL-3 3A2) 
abolished the interaction (Fig. 52C). Moreover, the active site plays also a role in this 
interaction since the trapping-mutant (GFP-PRL-3 C104S) was a stronger binder. 
Given that PRL-3 interacts with PI(4,5)P2, the lipid distribution over the plasma 
membrane could be driving PRL-3 localization toward regions where the lipid is 
enriched. Therefore, within a maturating CCP where PI(4,5)P2 is being 
dephosphorylated and where the phosphatase must compete with other interacting 
proteins involved in clathrin-coated vesicle formation, the phosphatase might be 
redirected to regions richer in PI(4,5)P2 like the ones surrounding the CCP.  
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Figure 52. PRL-3 specifically interacts with PI(4,5)P2 in vitro. The interaction between 
fluorophore-containing liposomes with different lipid composition and purified GFP-tagged 
phosphatase is measured by flow cytometry. A Interaction between GFP-PRL-3 WT and 
plasma membrane (PM)-like lipid composition liposomes containing increasing amounts of 
PI(4,5)P2. n = 4 samples. B Interaction between GFP-PRL-3 WT and phosphatidylcholine 
(PC) liposomes containing 8% of different PIP species. n = 8,3,8,6,6,8 and 8 samples 
respectively to the sample order in the chart. C Interaction between GFP-PRL-3 (WT, C104S, 
3A2 and ΔF160 KRas) and PC liposomes containing 8% PI(4,5)P2. n = 6 samples. c.F.U. 
= corrected fluorescence units. Mean ± SEM of three independent experiments.   
 
If the proposed hypothetical scenario is correct, disruption of PRL-3 WT 
distribution within the CCP without altering its phosphatase activity should also affect 
CCP dynamics and, consequently, CDE rate. The polybasic sequence of PRL-3 is 
formed by 6 positively charged amino acids scattered throughout 11 amino acids. In 
order to make it stronger, the C-terminus was exchanged from amino acid 160 until 
the end with the same amount of amino acids corresponding to KRas (GFP-PRL-3 
ΔF160 KRas), which contains 6 lysines in a row and can potentially interact more 
strongly with PI(4,5)P2. To confirm this, the interaction between PI(4,5)P2 and GFP-
PRL-3 ΔF160 KRas was tested in liposomes. Fig. 52C shows that the hypothesis was 
correct with an binding increase of 10 times compared to PRL-3 WT. To ensure that 
the chimera was still active, its PI(4,5)P2 phosphatase activity was tested in vivo in 
GFP-PH PLCδ overexpressing HeLa cells upon wortmannin treatment. As expected, 
the chimera was still active although the dephosphorylation efficiency was slightly 
lower compared to pmKATE2-PRL-3 WT (Fig. 53A).     
Then, this chimera was overexpressed in mEmerald-CLTB HeLa cells to 
analyze CCP dynamics by TIRF microscopy. As expected, polybasic sequence 
exchange was sufficient to avoid being expelled to the surrounding area of the CCP 
(Fig. 53B). This differential distribution affected the phenotype exerted by PRL-3, 
since the chimera did neither vary the productive CCP proportion nor lifetime of 
productive CCP (Fig. 53C,E). However, it did increase the lifetime of abortive CCPs 
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and also decreased the CCP initiation (Fig. 53D,F) density meaning that the chimera 
is affecting CCP nucleation maybe inhibiting PI(4,5)P2 spatial accumulation due to 
the strong interaction with the lipid, or, since it is not expelled, due to the 
dephosphorylation of PI(4,5)P2. Finally, in order to test if this differential CCP 
dynamics pattern had an effect on the CDE rate, a transferrin uptake assay was 
performed in HeLa cells overexpressing GFP-PRL-3 ΔF160 KRas. As expected from 
the strong decrease of CCP initiation density, the overexpression of the chimera led to 
a decrease of CDE rate, confirming the proposed hypothesis (Fig. 53G). The different 
phenotype exerted by the chimera confirms that the characteristic localization of 
PRL-3 WT during CCP formation and maturation is crucial for the phenotype.  
The results presented here strongly support the suggested scenario where the 
distribution of PRL-3 WT in the surrounding area of the CCP is crucial to stabilize 
the CCP, leading to an enhanced CDE rate. This distribution is driven by the specific 
interaction between the phosphatase polybasic sequence and PI(4,5)P2. This 
interaction must be strong enough to enable the lipid to alter PRL-3 distribution on 
the plasma membrane but not too strong to compete with other PI(4,5)2-interacting 
proteins required for CCP formation. Interestingly, overexpression of GFP-PRL-3 
ΔF160 KRas leads to similar outcomes as overexpression of the E50R mutant, in 
which the activity is slightly (about 3fold) increased (B. Hoeger, M. Köhn, 
unpublished results) while the polybasic sequence is intact. Altogether, this suggests 
that the exact combination of the PI(4,5)P2 affinity to the polybasic sequence and the 
low phosphatase activity is required for the effect on CDE, and that minor changes in 
either feature have a strong impact on the outcome in CDE.  
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Figure 53. PRL-3 localization within the CCP is driven by its interaction with PI(4,5)P2 
through the polybasic sequence. A Box and whisker chart representing GFP-PH-PLCδ 
fluorescence intensity ratio between plasma membrane (PM) and cytosol in HeLa cells transiently 
overexpressing GFP-PH-PLCδ and pmKATE2-CaaX, pmKATE2-PRL-3 WT or 
pmKATE2-PRL-3 ΔF160 KRas and treated with 50 μM wortmannin during 60 min prior to 
image acquisition. Thick dashed line at ratio 1 represent total PI(4,5)P2 dephosphorylation at the 
plasma membrane. Thin dotted line at ratio 4.5 represents PI(4,5)P2 level in HeLa cells in 
normal conditions. n = 105 cells. Three independent experiments. B-F Graph representation of 
Pearson correlation factor between the CCP (CLTB) and the given phosphatase (B), percentage of 
CCPs with a lifetime of less (abortive) or more (productive) than 30s (C), average lifetime of 
abortive (D) or productive (E) CCPs and CCP events initiation density (F) in HeLa cells 
transiently overexpressing pmKATE2-CaaX (69 cells, 75017 endosomes) (black), pmKATE2-
PRL-3 WT (70 cells, 37827 endosomes) (green) or pmKATE2-PRL-3 ΔF160 KRas (43 
cells, 42525 endosomes) (red). Mean ± SEM (C,F) or standard deviation (B,D,E) of three 
independent experiments. G Alexa Fluor® 633 transferrin incorporation in HeLa cells (Ctrl) 
(black) and HeLa cells transiently overexpressing GFP-PRL-3 WT (green) or GFP--PRL-3 
ΔF160 KRas (red) n = 5.000 cells/replicate. Mean ± SEM of sixteen (Ctrl), six (GFP-PRL-
3 WT) and three (GFP--PRL-3 ΔF160 KRas) independent experiments. 
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4.2. Discussion 
The molecular basis behind the carcinogenic behavior of the phosphatase PRL-
3 has remained obscure since its discovery due to the lack of a solid substrate. The 
challenge of finding PRL-3 substrate(s) is mainly due to its low intrinsic phosphatase 
activity and the lack of approaches sensitive enough to detect that in the cell (Rios et 
al., 2013; Fahs et al., 2016). Indeed, PRL-3 has been recently proposed to act as a 
pseudophosphatase (Zhang et al., 2017), but the PI(4,5)P2 phosphatase activity 
observed in the present study is in disagreement with this hypothesis. In fact, given 
the multitude of pathways that PRL-3 has an effect on (Rios et al., 2013), it is rather 
likely that both phosphatase and pseudophosphatase action contribute to the different 
phenotypes that PRL-3 causes. 
PRL-3 expression causes several different cellular phenotypes such as 
enhancing cell growth, migration, and invasion, and disrupting epithelial architecture, 
depending on the cell types and experimental settings used. Of these diverse 
phenotypes, cell migration is an extremely complex process that requires an 
uncountable amount of molecular and cellular processes where scientific 
investigations could also unveil only the tip of iceberg (Polacheck et al., 2013; Paul et 
al., 2015; Friedl et al., 2012; Petrie et al., 2009; Webb and Horwitz, 2003). However, 
recent investigations agree that PRL-3 might be enhancing cell migration altering 
integrin clustering in the FA through direct interaction between integrins and PRL-3 
(Foy et al., 2017; Peng et al., 2006; Peng et al., 2009) and/or through integrin turnover 
(Krndija et al., 2012; Chao and Kunz, 2009). While these two models can occur 
synergetically, in the present work I have focused in the second scenario. Recently, it 
was postulated that PRL-3 enhances integrin recycling without altering the 
concentration in the plasma membrane (Krndija et al., 2012), showing enhanced 
exocytosis and suggesting enhanced uptake, probably through CDE (Chao and Kunz, 
2009; Paul et al., 2015). I aimed to prove this proposed involvement of PRL-3 in 
CDE.  
Here, I show for the first time that PRL-3 is internalized from the plasma 
membrane selectively by CDE from where it goes to early endosomes, like it was 
previously observed (Qi Zeng et al., 2000). Together with the recycling endosome 
pathway from the Golgi apparatus that was recently shown (Krndija et al., 2012), now 
we have the larger picture of how PRL-3 localization in the plasma membrane and its 
turnover are achieved, although the pathway taken by the phosphatase from the early 
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endosomes back to the Golgi apparatus is still unknown. Further investigations in this 
regard would be helpful for rational drug design to disrupt the plasma membrane 
localization of PRL-3, which is crucial to exert its carcinogenic phenotype (Rios et al., 
2013; Foy et al., 2017).  
Moreover, PRL-3 is actively enhancing the CDE rate, which is consistent with 
the initial hypothesis where only a faster integrin uptake would explain that the 
integrin concentration in the plasma membrane can remain constant upon recycling 
enhancement (Krndija et al., 2012). In the formation of a clathrin-coated vesicle, there 
are three master keys: clathrin, AP2 and PI(4,5)P2 (McMahon and Boucrot, 2011; 
Posor et al., 2015). Since PI(4,5)P2 was proposed as an in vitro PRL-3 substrate 
(McParland et al., 2011), I further investigated in this direction to understand how 
PRL-3 interferes with CDE. However, the available approaches to quantify cellular 
PI(4,5)P2 levels were not sensitive enough and the variability among cells could not be 
taken into account, so the low activity of PRL-3 required the development of a more 
sensitive, quantitative and single cell-based approach to detect the small lipid 
variation exclusively in the plasma membrane. It was successfully achieved due to a 
specific PI(4,5)P2 reporter (PH-PLCδ) that was fluorescently tagged and followed in 
live cells by confocal microscopy. Moreover, the sensitivity of the approach was 
improved by inhibiting the PI kinases with wortmannin to avoid PI(4,5)P2 formation 
after being dephosphorylated by PRL-3. While I was able to corroborate that PRL-3 
is a PI(4,5)P2 phosphatase in vivo with this novel technique, it was not possible to use it 
to quantify PI(4,5)P2 within the CCP due to protein-protein interaction competition 
with several members of the endocytic machinery (Antonescu et al., 2011). I solved 
this obstacle by using a PI kinase (PIP5Kα) to rescue the PRL-3 phenotype in order to 
confirm that PRL-3 was indeed enhancing CDE by PI(4,5)P2 dephosphorylation. 
The study of CCP dynamics by TIRF microscopy upon PRL-3 WT was 
imperative to understand how PRL-3 affects the formation of the clathrin-coated 
vesicle (Antonescu et al., 2011). PRL-3 overexpression facilitates pit stabilization 
slowing down the assembly and maturation process but ensuring that the pit that is 
being formed can progress through the endocytic checkpoint. This finding is in 
disagreement with the effect exerted by other PI(4,5)P2 phosphatase like 5-ptase, Sjn1 
or SHIP2 (Posor et al., 2015; Antonescu et al., 2011; Nakatsu et al., 2010). PI(4,5)P2 is 
required only for CCP nucleation as an anchor in the plasma membrane for the 
endocytic machinery. Then, PI(4,5)P2 dephosphorylation must occur in the core of 
the pit during the maturation prior to vesicle scission. The aforementioned 
	  	   	   	  
	   4.	  The	  role	  of	  PRL-­‐3	  in	  clathrin-­‐dependent	  endocytosis	   	  	   	  
116	  
phosphatases are recruited to the core of the pit during maturation to 
dephosphorylate PI(4,5)P2, but the aberrant expression of any of them would 
destabilize the CCP leading to more abortive CCP (Antonescu et al., 2011). 
Moreover, 5-ptase overexpression leads to less PI(4,5)P2 available in the plasma 
membrane and, consequently, less CCP formed. The opposite behavior exerted by 
PRL-3 is due to two mayor differences between this phosphatase and all the others 
mentioned: 
• Low phosphatase activity: here I corroborate that the intrinsic phosphatase 
activity of PRL-3 is much lower compared to other lipid phosphatase like 5-ptase, 
which explains why the deletion of PI(4,5)P2 in the bulk plasma membrane by 
PRL-3 WT is not enough to affect CCP nucleation. In agreement with this, when 
the hyperactive PRL-3 mutant (PRL-3 E50R) was overexpressed, CCP initiation 
density decreased confirming that the observed phenotype on CCP nucleation 
was due to PRL-3’s low intrinsic enzymatic activity. 
 
• Spatial localization within the CCP: whereas Sjn1 or SHIP2 are recruited 
to the core of the CCP during pit assembly (Posor et al., 2015; Antonescu et al., 
2011; Nakatsu et al., 2010) and 5-ptase is also found within the CCP, PRL-3 gets 
concentrated in the surrounding area. This localization is driven by the specific 
interaction C-terminal polybasic sequence of the phosphatase with PI(4,5)P2 and, 
if the strength of the mentioned interaction is modified (PRL-3 F160 KRas), 
PRL-3 looses the characteristic spatial pattern within the CCP also affecting the 
phenotype. This result proves that the PRL-3 accumulation in the boundary of 
the CCP is crucial for pit stabilization, and also that the interaction affinity of the 
PRL-3 polybasic sequence with PI(4,5)P2 is the optimal one to provoke this 
localization. 
 
Taken together, these observations show that the pathological function of PRL-
3 cannot be explained only with the description of a substrate, but it also needs to be 
taken into account to which extent PRL-3 can dephosphorylate it in a concrete 
cellular context. PRL-3’s biological behavior unveils the presence of a fine-tuned 
regulation of cellular processes like CDE, where small variations of the rate of 
phosphorylation or dephosphorylation and alterations in the location of the activity 
can lead to opposite consequences. 
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Cell migration is accomplished by the formation and disassembly of FA, and 
how fast this structures are recycled control the migratory speed (Nagano et al., 2012). 
Krndija et al. demonstrated that PRL-3 enhances FA formation (Krndija et al., 2012) 
while Foy et al. have recently proposed that PRL-3 interact with β1 integrin and the 
focal adhesion kinase (FAK) facilitating their dephosphorylation (Foy et al., 2017). β1 
integrin T788/T789 phosphorylation is essential for ECM interaction (Margadant et 
al., 2011) and FAK Y397 dephosphorylation is necessary during integrin endocytosis 
(Nagano et al., 2012). Dephosphorylation of both proteins would lead to a faster FA 
disassembly through microtubule-stimulated CDE (Ezratty et al., 2009), which might 
be a possible scenario upon PRL-3 presence. In addition to these findings, here we 
demonstrate that PRL-3 accelerates CDE through PI(4,5)P2 dephosphorylation, 
shedding light on the complex puzzle of FA dynamics regulation by PRL-3. 
CDE is also required in the cleavage furrow probably for plasma membrane 
remodeling (Warner et al., 2006) and PI(4,5)P2 presence at the intercellular bridge is 
required for localizing cytoskeletal elements necessary for the late steps of cytokinesis 
(Echard, 2008). The present results open a new hypothetical scenario to be studied 
where PRL-3 might accelerate cytokinesis (see chapter 3) through an enhanced CDE 
or by remodeling PI(4,5)P2 within the intercellular bridge. 
In conclusion, here I demonstrate that PRL-3 acts not solely as a 
pseudophosphatase since it can dephosphorylate PI(4,5)P2 in cells. Moreover, I also 
found a function for this activity in CDE where its particular characteristics on 
binding and dephosphorylating PI(4,5)P2 reinforce CCP stabilization, facilitating the 
successful completion of a clathrin-coated vesicle. 
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In the presented study, I uncovered a new role for the cancer-promoting 
phosphatase PRL-3 in the productive enhancement of cellular cytokinesis timing. This 
new phenotype might be directly related with the epithelial architecture disruption 
driven by the phosphatase previously observed in Dr. Köhn’s group. Mimicking PRL-
3 clinical outcome in epithelial tumors, the phosphatase was overexpressed in 3D 
epithelial models leading to the generation of ectopic lumens, a consequence related 
to cancer formation (Debnath and Brugge, 2005; Hao et al., 2010; Jaffe et al., 2008; 
Schlüter et al., 2009). Here, I deduced that these ectopic lumens arise from 
mispositioned midbodies after cell division. This phenotype was previously associated 
with tumor suppressors like Par3 and Cdc42, whose knockdown disrupts the planar 
orientation of the mitotic spindle in polarized epithelial cells leading to midbody 
retention in the lateral membrane (Hao et al., 2010; Jaffe et al., 2008). As an 
alternative, loss of asymmetric furrow ingression during cell abscission was also 
postulated as a theoretical scenario that would retain the midbody far from the apical 
membrane (Jaffe et al., 2008). However, PRL-3 does neither interfere with spindle 
orientation nor with furrow ingression symmetry. Therefore, since the midbody is a 
structure derived from cell division, and spatial disturbance of cytokinesis leads to 
midbody mispositioning in the epithelial context, a temporal alteration of the 
abscission would likely infer also an alteration in the final position of the midbody. For 
that reason, the acceleration of cytokinesis timing by PRL-3 might be the cause of the 
ectopic lumen phenotype observed in 3D epithelial cysts. 
Unfortunately, the lack of PRL-3 consolidated substrates together with the 
unsuccessful phosphoproteomics assays in the epithelial context carried out in the 
present study highlight not only the challenge of deciphering PRL-3 substrates in vivo, 
but also impede to elucidate the molecular mechanism behind the observed cellular 
phenotype. PRL-3 substrate candidates related with epithelial polarity like ezrin, 
PI(4,5)P2 or NHERF1 where analyzed here and no change in the phosphorylation 
status or localization was observed. These conclusions were drawn upon observation 
of static fixed confocal pictures of the 3D cysts, so phosphorylation variation during 
dynamic processes like cell abscission were not possible to monitor due to physical and 
technical challenges impossible to solve with the state-of-art technology. Therefore, 
improvements in 3D cyst image acquisition would be required to further investigate 
the PRL-3 phenotype in this context and also to unequivocally prove that cytokinesis 
acceleration leads to midbody mispositioning. Moreover, a deeper study in the 
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cytokinesis process upon PRL-3 presence applying molecular biology techniques 
could unveil PRL-3 substrates. 
As aforementioned, several protein substrates and one lipid substrate have been 
postulated for PRL-3. The suggested lipid is PI(4,5)P2, which was shown to be 
dephosphorylated by PRL-3 in vitro (McParland et al., 2011). In the present study, I 
have confirmed the phosphoinositide phosphatase activity of PRL-3 in vivo through the 
development of a sensitive, selective, quantitative single-cell approach taking 
advantage of the selective interaction between PH-PLCδ and PI(4,5)P2. Thus, I 
disproved the current proposition that it acts solely as a pseudophosphatase (Zhang et 
al., 2017). PI(4,5)P2 plays a key role in several processes like inducing signal 
transduction in many signaling pathways, regulating the function of many membrane 
proteins and ion channels, or in cell polarity and endocytosis. Here, I focused the 
attention CDE since it is implicated in cell migration, which might explain how PRL-
3 exerts this cancer-related phenotype (Balla, 2013; Antonescu et al., 2011; Rios et al., 
2013). Enhanced CDE was shown to lead to faster turnover of integrins and focal 
adhesions (?, citation), and to contribute in this way to accelerating cell migration. 
Indeed, PRL-3 enhances the CDE rate through the stabilization of the CCP 
increasing the chances of succeeding in the final vesicle formation, although the time 
required for CCP nucleation and maturation is slightly longer. PRL-3 shows the 
opposite phenotype on CDE compared to other 5’-phosphatases like 5-ptase, SHIP2 
or Snj1. However, while the aforementioned 5’-phosphatases are recruited to the core 
of the CCP to dephosphorylate PI(4,5)P2, PRL-3 is enriched in the periphery of the 
pit probably delimitating and stabilizing the size of the pit. This particular spatial 
organization depends on its phosphatase activity together with the interaction 
between the polybasic sequence of the phosphatase and PI(4,5)P2. 
Although the presented study focuses on two different biological processes, it is 
possible that both are linked, and that PI(4,5)P2 could be the substrate relevant for 
cytokinesis. Indeed, PI(4,5)P2 is required in the intercellular bridge prior to the last 
step of cytokinesis to organize the cytoskeleton ensuring proper membrane abscission 
(Echard, 2008). Moreover, CDE and hence PI(4,5)P2 is also required for plasma 
membrane remodeling in the cleavage furrow (Warner et al., 2006). Therefore, as 
PRL-3 enhances CDE, the plasma membrane can be remodeled faster leading to a 
quicker membrane abscission. Unfortunately, this scenario could not be addressed 
with the techniques used here in the detection of PI(4,5)P2 dephosphorylation in 3D 
cysts upon PRL-3 overexpression, as the lipid turnover dynamics are too fast and 
	  	   	   	  
	   5.	  Conclusions	  and	  Outlook	   	  	   	  
123	  
spatio-temporally restricted to cell abscission. Therefore, although the general levels of 
PI(4,5)P2 in 3D cyst was undisturbed in presence of PRL-3, the lipid cannot be 
discarded as the cause of cytokinesis acceleration and hence the origin of the ectopic 
lumens. Refinement of currently available techniques and potentially the study in 2D 
polarized or non-polarized systems could help to clarify this scenario. 
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6.1. Materials and equipment 
6.1.1. Chemicals and reagents 
Analog 3 (PRL inhibitor) was purchased from Enamine (Z44389470). ZM447439 
(AuroraB inhibitor), dynasore (dynamin inhibitor) and nystatin (cholesterol 
sequestering reagent) were obtained from Santa Cruz Biotechnology. Wortmannin 
(PI3K inhibitor), the microtubule polymerization inhibitor methyl-(5-[2-
thienylcarbonyl]-1 H-benzimidazol-2-YL) carbamate (Nocodazole), 
paraformaldehyde (PFA), cyclohexamyde (CHX) (transcription inhibitor), MG132 
(proteasome inhibitor) and rapamycin were acquired from Sigma–Aldrich, and 
RNase inhibitor RNasin® from Promega. Brefeldin A (BFA) was a kind gift from Dr. 
Jeroen Krijgsveld (Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, 
Germany). BODIPY® FL C5-Lactosylceramide (LacCer) complexed with bovin serum 
albumin (BSA) was obtained from ThermoFisher Scientifics. PI(4,5)P2 diC8, PI(4,5)P2 
17:0/20:4 and PI4P 17:0/20:4 were purchased from Avanti Polar Lipids. For stable 
cell clone selection, the antibiotics used were: G418 (Geneticin) purchased from 
ThermoFisher Scientifics, puromycin from Santa Cruz Biotechnology, and 
nourseothricin (NTC) from Jena Bioscience. For 3D cell culture, BD MatrigelTM 
basement membrane matrix growth factor reduced was purchased from BD 
Biosciences and 3-D culture Collagen I (rat tail) from Cultrex®. For transient 
mammalian transfection, FugeneHD was purchased from Roche, jetPRIME® from 
Polyplus transfection®, Amaxa SF Cell Line 4D Nucleofector from Lonza and 
Lipofectamine 200 and Lipofectamine LTX from Invitrogen. IPTG for shRNA 
induction was from Peqlab. Dynabeads® Protein G for immunoprecipitation was from 
ThermoFisher Scientifics. Rapigest SF surfactant was from Waters. For protein 
extraction, the protease inhibitor cocktail (cOmplete, EDTA free) and the 
phosphatase inhibitor cocktail (phoSTOP) were acquired from Roche. BluEye pre-
stained protein marker was bought from Jena Biosciences. The EnzChek Phosphate 
assay kit was obtained from Life Technologies, and the BIOMOL® Green assay kit 
from Enzo Life Science. Mowiol® 4-88 mounting medium was purchased from 
Sigma-Aldrich.  
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6.1.2. Cell culture 
MDCK cells were obtained from Dr. Fernando Martin-Belmonte laboratory 
(Centro de Biología Molecular Severo Ochoa (CBMSO), Madrid, Spain). MDCK 
GFP-PRL-3 WT, MDCK GFP-PRL-3 C104S, MDCK pmKATE2-PRL-3 WT GFP-
PH PLCδ, MDCK pmKATE2-PRL-3 C104S GFP-PH PLCδ, Caco-2 GFP-PRL-3 
WT, Caco-2 GFP-PRL-3 C104S stable cell lines were provided by Dr. Giulia 
Varsano (European Molecular Biology Laboratory (EMBL), Heidelberg, Germany). 
Caco-2 BBe, MCF-7, HeLa Kyoto, Hek293 and U2OS cell lines were available at 
EMBL. HCT116 cell line was purchased from ATCC. Every not yet listed stable cell 
line used in the present project was developed during the course of the investigation. 
Minimum Essential Medium (MEM) and Dulbecco’s Modified Eagle’s Medium 
(DMEM) culture medium were provided by the EMBL Media Kitchen. McCoy’s 5A 
(Modified) medium, OptiMEM, fetal Bovine Serum (FBS) were purchased from 
Gibco. L-glutamine, Penecilin/Streptomycin and 0.5% trypsin was obtained from 
Sigma-Aldrich. BHI and Hemin were bought from Jena Bioscience. Standard cell 
culture dishes were acquired from Thermo Scientific, 35 mm glass bottom dishes (14 
mm, No. 1.5) from MatTek Corporation, and 8-chambered glass bottom dishes from 
NuncTM Lab-TekTM (ThermoFisher Scientific). All cell lines were tested for 
mycoplasma contamination (Lonza MycoAlert; LT07-118).  
 
6.1.3. DNA plasmids, siRNA, shRNA, molecular cloning and 
bacterial strains 
Mammalian expression vectors pEGFP-PRL-3 WT, pEGFP-PRL-3 C104S, 
pEGFP-PRL-1 WT, pmKATE2-PRL-3 WT, pmKATE2-PRL-3 C104S and pEGFP-
PH PLCδ were provided by Dr. G. Varsano, EMBL. pEGFP-PRL-1 WT and 
pEGFP-PRL-3 F160 KRas were supplied by Dr. Pablo Rios (EMBL, Heidelberg, 
Germany). mRFP-FKBP12-PRL-3 E50R ΔCaaX was provided by Dr. Birgit Höger 
(EMBL, Heidelberg, Germany). mEmerald-CLTB was obtained from Dr. Ori 
Avinoam (EMBL, Heidelberg, Germany). Finally, pEGFP-PRL-3 E50R, pmKATE2-
PRL-3 E50R, pEGFP-5-ptase, pmKATE2-5-ptase, pmKATE2-PRL-1 WT, BFP-
PIP5Kα and pmKATE2-PRL-3 F160 KRas were cloned during the development of 
the described project (see 6.2.5 and 6.2.8 in this section). 
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Synthetic double-stranded siRNA was obtained from Ambion (Life 
Technologies): Silencer Select Negative Control #1 siRNA and PRL-3 siRNA (sense 
5’-CCUUCAUUGAGGACCUGAATT-3’). For inducible PRL-3 knock down in 
MCF-7 cells, a stable cell line was developed instead: MISSION 3X LacO Inducible 
Non-Target shRNA Control Plasmid DNA (Sigma-Aldrich, catalog no. SHC332) was 
used as a control shRNA and was provided by Dr. Amy Cooke, EMBL. For PRL-3 
knock-down shRNA, sense 5’-CCGGAGCTCACCTACCTGGAGAAATCTCGAG 
ATTTCTCCAGGTAGGTGAGCTTTTTTG-3’ extracted from MISSION shRNA 
Plasmid DNA was inserted in the IPTG inducible vector pLKO-puro-IPTG-3xLacO. 
FastDigest restriction enzymes, T4 DNA ligase, Phusion HF DNA polymerase, 
dNTP mix, 6xDNA loading dye and GeneRuler 1kB DNA ladder were purchased 
from ThermoFisher Scientific. PCR primers were obtained from MWG Biotech, 
SYBR Safe DNA Gel Stain from Invitrogen, and agarose from Sigma-Aldrich. DNA 
was purified using QuickLyse Miniprep and HiSpeed Plasmid Maxi kits from 
QUIAGEN. DNA gel extraction kit and PCR purification kit were purchsed from 
QUIAGEN. Probes for DNA sequencing were sent to GATC Biotech. E. coli 
competent bacterial strains Top10 (prepared in-house) were use to amplify DNA 
plasmid content. RNA was extracted with RNeasy® purification kit and the RT-PCR 
with OneStep RT-PCR kit, both from QUIAGEN. 
 
6.1.4. Peptides, proteins and antibodies 
Phosphopeptides from KLC1 (Acetyl-GQVGSS-pS-PKRSG-NH2) and PKP4 
were synthetized by JPT Innovative Peptide Solutions. They were purified by high-
performance liquid chromatography (HPLC) with a purity >90%. λ -phopshatase was 
bought from Santa Cruz Biotechnology, and lysyl endopeptidase (Lys-C) from Wako. 
Transferrin from human serum conjugated with Alexa Fluor® 633 was purchased 
from ThermoFisher Scientifics, and transferrin unconjugated from BD Bioscience.  
Primary mouse antibodies used were: anti-Sec8 (1:100; Enzo Life Sciences; 
catalog no. ADI-VAM-SV016; clone 14G1; lot 08010910); anti-AuroraB (1:200; BD 
Transduction Laboratories; catalog no. 611082; clone 6/AIM-1); anti-PKP2 (1:100; 
MyBioSource; catalog no. MBS375114); anti-PKP4 (1:50; Progen; catalog no. 
651166; clones 406.3.1/433.10.3/7.7.9); anti-γ-tubulin (1:100; Sigma-Aldrich; clone 
GTU-88); anti-pSer (1:2500; BD Transduction Laboratories; catalog no. 612546); 
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anti-PIP2 (1:100; Santa Cruz Biotechnology; catalog no. sc-53412; clone 2C11), anti-
Ezrin (1:100; BD Transduction Laboratories, catalog no. 610602, lot 87352) and anti-
Flag (1:100; Sigma-Aldrich; catalog no. F3040; clone M1). Primary rabbit antibodies 
used were: anti-MKLP1 (1:1000; Santa Cruz Biotechnology; catalog no. sc-867; clone 
N-19; lot I1614); anti-KLC1 (1:200; LifeSpan BioSciences; catalog no. LS-C334131; 
lot 61746); anti-α-tubulin (1:500; Millipore; catalog no. 04-1117; clone EP1332Y); 
anti-EBP50 (NHERF1) (1:1000; Abcam; catalog no. ab3452); anti-ZO-1 (1:200; 
Invitrogen; catalog no. 40-2200; clone TJP1) and anti-phospho-ERM (Ezrin 
(pT567)/Radixin (pT564)/Moesin (pT558)) (1:100; Abcam; catalog no. ab76247; 
clone EP2122Y; lot GR14705-13). Primary goat antibody used were: anti-Cep55 
(1:100; Santa Cruz Biotechnology; catalog no. sc-162675; clone E-14; lot C0813) and 
anti-Anillin (1:25; Abcam; catalog no. ab5910; lot GR270489-1). GFP-Trap® 
nanobodies were from Chromotek and were used for immunoprecipitation of GFP-
fused proteins. For PRL-3 detection, antibodies used were: anti-PRL-3 (1:200; mouse 
antibody; Santa Cruz Biotechnologies; catalog no. sc-130355; clone 318; lot F2111), 
anti-PRL-3 (1:1000; rabbit antibody; Sigma-Aldrich; catalog no. P0498; lot 
104K4792) and anti-PTP4A3 (1:1000; rabbit antibody; Sigma-Aldrich; catalog no. 
SAB2101908; lot QC16627), but we did not observe a signal in Western Blot with any 
of them (data not shown). Alexa fluorophore-conjugated secondary antibodies (1:1000 
for all secondary antibodies; Invitrogen) or rhodamine phalloidin (1:1000; Invitrogen; 
catalog no. R415; lot 1090018) and, for nuclei labeling, Hoechst 33342 (10 μg/mL; 
Sigma-Aldrich; catalog no. B2261), 4’ ,6-Diamidine-2’ -phenylindole (DAPI) (1 
μg/mL; Roche, catalog no. 10236276001) and propidium iodide (PI) (1 μg/mL; 
Sigma-Aldrich; catalog no. P4170) were utilized.  
 
6.1.5. Cell media and buffers 
The composition of the buffers included in the commercial kits is not described 
here as their detailed composition is not disclosed by the companies. 
• Bacterial culture: LB medium 
5 g/L yeast extract, 10 g/L tryptone, 5 g/L NaCl, pH 7.7, 1 g/L glucose; selection 
medium contained ampicillin (100 µg/mL) or kanamycin (50 µg/mL), depending 
on the plasmids used; culture plates were supplemented with 15 g/L agar and 
prepared by the EMBL Media Kitchen. 
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• Bacterial culture: SOC medium 
0.5 % (w/v) yeast extract, 2 % (w/v) tryptone, 10 mM NaCl, 2.5 mM KCl, 10 mM 
MgCl2, 10 mM MgSO4 and 20 mM glucose.  
• MDCK culture medium 
MEM, 4.5 g/L glucose, 10% FBS, 100 U/mL penicillin and 100 μg/mL 
streptomycin and 2mM L-glutamine. 
• Caco-2 culture medium 
DMEM, 4.5 g/L glucose, 10% FBS, 100 U/mL penicillin and 100 μg/mL 
streptomycin, 2mM L-glutamine and 0.01 mg/mL transferrin. 
• MCF-7 and Hek293 culture medium 
DMEM, 4.5 g/L glucose, 10% FBS, 100 U/mL penicillin and 100 μg/mL 
streptomycin and 2mM L-glutamine. 
• HCT116 culture medium 
McCoy’s 5A (Modified), 4.5 g/L glucose, 10% FBS, 100 U/mL penicillin and 100 
μg/mL streptomycin and 2mM L-glutamine. 
• HeLa and U2OS culture medium 
DMEM, 1.5 g/L glucose, 10% (v/v) FBS, 100 U/mL penicillin and 100 μg/mL 
streptomycin and 2mM L-glutamine. 
• Serum-free medium (SFM) 
Prepare it as any other culture media without 10% (v/v) FBS. 
• Phosphate-buffered saline (PBS) 
137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4 and 1.8 mM KH2PO4. 
• TAE buffer for agarose gel electroforesis 
40 mM Tris-HCl, pH 8.0, 20 mM acetic acid and 1 mM ethylenediamine-
tetracetic acid (EDTA). 
• Ripa lysis buffer for WB 
125 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 % (v/v) NP-40, 0.25 % (v/v) sodium 
deoxycholate, 1tablet/25mL cOmplete, EDTA free and 1pill/10mL PoshSTOP 
when required. 
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• HNTG lysis buffer for WB 
50 mM Hepes pH 7.5, 150 mM NaCl, 10 % (v/v) glycerol, 0.1 % (v/v) Triton X-
100, 1 mM EDTA, 1 mM ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-
tetraacetic acid (EGTA), 1tablet/25mL cOmplete, EDTA free and 1pill/10mL 
PoshSTOP when required. 
• Reaction buffer (5x)   
1 M Tris-HCl pH 7.5, 5 M NaCl, 10 % (v/v) Triton X-100 and 1M dithiothreitol 
(DTT).  
• λ-phosphatase lysis buffer   
10 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5 % (v/v) NP-40 and 20 % (w/v) 
sacarose.  
• SDS sample buffer (4x) 
250 mM Tris-HCl pH 6.8, 40 % (v/v) glycerol, 8 % (w/v) SDS, 4 % (w/v) β-
mercaptoethanol, 50 mM EDTA and 0.05 % (w/v) bromophenol blue. 
• MOPS buffer for SDS-PAGE 
50 mM (3-(N-morpholino) propanesulfonic acid) MOPS, 50 mM Tris-HCl, pH 
7.7, 0.1 % (w/v) SDS and 1 mM EDTA. 
• Resolving gel solution 
12 % (v/v) acrylamide, 375 mM Tris-HCl, pH 8.8, 0.1 % (w/v) SDS, 0.1 % (w/v) 
ammonium persulfate and 0.04 % (v/v) tetramethylethylenamine TEMED. 
• Stacking gel solution 
5 % (v/v) acrylamide, 130 mM Tris-HCl, pH 6.8, 0.1 % (w/v) SDS, 0.1 % (w/v) 
ammonium persulfate and 0.1 % (v/v) TEMED. 
• WB transfer buffer 
25 mM Tris-HCl, pH 8.3, 190 mM glycine, 0.1 % (w/v) SDS and 20 % (v/v) 
methanol. 
• Ponceau staining 
0.2 % (w/v) Ponceau S and 5 % (v/v) glacial acetic acid. 
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• Tris-buffered saline with Tween (TBS-T) for WB 
20 mM Tris-HCl, pH 7.4, 150 mM NaCl and 0.05 % (v/v) Tween-20. 
• WB blocking solution 
TBS-T with 5 % (w/v) BSA or milk powder depending on the antibody used, 
according to the manufacturer’s instructions.  
• IF blocking solution 
10% (w/v) FBS in PBS and 0.5 % (v/v) Triton X-100. 
• RSB buffer for polysome fractionation (2x) 
200 mM Tris-HCl, pH 7.4, 20 mM NaCl, 3 mM MgCl2 and 1pill/25mL 
cOmplete, EDTA free. 
• Polysome extraction buffer 
100 mM Tris-HCl, pH 7.4, 10 mM NaCl, 1.5 mM MgCl2, 1 % (v/v) Triton X-
100, 2 % (v/v) Tween-20 and 1pill/25mL cOmplete, EDTA free. 
• Light and heavy sucrose solutions for polysome fractionation   
10 mM Tris-HCl, pH 7.4, 75 mM KCl, 1.5 mM MgCl2 and 20% (light) or 50 % 
(heavy) (w/v) sucrose. 
• Acidic buffer for transferrin uptake assay 
0.1 M glycine, 150 mM NaCl, pH 3. 
 
6.1.6. Equipment 
Thermomixer from Eppendorf and MixingBlock from Bioer were used for 
different temperature incubation in 1.5 mL Eppendorf tubes. Centrifugation was 
carried out on Eppendorf 5415R, Eppendorf 5810 and Sorvall RC6 centrifuges and 
Beckman Coulter Optima L-100 XP ultracentrifuge with a SW40 rotor. DNA and 
RNA concentration was measured on a NanoDROP 1000 Spectrophotometer. PCR 
and RT-PCR were performed on a Primus25 from Peqlab. For agarose and protein 
gel electrophoresis, power was supplied by a LBK-EPS 500/400 power supply from 
Pharmacia. Pre-cast Nu-PAGE 4-12 % Bis-Tris SDS gels were from Life 
Technologies. Dry protein transfer for WB was performed on iBlot from Invitrogen 
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with a BioRad power supply and revealed on a BioRad imager ChemiDoc Touch. 
Cell electroporation was performed in 4D-Nucleofector Core Unit from Lonza. 
 Microscopes used for immunofluorescence assays visualization were: 
PerkinElmer Ultraview VoX containing AOTF for fast switching of laser lines and 
PerkinElmer Ultraview ERS spinning disk confocal microscope using a Plan-
Apochromat 63x 1.4 NA objective, Olympus-ScanRcube5 microscope using a Plan-
Apochromat 20x 0.7 NA objective and Olympus Cell^R multi-color TIRF 
microscope with an UAPON 100XOTIRF 1.49 NA objective. Microscopes were 
provided by the EMBL Advanced Light Microscopy Facility. Flow cytometry was 
performed on a BD LSR-Fortessa bench top analyser (BD Bioscience) that belongs to 
EMBL Flow Cytometry Core Facility. TECAN Infinite M1000 Pro multiwell plate 
readers was used to measure Enzcheck and BioMol® Green assays.  
For mass spectrometry, an Agilent 1260 infinity HPLC was used with a Waters 
XBridge C18; 3.5 µm. The Sep-Pak tC18 1cc 100 mg cartridge, the nanoAcquity 
UPLC system, the nanoAcquity Symmetry C18; 5 µm; 180 µm x 20 mm, the 
nanoAcquity BEH C18; 1.7 µm; 75 µm x 200 mm and the Pico-Tip Emitter 360 µm 
OD x 20 µm ID; 10 µm tip were from Waters. The LTQ Orbitrap Velos Pro was 
from ThermoFisher Scientifics. The QTRAP 5500 was from AB Sciex and was 
equipped with a Triversa Nanomate from Advion Biosciences. 
 
6.1.7. Software 
Graph representation and ANOVA statistical analysis were processed with 
GraphPad Prism 6.0 software whereas Mann-Whitney rank sum test was performed 
with XLSTAT (XLSTAT for Excel). Western blots were analyzed with Image Lab 
5.2 software from BioRad. Microscope 2D pictures were processed and visualized 
using Fiji software (National Institute of Health). Microscope 3D reconstruction and 
TIRF time-lapses analysis were performed using Imaris software (Oxford 
Instruments). Spinning disc confocal microscopes were equipped with Volocity 
software (PerkinElmer) and TIRF microscope with Xcellence software (Olympus). 
Mass spectrometry raw data were processed with proteome discoverer (PD) software 
version 1.4.0.288 (Thermo Scientific) and LipidView from AB Sciex. Flow cytometry 
data were analyzed with FlowJo software.  
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6.2. General methods 
6.2.1. Mammalian cell culture 
All cells were grown at 37 °C in a humidified atmosphere containing 5 % CO2. 
Each cell line was grown in his respective medium as specified in section 6.1.5. De-
attaching of cells was carried out with 1 mL trypsin solution per 10 cm culture dish (2 
mL per 10 cm dish culture for MDCK) by incubation at 37 °C for 4 minutes, 
subsequent addition of growth medium and pelleting by centrifugation at 1000 RPM 
for 3 minutes. Pellet was resuspended in growth medium and part of the cells was re-
seeded on a new culture dish. 
 
6.2.2. Mammalian cell transfection and stable inducible expression 
Transient transfection of mammalian cells with DNA plasmids was performed 
with FugeneHD transfection agent 24 hr after seeding cells for HeLa, Hek293, U2OS 
and HCT116. In the appropriate amount of OptiMEM, DNA plasmid was added (60 
ng in 8-chambered glass bottom dish, 500 ng in a MatTek and 5 µg in a 10 cm dish 
culture) and then supplemented with Fugene HD (6 µL per 1 µg DNA). The mixture 
was incubated for 15 minutes at room temperature before adding to the sample 
containing fresh growth medium. Cells were transfected, at least, 16 hrs prior to assay.  
DNA plasmid and siRNA incorporation in MDCK were performed by 
electroporation. 2x105 cells are pelleted by centrifugation and resuspended in 20 µL 
Amaxa SF Cell Line 4D Nucleofector buffer. 0.4 µg DNA plasmid or 250 pmol 
siRNA were added to this cell suspension transferred to the electroporation device. 
After cell electroporation with program CA-152, 80 µL of RPMI medium was added 
to the cell mixture and incubated for 10 minutes at 37 °C. Finally, 2x104 cells were 
seeded for 3D cyst development in an 8-chambered glass bottom dishes (see section 
6.3.2.). Cells were transfected maximum 72 hrs prior to assay.   
siRNA transfection in Caco-2 cells was performed with jetPRIME® in 3.5 cm 
culture dish. 110 pmoles of siRNA are diluted in 200 µL of jetPRIME® buffer. Vortex 
10 s and spin it down. Add 4 µL of jetPRIME® reagent, vortex 10 s, spin it down and 
incubate 10 minutes at room temperature before adding to the sample containing 
fresh growth medium. Cells were transfected maximum 72 hrs prior to assay.  
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siRNA transfection in HCT116 cells was performed with Lipofectamine 2000. 
6x105 HCT116 cells were seeded in a 3.5 cm culture dish with 2 mL of culture 
medium 24 hr prior transfection. In a 1.5 mL Eppendorf tube, 250 pmol of siRNA 
was diluted in 250 µL of OptiMEM. In another 1.5 mL Eppendorf tube, 10 µL of 
Lipofectamine 2000 was diluted in 250 µL of OptiMEM. Both separated mixtures 
were incubated for 5 minutes at room temperature. After that, Lipofectamine 2000-
containing OptiMEM was added drop by drop over siRNA-containing OptiMEM 
and this new mixture was incubated at room temperature for 20 minutes before 
adding to the sample containing fresh growth medium. The experiments were 
performed 48 hrs post-transfection. 
For shRNA stable expression in MCF-7 cells, cells were transfected with 
Lipofectamine LTX. 2x106 MCF-7 cells are seeded in a 3.5 cm culture dish with 2 
mL of culture medium 24 hr prior transfection. In a 1.5 mL Eppendorf tube, 2.5 µg of 
DNA plasmid was diluted in 500 µL of OptiMEM. Then, 7.5 µL of LTX reagent and 
2.5 µL of Plus reagent was added to the transfection cocktail. Mixture was then 
incubated 25 minutes at room temperature before adding to the sample containing 
fresh growth medium. 48 hrs post-transfection, medium was replaced with fresh 
medium containing 1 µg/mL puromycin for positive clone selection. Puromycin 
containing medium was replaced every 2-3 days during 10 days to ensure that only 
positive clones stay alive. 4 different constructs were transfected: pLKO-puro-IPTG-
3xLacO-Ctrl and 3 different PRL-3 shRNA containing pLKO-puro-IPTG-3xLacO 
plasmids (#1: 5’-CCGGCACCTTCATTGAGGACCTGAACTCGAGTTCAGGT 
CCTCAATGAAGGTGTTTTG-3’; #2: 5’-CC GGGCGTGTGTGTGAAGTGAC 
CTACTCGAGTAGGTCACTTCACACACACGCTTTTT-3’; #3: 5’-CCGGAGC 
TCACCTACCTGGAGAAATCTCGAGATTTCTCCAGGTAGGTGAGCTTTT
TTG-3’). Then, the polyclonal mixture was tested for PRL-3 knockdown efficiency 
upon 4 days induction with 1 mM IPTG containing medium during 4 days changing 
the medium with fresh one containing IPTG every 2 days. RNA extraction (see 
section 6.2.3.) and RT-PCR (see section 6.2.4.) were performed to check PRL-3 
knockdown and only shRNA #3 was actually silencing PRL-3 mRNA production 
(data not shown). Thus, cells were plated individually in 96-wells dish for single clone 
expansion. When a considerable number of cells was reached, PRL-3 knockdown was 
induced in each clone upon IPTG treatment during 4 days and PRL-3 mRNA 
silencing is measured by RT-PCR (data not shown). The best candidate was then used 
for the experiments described in the present manuscript.      
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 6.2.3. RNA extraction from mammalian cell sample 
RNA content was extracted from different mammalian cell line samples using 
the RNeasy® purification kit and filtered tips to avoid RNA degradation by 
contaminant ribonucleases (RNases). Briefly, a full 3.5 cm culture dish was lysed with 
350 µL RLT buffer at room temperature. Lysed cells were scraped with a sterile 
spatula, collected in a 1.5 Eppendorf tube and further homogenized by passing the 
lysate at least 5 times throught a blunt 20-gauge needle (0.9 mm diameter) fitted to an 
RNase-free syringe. 350 µL ethanol was added to the sample and homogenized by 
pipetting. The sample was the transferred to an RNeasy spin column and centrifuged 
at 10,000 RPM for 15 s at room temperature. The flow-through was discarded and 
the column was rinsed once with RW1 buffer and twice with RPE buffer. Finally, 
purified RNA was eluted with 50 µL RNase-free water in a 1.5 collection tube by 
centrifugation at 10,000 RPM for 1 minute at room temperature. 
 
6.2.4. PCR and RT-PCR 
PCR for insert amplification with addition of restriction sites was performed in 
25 µL volume containing 30 ng DNA plasmid template, 0.2 µM forward and reverse 
primer (specific primers per plasmid are enlisted in sections 6.3.1. and 6.4.1.), 200 µM 
of each dNTP, 8 % DMSO, 0.5 µL Phusion DNA polymerase and 5 µL 5x HF 
Phusion buffer. The following cycling parameters were used: 95 °C for 2 minutes 
followed by 30 cycles of denaturing at 95 °C for 30 s, annealing at 56 °C for 45 s and 
extension at 72 °C with 40 s/kb. Final extension was performed at 72 °C for 5 
minutes and DNA storage was at 4 °C. Then, PCR was directly purified or run into 
an agarose gel for its identification and subsequently extracted from the gel. Either 
process was performed with the PCR purification kit or the gel extraction kit, 
respectively, following the manufacturer’s instruction. 
PRL-3 mRNA cell content together with receptor expression-enhancing protein 
(REEP) as a housekeeping gene were measured by RT-PCR. After RNA extraction 
from cell sample (see section 6.2.3.), RT-PCR was performed in 50 µL volume 
containing 250 ng RNA, 0.6 µM forward and reverse primer (PRL-3 fwd 5’-
GGTGAGCTACAAACACATGCG-3’; PRL-3 rev 5’-TTCCACTACCTTGCCG 
GGC- 3’; REEP fwd 5’-TGCAGATGCCATCACTAAAGA- 3’; REEP rev 5’-CA 
TCAAGCTCCAGTA GGAAGGT- 3’), 400 µM of each dNTP, 2 µL QUIAGEN 
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OneStep RT-PCR Enzyme Mix and 10 µL 5x QUIAGEN OneStep RT-PCR buffer. 
The following cycling parameters were used: reverse transcription at 50 °C for 30 and 
the initial PCR activation at 95 °C for 15 minutes followed by 30 (PRL-3) or 28 
(REEP) cycles of denaturing at 94 °C for 30 s, annealing at 57 °C (PRL-3) or 55 °C 
(REEP) for 30 s and extension at 72 °C for 1 minute. Final extension was performed 
at 72 °C for 10 minutes and DNA storage was at 4 °C. 
 
6.2.5. DNA digestion with restriction enzymes 
Plasmid or PCR product Restriction digestion with the respective restriction 
enzymes of interest was performed with FastDigest restriction enzymes. Briefly, 500 
ng of PCR product or 1 µg of plasmid was incubated with 4 µL/µg of DNA of the 
respective restriction enzymes and the adequate buffer according to the 
manufacturer’s instruction. Mix was incubated at 37 °C for 1 hr. Subsequently, DNA 
was directly purified or run into an agarose gel. DNA purification or gel extraction 
were performed with PCR purification kit or the gel extraction kit respectively 
following the manufacturer’s instruction and immediately subjected to ligation. 
 
6.2.6. DNA ligation for plasmid construction 
Ligation of digested DNA fragments with digested vector was subsequently 
performed. The appropriate amount of digested insert and vector was prepared with a 
ratio of 1:5 respectively. 0.5 µL of T4 DNA ligase and buffer were added and the final 
mix was incubated for 15 minutes at 22 °C. Then, the products were combined and 
directly subjected to transformation into competent E. coli Top10 cells. A variable 
number of grown colonies were chosen depending on the amount obtained, the 
plasmid construct was purified using the MiniPrep DNA purification kit, and test 
digestion was realized applying the restriction enzymes used in the previous step. 
Insert incorporation was then evaluated by agarose gel electrophoresis and the 
sequence of positive clones were checked by DNA sequencing.  
 
 
	  	   	   	  
	   6.	  Material	  and	  methods	   	  	   	  
139	  
6.2.7. Agarose gel electrophoresis 
1 % (w/v) (DNA cloning) or 2 % (w/v) (RT-PCR) agarose gels were prepared 
by adding the respective amount of agarose to TAE buffer. Additional boiling in a 
microwave is required for agarose complete dissolution. After cooling down the 
mixture SYBR Safe DNA gel stain was added and the mixture was poured into a gel 
chamber and left at room temperature for its polymerization. When required, DNA 
samples were mixed with appropriate amounts of 6x loading dye and loaded into the 
gel wells. To estimate DNA sample size, 5 µL GeneRuler 1kB DNA ladder was 
included in an extra well. Probes were separated at ≤120 V and illuminated in a UV 
illumination chamber. 
 
6.2.8. Bacterial transformation for plasmid amplification 
Bacterial cultures handling was performed with sterile equipment and in close 
proximity to a Bunsen flame. Total ligation mix was added to 100 µL homemade 
competent cells E. coli Top10 for transformation. After 30 minutes incubation on ice, 
bacteria were heat-shocked at 42 °C for 30 s and then kept on ice for 2 minutes more. 
Pre-warmed 250 µL SOC medium was added and the suspension was incubated at 37 
°C on a thermomixer with 400 RPM shaking for 45 minutes. The suspension was 
plated on LB-agar plates containing the respective antibiotic to ensure that only the 
colonies containing the antibiotic-resistant plasmid will grow and incubated at 37 °C 
over-night. Grown colonies were picked for MiniPrep DNA extraction and 
sequencing.  
 
6.2.9. DNA purification (MiniPrep/MaxiPrep) 
DNA plasmid of interest was amplified on transformed E. coli Top10 cells. A 
small volume of bacteria were grown over-night in 5 mL (MiniPrep) or 250 mL 
(MaxiPrep) LB medium containing the corresponding resistant antibiotic and 
subjected to DNA extraction according to the manufacturer’s instructions 
(QUIAGEN). 
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6.2.10. MS-based lipidomics for cellular phosphoinositide 
quantification (collaboration with the group of Dr. Britta Brügger, BZH) 
Phosphoinositide quantification was performed as described previously (Haag et 
al., 2012). Briefly, >1x106 cells were subjected to an acidic/neutral extraction on ice: 
Culture medium was aspirated, cells were rinsed three times with ice-cold PBS, 1.2 
mL ice-cold 0.5 M TCA was added and incubated for 5 minutes and subsequently the 
lysate was scraped out with a sterile spatula. The cell lysate was centrifuged at 
maximum speed for 20 minutes at 4 °C and the supernatant discarded. The pellet was 
rinsed two times with 1 mL ice-cold 5 % (w/v) TCA containing 1 mM EDTA and 
centrifuged at maximum speed for 3 minutes at 4 °C. The resulting pellet was then 
lash frozen in liquid N2. PI(4)P 17:0/20:4 and PI(4,5)P2 17:0/20:4 internal standards 
for quantification were added to TCA-washed cell pellets. Mass spectrometry was 
performed on a QTRAP 5500 equipped with a Triversa NanoMate. 
Phosphoinositides were measured by scanning for neutral losses of m/z 357 (PIP) and 
m/z 437 (PIP2) with collision energies of 25 eV and 35 eV, respectively. Mass spectra 
were evaluated with LipidView software. PIP and PIP2 amounts were normalized to 
total phospholipid, which was determined in neutral and acidic phase as described 
(Özbalci et al., 2013). 
 
6.2.11. Data analysis 
Ordinary two-tailed one- or two-way ANOVA and Tukey’s multiple 
comparision test were performed to study statistical significance except for CCP 
initiation density measurements that were analyzed with the Mann-Whitney rank sum 
test: (*) p≤0.05, (**) p≤0.01, (***) p≤0.001 and (****) p≤0.0001.  
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6.3. Methods applied in chapter 3 
6.3.1. Plasmid cloning 
Molecular cloning was performed as described in sections 6.2.4. – 6.2.9. pEGFP 
and pmKATE2 versions of PRL-3 E50R were generated by EcoRI and BamHI 
restriction sites incorporation by PCR using pcDNA5/FRT/TO-3xFlaf-PRL-3 E50R 
(provided by Dr. Birgit Höger) as a template. The same PCR product was useful for 
both plasmid vectors since they share the same multiple cloning site. The primer pair 
used was: 5’-CGGAATTCTATGGCTCGGATGAACCGCC-3’ and 5’-CGGGATC 
CTTACTACATAACGCAGCACCGGG-3’.  
 
6.3.2. 3D cell culture in ECM (MatrigelTM) 
3D cell cyst formation was performed as previously described (Martin-Belmonte 
et al., 2007). MDCK, Caco-2 or MCF-7 cells were trypsinized to a single cell 
suspension of 5x104 cells/mL in its correspondent culture medium containing 2% 
(MDCK), 5% (Caco-2) or 10% (MCF-7) of BD MatrigelTM. 250μL of cell suspension 
were then plated into 8-chambered glass bottom dishes, pre-coated with 100 μL of 
10% BD MatrigelTM in serum-free MEM (MDCK), 10% BD MatrigelTM in serum-
free DMEM (Caco-2) or 100% BD MatrigelTM (MCF-7). To study cell invasion in 3D 
cysts, MDCK were seeded as previously described but with a mix of BD MatrigelTM-
Collagen I (1:1) instead of only BD MatrigelTM. In order to inhibit PRL-3, analog 3 
(Enamine) was added to MDCK, Caco-2 and MCF-7 cysts and culture medium was 
replaced with fresh inhibitor every 2. Live cell images were recorded on the same 
microscope with stable monitored temperature of 37 °C and 5% CO2 acquiring single 
plane every 3 minutes during 90 minutes in 3D MDCK YFP-MKLP-1 pmKATE2-
PRL-3 WT and every 5 minutes during 14 hr in 3D MDCK YFP-MKLP-1 
pmKATE2-PRL-3 C104S. For 3D cyst pictures, a confocal picture was taken every 1 
µm and the subsequent digital reconstruction was performed with Imaris software.  
 
6.3.3. Immunofluorescence staining 
3D cyst immunolabelling was performed as previously described (Elia and 
Lippincott-Schwartz, 2009). Briefly, samples were rinsed twice with PBS and fixed 
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with 4 % (w/v) PFA for 30 minutes. Cell fixation was subsequently quenched with 0,1 
M glycine in PBS for 20 minutes, permeabilized with 0.5 % (v/v) Triton X-100 in 
PBS for 10 minutes and IF blocking solution for 30 minutes. Samples were then 
incubated with primary antibodies in IF blocking solution at 4 °C over-night, followed 
by rinsing three times with PBS and incubation with Alexa fluorophore-conjugated 
secondary antibody (together with Hoechst and/or rhodamin phalloidin when 
required) for 1 hr at room temperature that was removed rinsing three times with 
PBS. Samples were stored in PBS at 4 °C for microscopy analysis.  
 
6.3.4. Mitotic spindle angle measurement in 3D cysts 
Mitotic spindle orientation was measured as previously described (Hao et al., 
2010; Jaffe et al., 2008; Wei et al., 2012; Zhen Zheng et al., 2010; Rodriguez-Fraticelli 
et al., 2010). Briefly, MDCK cyst were grown and fixed at 72 hr as described for 
immunofluorescence labeling (see section 6.3.3.). Anti-γ-tubulin antibody and Hoechst 
were used to stain the mitotic spindle. Confocal images of cells in metaphase in the 
middle plane of the cyst were then taken. A line in the direction of the mitotic spindle 
was drawn using Fiji software. Another radial lane between the center of the cyst and 
the basal membrane was drawn crossing the first line. The small angle formed 
between both lines was quantified. 
 
6.3.5. Cleavage furrow ingression measurement in 3D cysts 
Cleavage furrow ingression symmetry during cell division was measured as 
previously described (Liu et al., 2012). Briefly, MDCK cyst were grown and fixed at 72 
hr as described for immunofluorescence labeling (see section 6.3.3.). Anti-anillin 
antibody was used to stain the cleavage furrow together with rhodamine phalloidin 
and Hoechst. Confocal images of cells in cytokinesis were taken when the cleavage 
furrow was around 50% ingressed. A line tangent to the apical membrane and 
another to the basal membrane were drawn using Fiji software. The shortest distance 
between each line and the cleavage furrow were measured and the ratio between 
basal and apical membrane furrow ingression was plotted. A value of 1 represents 
symmetric abscission. 
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6.3.6. GFP-PRL-3 level in MDCK measured by flow cytometry 
To quantify the heterogeneous intercellular GFP-PRL-3 WT and C104S 
protein level in stably expressing MDCK cell lines by flow cytometry, 3x106 
cell/sample were resuspended in 200 μL ice-cold PBS. GFP content of life 2 x105 cells 
was measured by flow cytometry in a LSR-Fortessa bench top analyzer. Life cell were 
gated using 1 μg/mL DAPI, a plasma membrane impermeable nuclei stain that can 
only be incorporated in dead cells. 
 
6.3.7. Mammalian cell lysis, SDS-PAGE and Western Blot 
Cell line of interest was cultured on a 10 cm culture dish and grown up to 90-95 
% confluence. The following steps were carried out always on ice: Culture medium 
was aspirated, cells were rinsed with ice-cold PBS, lysed with 250 µL ice-cold Ripa 
lysis buffer and subsequently lysate was scraped out with a sterile spatula. Collected in 
a 1.5 mL Eppendorf tube, the cell lysate was passed through a blunt 20-gauge needle 
(0.9 mm diameter) fitted to a syringe and then incubated during 30 minutes. After 
incubation, the sample was centrifuged at maximum speed for 15 minutes at 4 °C. 
The supernatant was then collected and subjected to total protein determination 
concentration using Bradford reagent following the manufacturer’s instructions. Equal 
amounts of boiled protein containing SDS sample buffer 4x were loaded onto SDS 
gels in a range of 30-400 μg protein/sample. Under 75 μg protein/sample, pre-casted 
Nu-PAGE 4-12 % Bis-Tris SDS gels were used. However, homemade 12% 
acrylamide gels were set for higher amount of protein loaded. glass sheets (20 cm x 20 
cm) are clamped together leaving a gap of 0.75 mm with rubber stripes. Then, 
resolving gel solution is added leaving 2-3 cm gap at the upper part. After 
polymerization at room temperature, stacking gel solution is added together with the 
comb to generate the wells. Upon acrylamide polymerization, the comb can be then 
removed and the gel used for electrophoresis. Gels were blotted onto nitrocellulose 
membrane by dry transfer if the pre-casted gels or by wet transfer if homemade 
acrylamide gels were used instead. Then, the membrane was stained in Ponceau 
staining solution for 30 seconds to check that protein amount loaded was balanced 
and to discard running or transferring problems. De-staining was performed by 
consecutive washing steps with TBS-T. Blocking of membranes was performed for 45 
minutes at room temperature in TBS-T containing 5 % (w/v) milk powder. After the 
	  	   	   	  
	   6.	  Material	  and	  methods	   	  	   	  
144	  
membrane is blocked, TBS-T containing 5 % (w/v) BSA and primary antibody was 
added and incubated rocking over-night at 4 °C. After 3 steps of washing with TBS-
T, membrane was incubated with TBS-T containing 5 % (w/v) milk powder and the 
respective secondary antibody for 1 hr at room temperature, followed by another 3 
steps of washing with TBS-T. Developing was performed by incubation with ECL+ 
detection reagents for 1 minute and imaging on a BioRad imager ChemiDoc Touch. 
 
6.3.8. Protein immunoprecipitation (IP) in mammalian cell lysate 
6.3.8.1. PRL-3 IP in MCF-7 cells 
MCF-7 cells were cultured on a 10 cm culture dish and grown up to 90-95 % 
confluence. On ice: Culture medium was aspirated, cells were rinsed with ice-cold 
PBS, lysed with 450 µL ice-cold Ripa lysis buffer and subsequently lysate was scraped 
out with a sterile spatula. Collected in a 1.5 mL Eppendorf tube, the cell lysate was 
passed through a blunt 20-gauge needle (0.9 mm diameter) fitted to a syringe and then 
incubated during 30 minutes. After incubation, the sample was centrifuged at 
maximum speed for 15 minutes at 4 °C and 9 µL were taken as an “input” sample. 2 
µL of anti-PRL-3 (Sigma-Aldrich; P-0498) was added to the collected supernatant and 
the incubation underwent over-night at 4 °C rocking on a wheel. 20 µL of 
Dynabeads® Protein G were washed three times with Ripa lysis buffer. Magnetic 
beads were then added to the sample and incubated for 2 hr at 4 °C rocking on a 
wheel. Once the beads are conjugated to the antibody, the complex is pulled down 
using a magnetic support. 9 µL of sample was taken as “supernatant” sample. Beads 
were washed three times with Ripa lysis buffer before adding 20 µL of SDS sample 
buffer 4x and boiling to detach PRL-3 from the beads. Samples were loaded on a pre-
casted Nu-PAGE 4-12 % Bis-Tris SDS gels and proceeded as describe in section 
6.3.7.   
6.3.8.2. NHERF1 IP in MDCK cells 
Parental MDCK and MDCK stably overexpressing GFP-PRL-3 WT and GFP-
PRL-3 C104S were cultured on a 10 cm culture dish and grown up to 90-95 % 
confluence. On ice: Culture medium was aspirated, cells were rinsed with ice-cold 
PBS, lysed with 450 µL ice-cold HNTG lysis and centrifuged at maximum speed for 
15 minutes at 4 °C and 9 µL were taken as an “input” sample. 2 µL of anti-NHERF1 
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was added to the collected supernatant and the incubation underwent over-night at 4 
°C rocking on a wheel. 25 µL of Dynabeads® Protein G were washed three times with 
Ripa lysis buffer. Magnetic beads were then added to the sample and incubated for 2 
hr at 4 °C rocking on a wheel. Once the beads are conjugated to the antibody, the 
complex is pulled down using a magnetic support. 9 µL of sample was taken as 
“supernatant” sample. Beads were washed three times with HNTG lysis buffer before 
adding 20 µL of SDS sample buffer 4x and boiling to detach NHERF1 from the 
beads. Samples were loaded on a pre-casted Nu-PAGE 4-12 % Bis-Tris SDS gels and 
proceeded as describe in section 6.3.7. 
6.3.8.3. GFP-Trap® nanobodies co-IP in MDCK cells 
Parental MDCK and MDCK stably overexpressing GFP-PRL-3 WT and GFP-
PRL-3 C104S were cultured on a 10 cm culture dish and grown up to 90-95 % 
confluence. On ice: Culture medium was aspirated, cells were rinsed with ice-cold 
PBS, lysed with 300 µL ice-cold HNTG lysis buffer and subsequently lysate was 
scraped out with a sterile spatula. Collected in a 1.5 mL Eppendorf tube, the cell 
lysate was passed through a blunt 20-gauge needle (0.9 mm diameter) fitted to a 
syringe and then incubated during 30 minutes. After incubation, the sample was 
centrifuged at maximum speed for 15 minutes at 4 °C and 6 µL were taken as an 
“input” sample. 15 µL of GFP-Trap® nanobodies were washed three times with 
HNTG lysis buffer. Cell lysates were then added to the nanobodies and incubated for 
2 hr at 4 °C rocking on a wheel. Once the GFP tagged proteins were conjugated to 
the nanobodies, the complex was pulled down by mild centrifugation at 800 RPM for 
1 minute at 4 °C. 6 µL of sample was taken as “supernatant” sample. Beads were 
washed three times with HNTG lysis buffer before adding 10 µL of SDS sample 
buffer 4x and boiling to detach PRL-3 from the beads. Samples were loaded on a pre-
casted Nu-PAGE 4-12 % Bis-Tris SDS gels and proceeded as describe in section 
6.3.7. 
In order to perform the previously described assay in synchronized MDCK cells 
in cytokinesis, cells were treated with 0.2 μg/mL nocodazole for 16 hr at 37 °C in a 
humidified atmosphere containing 5 % CO2. Then, culture media was replaced with 
nocodazole-free pre-warmed fresh culture media for 30 minutes to let the cell proceed 
from metaphase up to cytokinesis. Subsequently, HNTG lysis buffer was added and 
the protocol proceeds as previously described.  
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To further increase the chances of detecting PRL-3 substrate, interacting 
partners were cross-linked with PFA. For that, confluent cells were trypsinized as 
described in 6.2.1. and resuspended in 1 % (w/v) PFA-containing PBS. Cross-linking 
was incubated for 7 minutes at room temperature followed by centrifugation at 1000 
RPM for 3 minutes at room temperature. Cell lysis and co-IP was then continued as 
described.  
6.3.8.4. PKP4 IP in MDCK and in vitro dephosphorylation with purified PRL-3 
MDCK cells were cultured on a 10 cm culture dish and grown up to 90-95 % 
confluence. On ice: Culture medium was aspirated, cells were rinsed with ice-cold 
PBS, lysed with 500 µL ice-cold HNTG lysis buffer without PhosSTOP and 
subsequently lysate was scraped out with a sterile spatula and collected in a 1.5 mL 
Eppendorf tube. On the other hand, 20 µL of Dynabeads® Protein G were washed 
three times with HNTG lysis buffer and 100 µL of anti-PRL-3 (Sigma-Aldrich; P-
0498) was added to the beads and the incubation underwent over-night at 4 °C 
rocking on a wheel. Antibody conjugated magnetic beads were then added to the cell 
lysate and incubated all together over-night at 4 °C rocking on a wheel. Once the 
protein-antibody-beads complex is established, it is pulled down using a magnetic 
support and washed three times with HNTG lysis and three more times with reaction 
buffer 1x. 20 µL of reaction buffer 1x containing purified human PRL-3 was then 
incubated with the beads for 1 hr at 37 °C before adding 6.7 µL of SDS sample buffer 
4x and boiling to detach PKP4 from the beads. Samples were loaded on a pre-casted 
Nu-PAGE 4-12 % Bis-Tris SDS gels and proceeded as describe in section 6.3.7. 
 
6.3.9. MS-based PRL-detection in MDCK cells (collaboration with 
Dr. Marco L. Hennrich from Dr. Anne-Claude Gavin’s group, EMBL) 
6.3.9.1. Cell lysis, protein digestion and peptide labeling  
3x106 MDCK cells and MDCK stably overexpressing GFP-PRL-3 WT and 
GFP-PRL-3 C104S cells from 3D culture were suspended in a buffer containing 
HEPES 200mM pH 7.8, 1 mg/mL Rapigest SF and cOmplete, EDTA-free. Cell 
lysate was subsequently heated for 5 minutes at 95 °C and sonicated for 20 minutes. 
Then, proteins were reduced with DTT and cysteine residues were 
carbamidomethylated with iodoacetamide followed by digestion with Lys-C for 4 hrs 
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at 37 °C followed by a tryptic digestion overnight at 37 °C. The resulting peptides 
were desalted and dimethyl labeled on Sep-Pak tC18 1cc 100 mg cartridges as 
described previously (Boersema et al., 2009). The three samples were light, 
intermediate or heavy dimethyl labeled with either 4 % formaldehyde (CH2O) 
(ThermoFisher Scientifics), deuterated formaldehyde (CD2O) (Sigma-Aldrich) or 
heavy deuterated formaldehyde (13CH2O) (Isotec) in 50 mM Na3PO4 pH 7.5 buffer 
containing 0.6 M cyanoborohydride (Sigma-Aldrich) or cyanoborodeuterate (Sigma-
Aldrich). The peptides were flushed for 10 minutes with labeling solution, washed 
with 0.6 % (v/v) acetic acid and eluted using 0.6 % (v/v) acetic acid in 80% (v/v) 
acetonitrile.  
6.3.9.2. Peptide fractionation  
The dimethyl labeled samples were evenly mixed and concentrated in a vacuum 
centrifuge. The sample pH was increased over pH 10 with 25 % (v/v) NH3 in a final 
volume up to 50 μL. The sample was separated on an Agilent 1260 infinity HPLC 
system equipped with a Waters XBridge C18; 3.5 μm; 1 x 100 mm reversed phase 
column at a flow rate of 75 μL/min with 20 mM NH4HCO2 at pH 10 and 100 % 
(v/v) acetonitrile as buffers. 90 fractions were collected and concentrated under 
vacuum. Then, fractions were desalted and pooled into 18 pooled fractions. 16 of 
these were pooled by collecting one early, one middle, and one late eluting fraction 
and 2 were created by mixing a part of the earliest and latest fractions together.  
6.3.9.3. NanoLC-MS/MS analysis 
The 18 fractions were analyzed on a nanoAcquity UPLC system directly 
connected to an LTQ Orbitrap Velos Pro through a Proxeon nanospray source. The 
peptides were trapped on a nanoAcquity Symmetry C18, 5 µm, 180 µm x 20 mm 
trapping column and further separated on a nanoAcquity BEH C18, 1.7 µm, 75 µm x 
200 mm analytical column. The mobile phases were 0.1 % (v/v) CH2O2 in water and 
0.1 % (v/v) CH2O2 in acetonitrile. The applied three-step gradient had a range from 
3 % to 40 % (v/v) acetonitrile in a flow rate of 300 nL/min. The eluent was directly 
introduced into the mass spectrometer via a Pico-Tip Emitter 360 µm OD x 20 µm 
ID; 10 µm tip. The capillary temperature was set to 300 °C and the applied spray 
voltage was 2.2 kV. The mass range of the full scan MS spectra was 300-1700 m/z. 
MS1 spectra were recorded in profile mode in the Orbitrap with a resolution of 
30,000. Lock mass correction was used for internal calibration using a background ion 
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at m/z 446.12003. The 15 most abundant parent ions were subjected to 
fragmentation by CID setting normalized collision energy of 40. Charge state 
screening was enabled with only multiply charged ions being selected for 
fragmentation.  
6.3.9.4. Data analysis 
Raw data were processed with PD software. The MS2 spectra were filtered with 
a Top N peaks filter set to 6 with a 100 Da mass window. The resulting data was 
searched against the Uniprot dog database (26,106 sequences) and against a database 
consisting of the Uniprot human database and common contaminants (86,945). The 
search algorithm applied was Mascot version 2.2 (Matrix Science). The search 
parameters were 2 missed cleavages with trypsin as enzyme; a mass tolerance of 20 
ppm for MS1 and 0.5 Da for MS2. As fixed modification, carbamidomethylation as a 
fixed modification for cys and oxidation on methionine were chosen. Phosphorylation 
on serine, threonine and tyrosine as variable modifications. A false discovery rate of 1 
% was calculated by the percolator algorithm that is implemented in PD. 
Quantification was also done with PD with a mass precision set to 2 ppm and the 
quantification spectra of all peptides of any PRL isoform were checked manually. 
 
6.3.10. MS-based phosphoproteomics in 3D MDCK cysts upon PRL-3 
overexpression (collaboration with Dr. Marco L. Hennrich from Dr. 
Anne-Claude Gavin’s group, EMBL) 
1x106 3D MDCK cysts and 3D MDCK stably overexpressing GFP-PRL-3 WT 
and GFP-PRL-3 C104S cysts were treated with 0.25 % (v/v) trypsin, centrifuged at 
1000 RPM for 3 minutes at room temperature to remove the BD MatrigelTM. Then, 
cells were lysed to extract the protein content that was digested and labeled as 
described in section 6.3.9.1. After that, samples were enriched for phosphopeptides in 
a homemade TiO2-packed column. The sample was washed with 6% TFA to remove 
unspecific binding and the elution was done under alkaline conditions using 25 % 
(v/v) NH3 pH 10 solution. The elution was then immediately neutralized with 0.1 % 
(v/v) CH2O2 in water to prevent alkaline hydrolysis of the phosphoesters on serine 
and threonine. The elution and the flow through (corresponding to the none 
phosphorylated peptides) were analyzed on a nanoflow LC-MS/MS platform as 
described in section 6.3.9.3. The data was analysed as explained in section 6.3.9.4. 
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6.3.11. Cell proteome dephosphorylation by λ-phosphatase 
MDCK cells were cultured on a 10 cm culture dish and grown up to 90-95 % 
confluence. On ice: Culture medium was aspirated, cells were rinsed with ice-cold 
PBS, lysed with 500 µL ice-cold λ-phosphatase lysis buffer and subsequently lysate was 
scraped out with a sterile spatula and collected in a 1.5 mL Eppendorf tube. Cell 
lysate was passed through a blunt 20-gauge needle (0.9 mm diameter) fitted to a 
syringe and centrifuged at maximum speed for 15 minutes at 4 °C. The supernatant 
was then collected and subjected to total protein determination concentration using 
Bradford reagent following the manufacturer’s instructions. 15 µL of sample 
containing 2 µg/µL was then used for the assay. 2 µL λ –phosphatase buffer 10x, 2 µL 
MnCl2 and 1 µL λ –phosphatase were added to the sample and incubated for 30 
minutes at 37 °C. 6.7 µL of SDS sample buffer 4x were added to stop the reaction and 
loaded on a pre-casted Nu-PAGE 4-12 % Bis-Tris SDS gels and proceeded as 
describe in section 6.3.7. 
 
6.3.12. In vitro phosphatase activity assays 
6.3.12.1. EnzChek Phosphatase Assay 
Peptide dephosphorylation by PRL-3 was quantified using the EnzChek 
Phosphate Assay kit. The reaction was carried out in a total volume of 50 µL 
containing: 6 µM PRL-3, 100 µM – 1 mM peptide, 10 µL MESG (fluorogenic 
substrate), 0.8 µL PNP (conjugated enzyme), 10 mM DTT, kit buffer 20x and water. 
100 µM PI(4,5)P2 diC8 was used as a positive control. Kinetics were followed 
measuring absorbance at 360 nm every 20 s at 37 °C for 2 hr.  
6.3.12.2. BIOMOL® Green Assay 
Peptide dephosphorylation by PRL-3 was also quantified using the BIOMOL® 
Green Assay kit as an end-point free phosphate quantification approach. The reaction 
was carried out in a total volume of 100 µL containing: 6 µM PRL-3, 100-500 µM 
peptide, 200 mM NaCl, 10 mM DTT and water. After given time points, the reaction 
carried at 37 °C was stopped adding 1 mL of the BIOMOL® Green reagent and 
incubated for 30 minutes at room temperature. 100 Then, fluorescence was measured 
at 620 nm. In order to quantify free phosphate concentration in each sample, a 
	  	   	   	  
	   6.	  Material	  and	  methods	   	  	   	  
150	  
phosphate titration was performed in the same buffer with a scale of serial dilutions of 
H3PO4 from 0 to 2 µM.  
 
 6.3.13. Polysome fractionation 
6.3.13.1. Gradient preparation 
Sucrose solution must be the maximum time possible on ice. Light sucrose 
solution was carefully added in a Polyallomer 14x95 mm (BeckmanCoulter) centrifuge 
tube up to the middle line. Heavy sucrose solution was loaded in a syringe with a long 
needle attached to fill the centrifuge tube from the bottom until the middle line. The 
tube was closed carefully to avoid bubbles, and the tube was placed in the sucrose 
mixer, which was set to generate a gradient from 20-50 %.   
6.3.13.2. Sample preparation 
MDCK GFP-PRL-3 WT cells were cultured on a 10 cm culture dish and grown 
up to 90-95 % confluence. Prior to cell lysis, live cells were treated with 100 µg/mL 
CHX for 30 minutes at 37 °C in a humidified atmosphere containing 5 % CO2 to 
block transcription linking the ribosome to the transcribed mRNA. Working on ice, 
medium was aspirated, the cells were rinsed with ice-cold 100 µg/mL CHX-
containing PBS, scraped out with a sterile spatula and centrifuged at 1200 RPM for 5 
minutes at 4 °C. Cell pellet was resuspended in 175 µL RSB buffer 1x containing 0.5 
% RNasin and 175 µL polysome extraction buffer was added to lyse the cells and 
incubated for 10 minutes. Samples were spinned for 10 s to pellet the nuclei and 
supernatant was centrifuged at maximum speed for 10 minutes at 4 °C. The 
supernatant was then collected and subjected to total protein determination 
concentration using Bradford reagent following the manufacturer’s instructions. 2 mg 
protein was loaded on top of the sucrose gradient and the centrifuge tube was firmly 
closed and placed in the SW40Ti rotor. Samples were ultracentrifuged at 350,000 
RPM for 2 hr and 39 minutes at 4 °C.  
6.3.13.3. Fraction collection 
1 mL sample fractions are collected in 1.5 Eppendorf tubes from the bottom of 
the tube using the pump of the ÄKTA protein purification system and an absorbance 
detector at 254 nm and 280 nm to determine in which fraction the polysomes are 
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contained. After that, all polysome fractions and all free mRNA fractions are pooled 
together for RNA extraction (see section 6.2.3.) to perform an RT-PCR (see section 
6.2.4.) to analyze specific mRNA content in each pool. Renilla mRNA was added 
prior to RNA extraction as an internal standard. 
 
6.3.14. Cell cycle analysis  
MDCK cells were treated with 2 μM ZM447439 during 48 hr before the assay. 
Cell cycle analysis in treated and untreated MDCK by flow cytometry was performed 
as described previously (Schmid and Sakamoto, 2001). Briefly, MDCK cells were 
resuspended in MEM culture medium without phenol red to a final concentration of 
2.6x106 cells/mL. 30 μg/μL of Hoechst 33342 was added to the cell suspension and 
the incubation was carried out for 45 minutes at 37 °C. Finally, DNA content was 
measured by flow cytometry in the LSR-Fortessa bench top analyzer. Data was 
analyzed with FlowJo software. 
 
6.3.15. Abscission timing measurement 
Measurement of cytokinesis duration was carried out in 2D non-polarized 
MDCK cells. mCherry-AuroraB was electroporated to stain the cleavage furrow and 
cells were seeded on an 8-chambered glass bottom dish. Pictures were taken every 10 
minutes during 24 hr in Olympus-ScanRcube5 microscope with an incubation 
chamber able to monitor the temperature at 37 °C in a humidified atmosphere 
containing 5 % CO2. Time between cytokinetic bridge formation and complete 
abscission was quantified. 
 
 
6.4. Methods applied in chapter 4 
6.4.1. Plasmid cloning 
Molecular cloning was performed as described in sections 6.2.4. – 6.2.9. pEGFP 
and pmKATE2 versions of 5-ptase were generated by EcoRI and BamHI restriction 
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sites incorporation by PCR using mRFP-FKBP12-5-ptase ΔCaaX (provided by Dr. 
Giulia Varsano) as a template. The 5-ptase C’-terminal CaaX motif was also 
incorporated in the reverse primer. The same PCR product was useful for both 
plasmid vectors since they share the same multi restriction site. The primer pair used 
was: 5’-AATCGGAATTCAATGCCGTC-3’ and 5’-CGGGATCCTCAAGAAAC 
GGAGCAGCTGGTGCTG-3’. pmKATE2-PRL-1 WT was subcloned from 
pEGFP-PRL-1 WT (provided by Dr. Pablo Rios) using the EcoRI and BamHI 
restriction sites included in the multiple cloning site of both vectors. mRFP-NES-
FKBP12-PRL-3 E50R ΔCaaX was generated by HindIII and BamHI restriction sites 
incorporation by PCR using pmKATE2-PRL-3 E50R as a template. The CaaX motif 
was also removed in the PCR. The primer pair used was: 5’-ATCAAGC 
TTATGGCTCGGATGAACCGCC-3’ and 5’-CGGGATCCCTACCGGGTCTTG 
TGCGTGT-3’. BFP-PIP5Kα was made by BglII and SalI restriction sites 
incorporation by PCR using pWZL-Neo-Myr-Flag- PIP5Kα (purchased from 
Addgene #20580) as a template. The primer pair used was: 5’-AGTAGA 
TCTATGGCGTCGGCTCCTCC-3’ and 5’-TCAGTCGACTTAATGGGTGAA 
CTCTGACTCT-3’. pmKATE2-PRL-3 F160 KRas was subcloned from pEGFP- 
PRL-3 F160 KRas (provided by Dr. Pablo Rios) by digestion with EcoRI and BamHI 
restriction enzimes from pEGFP and transferred into pmKATE2 vector by ligation.  
 
6.4.2. PRL-3 localization in HeLa cells followed by confocal 
microscopy  
HeLa cells were cultured on a 10 cm culture dish and grown up to 100 % of 
confluence. Cells were trypsinized and diluted 1/100. 250 μL of diluted HeLa cells 
were then plated in 4 wells from an 8-chambered glass bottom dish. 24 hr after, cells 
were transfected with pEGFP-PRL-3 WT plasmid with FugeneHD (see section 6.2.2.). 
24 hr later, medium was replaced with 100 μL fresh HeLa culture medium without 
phenol red containing 100 μM dynasore, 25 μg/mL nystatin or the equivalent volume 
of DMSO depending on the sample condition. After 1 hr incubation, another 100 μL 
fresh HeLa culture medium without phenol red containing 100 μM dynasore, 25 
μg/mL nystatin, 20 μM BFA, 20 μM BFA + 100 μM dynasore, 20 μM BFA + 25 
μg/mL nystatin or the equivalent volume of DMSO depending on the sample 
condition were added. Immediately after adding it, several pictures were taken for 
each condition every 30 minutes during a 90 minutes period. PerkinElmer Ultraview 
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VoX microscope equipped with a Plan-Apochromat 63x 1.4 NA objective and an 
incubation chamber able to monitor the temperature at 37 °C in a humidified 
atmosphere containing 5 % CO2 was used for the experiment.  
To quantify GFP-PRL-3 WT translocation from the plasma membrane to the 
cytosol upon cell treatment, the ratio of GFP fluorescence intensity between both 
compartments was measured with Fiji software. Firstly, background subtraction 
(rolling ball radius = 25) and 1 pixel median filters were applied. Then, pixel intensity 
threshold was used to segment PM and cytosol independently. Finally, mean 
fluorescence intensity in each compartment was measured and the ratio was 
calculated.    
 
6.4.3. Transferrin uptake assay by flow cytometry  
HeLa, HCT116 or MCF-7 cells were seeded in 10 cm culture dish and 
phosphatase sequence-containing plasmid or PRL-3 siRNA were transfected or 
shRNA expression was induced according to section 6.2.2. When the cell culture in 
the dish was grown up to 95-100 % confluence, culture media was aspirated and cells 
were rinsed twice with its corresponding pre-warmed SFM. 7 mL of SFM were then 
added to the cells and incubated for >30 minutes at 37 °C in a humidified atmosphere 
containing 5 % CO2. SFM was aspirated, cells were rinsed with PBS and trypsinized 
with 1 mL 0.5 % (v/v) trypsin and collected in SFM as a single cell suspension that 
was split in 8 1.5 mL Eppendorf tubes. The following steps were carried out always on 
ice: Cells were centrifuged at 1000 RPM for 3 minutes at 4 °C, supernatant was 
discarded and pellet was resuspended in 100 μL ice-cold SFM containing Alexa 
Fluor® 633-transferrin. The mixture was incubated for 10 minutes at 4 °C prior to 
different incubation times at 37 °C to activate the endocytic machinery. Cells were 
centrifuged at 1000 RPM for 3 minutes at 4 °C, the supernatant was discarded, and 
the pellet rinsed once with 150 μL ice-cold SFM + once with 150 μL ice-cold PBS + 
twice with 150 μL ice-cold acidic buffer + once with 150 μL ice-cold PBS. Cells were 
finally resuspended in 200 μL ice-cold PBS with 1 μg/mL DAPI when only 1 
fluorescently tagged protein was overexpressed or 1 μg/mL PI when 2 fluorescently 
tagged proteins were overexpressed. Samples were filtered with a 70 μm strainer and 
loaded into the proper cytometry tube. Internalized Alexa Fluor® 633-transferrin was 
quantified by flow cytometry in a LSR-Fortessa bench top analyzer and data was 
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analyzed with FlowJo software. 
The same procedure was realized to see transferrin internalization by confocal 
microscopy directly on an 8-chambered glass bottom dish where no cell suspension is 
required. 
 
6.4.4. LacCer uptake assay by flow cytometry  
HeLa cells were cultured on a 10 cm culture dish and grown up to 95-100 % 
confluence. Culture medium was aspirated, cells were rinsed with PBS and trypsinized 
with 1 mL 0.5 % (v/v) trypsin and collected in 10 mM HEPES containing MEM 
culture medium (HMEM) as a single cell suspension that was splited in 8 1.5 mL 
Eppendorf tubes. The following steps were carried out always on ice: Cells were 
centrifuged at 1000 RPM for 3 minutes at 10 °C, supernatant was discarded and 
pellet was rinsed once with 150 μL ice-cold HMEM. Cells were resuspended in 50 μL 
ice-cold HMEM containing BODIPY® FL C5-LacCer and the mixture was incubated 
for 30 minutes at 10 °C. Cells were centrifuged to discard free LacCer at 1000 RPM 
for 3 minutes at 4 °C and rinsed once with 150 μL ice-cold HMEM. Cells were 
resuspended in 100 μL ice-cold HMEM and incubated at 37 °C for different time 
points. Endocytosis was stopped cooling down the samples that were rinsed once with 
HMEM. Then, cells were resuspended in ice-cold 5% (w/v) defatted (DF)-BSA-
containing HMEM, incubated for 10 minutes at 10 °C, centrifuged at 1000 RPM for 
3 minutes at 10 °C and the supernatant was removed. This step was repeated 5 times. 
Cells were rinsed once more with ice-cold PBS prior to resuspend them in 200 μL ice-
cold PBS with 1 μg/mL DAPI. Internalized BODIPY® FL C5-LacCer was quantified 
by flow cytometry in the LSR-Fortessa bench top analyzer and data was analyzed 
with FlowJo software. 
The same procedure was realized to see transferrin internalization by confocal 
microscopy directly on an 8-chambered glass bottom dish where no cell suspension is 
required. 
 
6.4.5. TIRF acquisition  
HeLa, HCT116 or MCF-7 cells were seeded in 35 mm MatTek and 
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phosphatase sequence-containing plasmid or PRL-3 siRNA were transfected or 
shRNA expression was induced according to section 6.2.2. Moreover, 24 hr prior to 
TIRF microscopy picture acquisition, cells were transfected with mEmerald-CLTB as 
a reporter of CCPs. 24 hr after DNA transfection, 48 hr after siRNA transfection or 4 
days after shRNA expression induction, pictures from the cellular plasma membrane 
in contact with the cover glass were recorded with an Olympus Cell^R multi-color 
TIRF microscope equipped with an UAPON 100XOTIRF 1.49 NA objective and an 
incubation chamber able to monitor the temperature at 37 °C in a humidified 
atmosphere containing 5 % CO2. Pictures were taken every 5 s during 8 minutes and 
20 s (100 time points). The parameter required for CCP analysis that can be extracted 
from these data is the CCP lifetime and it was quantified using the “particle tracking” 
plugin of Imaris software. Data was filtered according to: estimate XY diameter = 
0.65 μm; quality = 500 a.u.; Brownian motion consideration with a maximum 
distance of 0.6 μm and a maximum gap size of 2 frames; track duration = 5-490 s and 
track intensity maximum mEmerald-CLTB > 4000 a.u. 
CCP lifetimes were distributed between abortive (< 30 s) and productive (30-
180 s) pits, as well as plaques (> 180 s). Percentages of CCPs in each population were 
represented as population distribution and the mean of each population was plotted 
ad CCP lifetime. Pearson correlation between CLTB and the phosphatase 
overexpressed was measured in a region of the area of plasma membrane in contact 
with the cover glass without any major shape artifacts that could lead to false 
correlation. Finally, the amount of CCPs formed was divided per cell surface area in 
contact with the cover glass and time to measure CCP density. 
 
6.4.6. Microsomal fractionation for nuclei extraction in HeLa cells  
HeLa cells were seeded in 24.5 x 24.5 cm squared culture plate and grown up to 
90-95 % confluence. The following steps were carried out always on ice: Culture 
medium was aspirated, cells were rinsed twice with 10 mL ice-cold PBS, and 
harvested in 12 mL ice-cold PBS using a sterile spatula. Cells were pelleted by 
centrifugation at 500 g during 5 minutes at 4 °C and rinse one more time with 10 mL 
ice-cold PBS. Then, hypotonic lysis was carried out resuspending the cell pellet in 7.5 
mL ice-cold 50 mM Tris pH 7.5 and incubating for 30 minutes at 4 °C. Cell swelling 
was checked under vertical microscope and extra incubation time was applied if 
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required. Plasma membrane of swollen cells was disrupted with a Dounce 
homogenizer. The amount of strokes required depends on the lysis efficiency that 
must be checked under microscope. Sample is finally centrifuged at 1000 g during 13 
minutes at 4 °C to discard free nuclei and intact cells.  
 
6.4.7. PI(4,5)P2 detection with specific antibody 
(immunofluorescence)   
HeLa cells seeded in an 8-chambered glass bottom dish were rinsed twice with 
PBS and different fixation and permeabilization condition were tested. For fixation 
cells were treated with: 4 % (w/v) PFA for 30 minutes, methanol for 5 minutes at -20 
°C, or ice-cold acetone for 2 minutes. Then cells were permeabilized with either 0.3 
or 0.05 % (v/v) Triton X-100 in PBS for 10 minutes. Then, immunofluorescence was 
finished as described in section 6.3.3.  
 
6.4.8. PI(4,5)P2 detection with specific interacting PH-PLCδ by life-
cell confocal microscopy  
HeLa, HCT116 or MCF-7 cells were seeded in an 8-chambered glass bottom 
dish. pmKATE2 plasmid containing the sequence of the phosphatase of interest or 
PRL-3 siRNA were transfected or shRNA expression was induced together with GFP-
PH PLCδ plasmid according to section 6.2.2. 24 hrs after transfection, cells were 
mock treated or treated with 50 μM wortmannin added to fresh culture medium 
without phenol red. 1 hr after treatment, pictures are taken in a PerkinElmer 
Ultraview VoX microscope equipped with a Plan-Apochromat 63x 1.4 NA objective 
and an incubation chamber able to monitor the temperature at 37 °C in a humidified 
atmosphere containing 5 % CO2. 
To quantify GFP-PH PLCδ attachment to the plasma membrane, the ratio of 
GFP fluorescence intensity between both compartments was measured with Fiji 
software. Firstly, background subtraction (rolling ball radius = 50) and 1 pixel median 
filters were applied. Then, pixel intensity threshold was used to segment PM and 
cytosol independently. Finally, mean fluorescence intensity in each compartment was 
measured and ratio calculated. 
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Gene Name Ratio 
CSTF1 0.012 
PSAP 0.026 
WDR74 0.041 
FOLR2 0.043 
UBR4 0.054 
UBE2M 0.063 
OTUB1 0.073 
FTH1 0.074 
PFKP 0.075 
COG6 0.086 
HDGF 0.092 
CASP8 0.117 
SUPV3L1 0.117 
UFC1 0.117 
COQ2 0.122 
TPT1 0.124 
SULT1A1 0.129 
ETF1 0.144 
SNX2 0.152 
ANXA4 0.157 
GRN 0.165 
SNCG 0.170 
PSIP1 0.172 
UBAP2 0.172 
DKC1 0.176 
CLIC4 0.186 
NACA 0.190 
CASP10 0.194 
TBRG4 0.197 
PAFAH1B3 0.197 
EIF3H 0.202 
COPE 0.208 
HPRT1 0.210 
HYAL1 0.213 
Cfa.23622 0.214 
IPO5 0.222 
STIP1 0.227 
CMPK1 0.228 
RBM5 0.230 
CDK9 0.233 
GLUL 0.234 
LOC486100 0.236 
LOC491969 0.239 
GPI 0.241 
CTTN 0.248 
RRAGD 0.249 
IFI30 0.251 
CUL1 0.255 
AKT1 0.256 
PSME1 0.258 
DCUN1D1 0.260 
MCEE 0.265 
CARHSP1 0.267 
IL17RC 0.278 
ANXA11 0.283 
GLB1 0.285 
HMGCL 0.285 
KIAA0664 0.289 
PGK1 0.290 
FBP2 0.297 
TPI1 0.304 
FMO5 0.305 
HPF1 0.310 
PGD 0.313 
RPS21 0.316 
CLIC1 0.317 
ANXA10 0.318 
WARS 0.319 
PGAM1 0.324 
PRDX6 0.324 
TALDO1 0.325 
RNH1 0.325 
CTSB 0.325 
LNPEP 0.328 
RPIA 0.328 
PAFAH1B2  0.330 
CYLD 0.331 
SH3GL1 0.335 
PXDN 0.337 
CHCHD2 0.338 
MAPK8 0.343 
PTGES2 0.345 
ARPC5L 0.348 
TXN 0.350 
OSTF1 0.351 
BCAS2 0.361 
DAK 0.364 
ARHGDIA 0.367 
ERAP1 0.368 
SORL1 0.370 
ZCCHC8 0.372 
DYNLL1 0.374 
ANP32A 0.375 
DSTN 0.382 
RRS1 0.389 
CRYAB 0.392 
APEX1C 0.394 
CLIC2 0.398 
MUT 0.400 
DST 0.404 
CTCF 0.405 
SEC23A 0.408 
THOP1 0.412 
GOLT1B 0.413 
CCBL1 0.424 
NPEPPS 0.426 
CA2 0.428 
SEPHS1 0.428 
ANXA7 0.429 
LDHA 0.435 
GNB2L1 0.438 
NUP62 0.441 
TPP1* 0.442 
IPO7 0.454 
UQCRH 0.457 
MAN2B1 0.459 
LIPA 0.466 
ERC1 0.467 
PNPO 0.473 
GGCX 0.474 
CTNNBL1 0.475 
UPP1 0.477 
PDHX 0.481 
ADH5 0.484 
CDC42 0.486 
GPRC5C 0.486 
UBE2H 0.486 
COMMD2 0.489 
TPP1* 0.491 
NAGPA 0.493 
FAAH 0.498 
MBOAT7* 2.020 
GNA13 2.026 
TIMM50 2.039 
RPL18A 2.056 
GNA11 2.077 
OCLN 2.080 
GOLPH3 2.118 
LONP1 2.119 
ATP2A2 2.123 
TOR1AIP1 2.137 
SLC25A12 2.139 
MKI67 2.149 
CLPTM1L 2.152 
P4HA1 2.152 
RAB33B 2.160 
TBL2 2.184 
GNG12 2.198 
CD47 2.206 
HSD3B7 2.209 
IK 2.224 
LMNB2 2.227 
COX7A2L* 2.228 
GRAMD3 2.229 
PYCR1 2.231 
TRPA1 2.231 
LMAN1 2.235 
RPL6 2.240 
CEBPZ 2.247 
NDUFA2 2.249 
SPTLC2 2.260 
RAVER1 2.273 
GLB1 2.280 
DHRS7B 2.308 
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RAB18 2.331 
UBE2C 2.346 
FBL 2.361 
SLC3A2 2.363 
RBM14 2.370 
SLC35F2 2.379 
RBMX 2.463 
ACOT13 2.468 
PRKAR1A 2.473 
MLEC* 2.475 
NOP2 2.496 
MCCC2 2.529 
MYO18A 2.544 
DAP3 2.569 
NAT10 2.578 
PRDX4 2.584 
PREB 2.590 
PYGB 2.685 
MYO5B 2.696 
NDUFS7 2.698 
MRPS27 2.712 
POLDIP2* 2.721 
USP39 2.727 
ERLIN1 2.729 
TIMM17B 2.732 
ATP6V1G1 2.771 
SEC61A1 2.797 
DNAJB1 2.805 
MYO1D 2.853 
MAGT1 2.853 
DDX54 2.868 
TMEM33 2.927 
MYO19 2.938 
NDUFS3 2.993 
SLC2A1 3.034 
ZMPSTE24 3.036 
SLC38A10 3.101 
RSU1 3.102 
VDAC3 3.108 
RBM12B 3.152 
POLDIP2* 3.200 
ESYT2 3.216 
PARL 3.240 
NDUFV1 3.242 
EBP 3.256 
CYP51A1 3.355 
ERP44 3.372 
REEP4 3.401 
DDX21 3.402 
ABCD3 3.432 
TMEM120A 3.482 
NDUFS2 3.544 
FNBP4 3.552 
SYVN1 3.628 
WDR36 3.641 
DNAJC11 3.645 
DNAJC10 3.651 
SSFA2 3.652 
PRPSAP1 3.686 
TMEM256 3.777 
MLEC* 3.816 
ATP13A1* 3.824 
CYB5R1 3.847 
PRKACB 3.883 
AKAP1* 3.913 
SQRDL 3.921 
ZNF598 3.943 
LSR 4.071 
TECR 4.109 
TMEM11 4.156 
SMARCB1 4.159 
OGT 4.184 
VTA1 4.206 
BMS1 4.319 
TMEM48 4.336 
ATAD3A 4.382 
SIGMAR1 4.405 
DHCR7 4.414 
GGTLA4 4.449 
SUPT16H 4.499 
EBNA1BP2  4.542 
DERL1* 4.565 
SF3B6 4.582 
PTCD3 4.608 
PTPLAD1 4.703 
DERL1* 4.724 
VPS13C 4.731 
DHCR24 4.772 
AKAP1* 4.783 
HINT2 4.806 
MRPS34 4.821 
SCD 4.882 
AIP 5.031 
LBR 5.049 
MBOAT7* 5.130 
BAG2 5.207 
RPL7L1 5.265 
GHITM 5.292 
SRP54 5.320 
RBM8A 5.612 
ATP13A1* 5.859 
COX7A2L* 6.017 
YIF1A 6.141 
MOGS 6.163 
GTPBP4 6.359 
MFSD10 6.379 
JAGN1 6.383 
LPCAT3 6.426 
SKIV2L 6.642 
GALNT2 6.808 
ND5 6.984 
PKP4 7.036 
NUP205 7.105 
RAB14 7.507 
CDS2 7.631 
GALK1 7.790 
TPD52L2  7.829 
SLC22A18 8.408 
NKRF 10.247 
EIF3K 10.685 
LARP1 12.441 
WDR46 12.648 
SDHC 12.681 
NFKB2 27.711 
PDCD10 41.076 
TMED5 100.000 
 
Table 1. Phosphorylated and dephosphorylated protein in 3D MDCK cysts upon PRL-3 WT 
overexpression. List of proteins obtained in the phosphoproteomic assay carried out in 3D MDCK cysts 
stably overexpressing GFP-PRL-3 WT compared to parental and GFP-PRL-3 C104S 
overexpressing MDCK cysts. Data was sorted according to the ratio between the phosphorylated 
protein in GFP-PRL-3 WT MDCK cysts and the phosphorylated protein in parental and GFP-
PRL-3 C104S MDCK cysts. Dephophosporylated proteins upon PRL-3 WT presence (red) have a 
ratio below 0.666 and proteins that showed an increment of their phosphorylation status upon PRL-3 
overexpression (blue) have a ratio over 1.5. (*) Hits shown in 2 replicates. The experiment was 
performed in triplicate. 
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